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Abstract 
A series of BODIPY dyes have been successfully synthesised and structurally characterised to 
examine the effect of halogenation at the 2,6-positions and the introduction of styryl and 
vinylene groups at the 3,5-positions. The photophysical properties were studied, to assess 
the effect of the enhancement of the rate of intersystem crossing through halogenation on 
the fluorescence properties and the generation of reactive oxygen species. This is important 
in the assessment of the suitability of applying these molecules as photosensitizer dyes for 
photodynamic therapy and photodynamic antimicrobial chemotherapy. Upon bromination, 
the dyes showed moderately high singlet oxygen quantum yields. The inclusion of BODIPY 
dyes into cyclodextrins was explored since it makes them water soluble and hence suitable 
for biomedical applications, but no singlet oxygen was detected in aqueous media for the 
inclusion complexes. 
In order to red-shift the main spectral band of the BODIPY dyes into the therapeutic 
window, styryl groups were introduced at the 3,5-positions via a modified Knoevenagel 
condensation reaction. Since the main spectral band lies well above 532 nm, the second 
harmonic of the Nd:YAG laser, there is relatively weak absorbance at this wavelength. The 
3,5-distyryl and 3,5-divinylene BODIPY dyes were assessed for their potential utility for 
application in nonlinear optics (NLO), and they demonstrated typical nonlinear absorption 
behaviour characterised by reverse saturable absorption (RSA) in z-scan measurements. 
Furthermore, the dyes possess excellent optical limiting parameters, such as their third-
order suspectibility and hyperpolarizability values, in a wide range of solvents. One dye 
containing dimethylamino moieties on styryl groups attached at the 3,5-positions was 
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assessed for potential application as an on/off fluorescence sensor. The dye proved to be 
successful, since intramolecular charge transfer in the S1 state was eliminated in the 
presence of acid and this results in a fluorescence “turn on” effect. This process was found 
to be reversible with the addition of a base. 
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Chapter 1:  
 Introduction 
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What BODIPY dyes are: discovery, structure and general properties 
Boradiazaindacenes or boron-dipyrromethene (BODIPY) fluorescent dyes consist of two 
pyrrole units linked by an interpyrrolic methene bridge, a boron atom and the heteroatoms 
bonded to the boron atom (typically a BF2 moiety).1–4 These dyes are structural analogues of 
porphyrins, hence the 8-position is typically termed the meso-carbon (Figure 1).5 The 
synthesis of these dyes was first described by Treibs and Kreuzer in 1968 after they were 
prepared when the acylation of 2,4-dimethylpyrrole with acetic anhydride and boron 
trifluoride as a Lewis acid catalyst resulted in the serendipitous formation of a highly 
fluorescent compound.6,7 
 
 
Figure 1. The numbering system of the BODIPY core. The 8-position is termed the meso-
carbon following the naming system of porphyrins. Reprinted with permission from 
reference 3; Copyright Royal Society of Chemistry, 2014.  
BODIPYs have been shown to have high fluorescence quantum yields (0.6–1.0), insensitivity 
to solvent polarity and pH changes, large extinction coefficients (60 000–80 000 M-1cm-1) 
and stability under common physiological conditions. These properties have led to research 
on a wide range of diverse applications.8 
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Synthetic routes towards the BODIPY core and possible structural modifications 
Typically, the synthesis of the BODIPY core (Figure 1) is based on an acid-catalysed 
condensation reaction between a pyrrole unit and a highly electrophilic carbonyl compound 
such as an acid anhydride, acyl chloride or an aldehyde, forming an unstable 
dipyrromethane which is immediately oxidised with 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) or p-chloranil to form a dipyrromethene.5 Finally, a boron atom is 
complexed by the dipyrromethene in the presence of a tertiary amine which provides basic 
conditions. To prevent polymerisation and porphyrin formation, the pyrrole used is typically 
substituted at the 3,5-positions adjacent to the nitrogen atom.5 In this study, 2,4-
dimethylpyrrole is used as a precursor to form a series of 1,3,5,7-tetramethylBODIPY dyes. 
The initial product formed through the condensation reaction with a carbonyl compound is 
normally referred to in the literature as a BODIPY core. 
In addition to synthesising substituted BODIPYs using a starting pyrrole with the functional 
groups of interest, post-synthetic structural modifications are possible because the BODIPY 
core is highly robust. The stability of the BODIPY core and the various structural 
modifications which can also be performed allow for the enhancement of selected 
properties depending on the potential application of the dye being synthesised. 
Spectroscopic properties such as absorption, fluorescence (including the fluorescence 
quantum yields) can be altered by the substituents present on the core.9,10 Various 
applications require different functional groups and properties, and these can also be 
introduced onto the starting pyrrole units, but the disadvantages of this approach are the 
long experimental times and low yields.6 
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Modifications to the structure can also be performed on the core subsequent to synthesis 
and purification. Among the various modifications, the following are possible: 
a. Modifications at the meso-position: The meso-position, which usually contains an aryl 
group is the most used for the introduction of specific functional groups. This is mainly 
because when there are methyl groups at the 1,7-positions as is the case with all of the 
BODIPY dyes in this study, the meso-aryl group lies orthogonal to the BODIPY core and 
as such this modification usually does not give rise to changes in absorption and 
emission bands, i.e. the spectroscopic properties are not affected because there is 
typically minimal interaction between meso-aryl substituents and the BODIPY core.3,9 
b. Electrophilic substitution: The 2- and 6-positions of the 1,3,5,7-tetramethylBODIPY core 
when they have no substituent attached, bear the least positive charge so they should 
be most susceptible to electrophilic attack (Figure 2).9 This substitution does not result 
in any additional changes to the BODIPY structure, especially to the B-F bond.5 
 
Figure 2. Possible positions for electrophilic attack. Reprinted with permission from 
reference 9; Copyright American Chemical Society, 2007.  
c. Modification of methyl groups at the 3- and 5-positions: Methyl groups at the 3,5-
positions can be modified, owing to their nucleophilic character, i.e. they can be 
deprotonated to give intermediates that readily add to electron-rich aromatic 
aldehydes, resulting in a styryl group.11 Sometimes this modification method is used for 
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extending the degree of π-electron conjugation; an approach usually applied in the 
production of dyes that absorb and fluoresce at longer wavelengths; typically in the 
near-infrared region (NIR).5 The most commonly used functional groups are phenyl, 
vinyl, or thiophene groups.5,12 
d. Cross-coupling and functionalisation using palladium-catalysed coupling reactions: A 
halogen atom on the BODIPY core or on an aryl ring can be used in palladium-catalysed 
coupling reactions, such as the Heck, Sonogashira, Stille, or Suzuki reactions.13 Similar to 
the electrophilic substitution reactions mentioned above, the B-F bonds remain intact.5 
e. Nucleophilic substitution of leaving groups: Typically, substituents on the 3- and 5-
positions come from substituted pyrroles which are used to synthesise the BODIPY of 
interest, but there has been a shift towards the use of good leaving groups such as 
chlorine atoms, i.e. leaving groups located on the 3- and/or 5-positions are 
nucleophilically substituted with functional groups like amines, alkoxides and 
thioalkoxides.9,10 The substitution may be at either of the positions or at both to give 
monosubstituted or disubstituted products, respectively.10 
f. Modifications at the boron centre: More recently, there has been a move to replace the 
fluorine atoms on the boron centre with various functional groups which are typically 
hard nucleophiles since this is a hard centre.6,14 
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Physicochemical properties 
The numerous processes that a BODIPY dye can undergo upon interaction with 
electromagnetic radiation can be visualised using a Jablonski diagram (Figure 3).  
 
Figure 3. Jablonski diagram of possible electronic transitions. These include a transition from 
the ground state (S0) to the second excited state (S2), internal conversion (IC), fluorescence 
from the first excited state (S1) to ground state (S0), intersystem crossing (ISC) from the first 
excited state (S1) to the first excited triplet state (T1) and phosphorescence from the first 
excited triplet state (T1) to ground state (S0). Excitation can also access other nth electronic 
states, exciting the molecule to higher Sn excited states.15 
When a photon is absorbed, an electron is promoted to an Sn excited state, and it then 
relaxes to the lowest vibrational level of the S1 state through internal conversion and 
eventually relaxes to the ground state by releasing a photon via fluorescence (Figure 3). 
Rapid internal conversion ensures that Kasha’s rule is obeyed.16,17 This rule states that the 
fluorescence (a photon emission process) usually only occurs from the lowest vibrational 
level of the S1 state (lowest excited state). The presence of a heavy atom on the BODIPY 
enhances intersystem crossing to the T1 state due to the heavy atom effect which promotes 
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spin-orbit coupling. A photon in the T1 state can be emitted via phosphorescence (a lower 
energy process relative to fluorescence). Energy transfer from the T1 state to ground state 
molecular dioxygen can occur, producing radicals and other reactive oxygen species, among 
which is singlet oxygen which is utilised in some applications of BODIPYs.5,18–20 
Absorption spectra of BODIPY dyes 
Unfunctionalised BODIPY dyes typically absorb in the 490–520 nm region and are usually 
resistant to changes in pH and solvent polarity because they are zwitterionic molecules.21 
Their absorption spectrum is dominated by a single absorption band that arises from the S0 
to S1 transition, whereas a shoulder band appears around 475–485 nm due to a vibrational 
overtone. Typically, a weaker absorption band observed in the 300–400 nm region is 
associated with the S0 to S2 transition.3  
Applications of BODIPY dyes 
Although Treibs and Kreuzer noted in the late 1960s that these compounds have intense 
absorbance around 500 nm and are highly fluorescent, there was minimal research activity 
on them until relatively recently. Interest in their possible use in applications has increased 
enormously over the past three decades.5,7,22 Common research areas include 
chemosensing, fluorescent labelling of biomolecules, lasers dyes, cellular imaging, 
photodynamic therapy (PDT), biolabels and light harvesting systems.1,8,23–28 The applications 
of interest to this thesis are listed below. 
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1. Photodynamic therapy 
Cancer is defined as a disease characterised by an uncontrolled growth and spread of body 
cells as a result of damages to genetic material, which in most instances is DNA.29 This 
damage, in turn leads to tumours which may be treated by surgical removal, through 
chemical drugs or chemotherapy and/or the use of radiation if there are remaining cancer 
cells after surgery.29 During chemotherapy, the drugs are distributed via the circulatory 
system and accumulate in body cells, especially abnormal cells, tumours and cancer cells.29 
Radiation therapy relies on high energy ionisation particles in the form of x-rays, gamma 
rays or electrons.29 As successful as these treatments have been, they have their limitations 
and disadvantages. Some of the limits and trade-offs of these treatment techniques are: 
 The failure of surgery to remove non-accessible tumours such as non-primary 
tumours and those located in vital or poorly accessible tissues.29,30 
 Radiation damages healthy cells close to the cancer cells or in the path of the 
radiation beam.29 
 The reproductive life of patients may be compromised as a result of chemotherapy 
and/or radiotherapy.31 
The limits listed above are some of the reasons that have resulted in new therapeutic 
approaches and the development of those which exist but are under-researched or are not 
given priority. One of these is PDT, which is a cancer treatment technique which uses light, 
oxygen and a photosensitizer (PS) dye. During PDT treatment, the PS is administered onto 
the targeted tumour(s) which are then irradiated with light of appropriate wavelength, 
allowing the PS to generate reactive oxygen species (ROS) which kill cells via apoptosis or 
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necrosis.32,33 This is because the PS selectively localises in tumours as a result of leaky 
tumour blood vessels due to neovascularization and the absence of lymphatic drainage, a 
phenomenon known as the enhanced permeability and retention (EPR) effect.33 PDT 
destroys cancer cells either by inducing direct cytotoxic effects on the cells, damage to the 
tumour vasculature or by induction of a robust inflammatory reaction that can lead to the 
development of systemic immunity.33 This depends on factors such as the type and dose of 
PS used, the time between PS administration and light exposure, total light dose, its fluence 
rate and tumour oxygen concentration.33 
The main ROS of interest in PDT is singlet oxygen. PDT occurs in a two-step process, where 
the photosensitizer absorbs a photon of light in the ground state which promotes the PS to 
the short-lived excited singlet state. The singlet excited state may decay to the ground state 
via the emission of a photon, a process known as fluorescence.34 Apart from fluorescence, 
the PS molecule can also undergo intersystem crossing from the excited singlet state to the 
more stable, long-lived triplet excited state.34 In the triplet state, the PS can undergo 
radiationless decay to the ground state or transfer its energy to molecular oxygen (O2), 
which has a triplet ground state. The transfer of energy to oxygen generates singlet oxygen 
which is toxic, through what is termed a type II process. In a type I process, the PS reacts 
directly with an organic molecule in a cellular environment, acquiring a hydrogen atom or an 
electron to form reactive species, such as a superoxide, hydrogen peroxide or hydroxyl 
radicals.33 Some of the advantages of PDT over the traditional therapies mentioned above 
are: 
 In 2011, of all the PSs that were clinically approved, none accumulates in cell nuclei, 
and as such, no DNA damage that could be carcinogenic occurs.33 
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 The adverse effects of chemotherapy and radiotherapy are absent.33  
 PDT procedures can be performed in an outpatient or ambulatory setting, thereby 
making the treatment patient-friendly.33  
 The success of PDT is recognised even by the United States of America’s Food and Drug 
Administration (FDA) which approved it for neoplastic and non-malignant diseases 
even though it lacks popularity and remains clinically underutilised.33 
Light Sources used in PDT 
In PDT, blue light is not efficient because it fails to penetrate through tissue.33 Red and 
infrared radiations are the most efficient since light of 600 to 1200 nanometers (nm) 
wavelength is known as the optical window of tissue. Light of the appropriate wavelength 
can be generated from lasers and incandescent light sources, with diode lasers more 
preferable when compared to pumped dye lasers as a result of their small size, cost-
effectiveness and longer operational life.33 
BODIPY dyes in PDT 
Photosensitizers are typically defined as “organic delocalised aromatic molecules consisting 
of large conjugated systems of double bonds that may be considered as a central 
chromophore with auxiliary side chains attached (auxochromes) which are responsible for 
further electron delocalisation of the PS thus altering the absorption spectra of the PS”.35 
This electron delocalisation gives PSs their deep colour. Furthermore, electron delocalisation 
causes the energy required to excite the electrons in the HOMO to the LUMO to be low 
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compared to less delocalised molecules, hence PS absorption bands are in the longer 
wavelength (red) spectral region and ideally are very intense. 
The traditional PSs for the treatment of cancer are mostly based on the tetrapyrrole 
nucleus, with porphyrins at the forefront. Due to their unfavourable absorption spectrum in 
the 630 nm region, however, porphyrins were replaced with other tetrapyrroles such as 
chlorins, bacteriochlorins, and phthalocyanines due to their more intense absorption peaks 
at longer red wavelengths.36 The versatility of the BODIPY core allows modifications that 
enable the dyes to: (i) undergo intersystem crossing to the triplet state, hence generating 
singlet oxygen, (ii) have their main spectral band shifted to longer wavelengths so as to 
absorb light in the NIR region and (iii) possess π-conjugated systems. This has opened 
avenues for research as potential PDT agents.28  
The most important properties of a useful PS agent are: 
 It should be a single pure compound to allow quality control analysis.33 
 Its manufacturing costs must be low and it must be stable in storage.33 
 It should have a high absorption peak between 600 and 800 nm since long-wavelength 
photons do not provide enough energy to excite oxygen to its singlet state and 
subsequently lead to the formation of sufficient ROS.33,37 
 It should have no dark toxicity and relatively rapid clearance from normal tissues, 
thereby minimising phototoxic side effects.33,38 
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2. Achieving water solubility of BODIPY dyes 
There are various methods which can be utilised to achieve water solubility in BODIPY dyes. 
Among these, the incorporation of suitable functional groups such as sulfonates and 
quaternised amines; but in this thesis, the focus will be on cyclodextrin (CDx) inclusion to 
induce water solubility. Cyclodextrins are also known as cycloamyloses, cyclomaltoses or 
Schardinger dextrins and they are cyclic oligosaccharides with a diameter of 5–8 Å; they are 
made up of six (α-cyclodextrin), seven (β-cyclodextrin), eight (γ-cyclodextrin) or more 
glucopyranose units linked by α-(1,4) bonds.39–45 The chair conformation of the 
glucopyranose units gives the cyclodextrins a truncated cone or torus shape.42–44 α-, β and γ-
Cyclodextrin are known as the first generation or parent cyclodextrins.39–41 Cyclodextrins 
were first discovered in 1891 by A. Villiers, a French scientist as a result of isolating a 
bacterial digest from starch and the first isolate was labelled as a dextrin named 
cellulosine.42,46 This was followed by Franz Schardinger’s isolation of two crystalline 
compounds from a bacterial digest of potato starch which he named α-dextrin and β-
dextrin, with the latter referred to as Villiers' cellulosine.42,47 Schardinger was also able to 
isolate an organism, Bacillus macerans, capable of producing acetone and ethyl alcohol from 
sugar and starch-containing plant material, which also produced dextrins from starch.40,48 
The discovery of γ-cyclodextrin came at a later stage as a result of work by Freudenberg and 
Jacobi, in 1935.49 Although only α-CDx, β-CDx and γ-CDx and some of their derivatives are 
available in the market as white crystalline powders, there were other cyclodextrins 
discovered, particularly those referred to as large ring cyclodextrins (LR-CDs).41–43 Their 
production was later described to be as a result of an “intramolecular transglycosylation 
reaction from degradation of starch by cyclodextrin glucanotransferase (CGTase) enzyme”.48  
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Ability to form complexes and description of process of complex formation 
There is one particularly important feature which makes cyclodextrins interesting research 
compounds for drug-related research, and that is their ability to form inclusion complexes 
with several compounds irrespective of whether they are in the solid, liquid or gaseous 
phase.44 For this reason, the pharmaceutical, food, biotechnological, environmental 
protection, bioconversion, chemical, textile and cosmetic industries apply cyclodextrins in 
many of their products.41,47,50–61 From the X-ray structures which were first elucidated in 
1942, the cyclodextrins’ secondary hydroxyl groups are located on the wider edge of the 
ring, and the primary hydroxyl groups are on the other edge, whereas the apolar hydrogens 
and ether-like oxygens are on the inside.42,44,47,55,62,63 Such an arrangement gives 
cyclodextrins a hydrophilic outer surface and a hydrophobic internal cavity, with the former 
affording them their water solubility.40,63  
Because the polarity of the cyclodextrin cavity is similar to that of an aqueous ethanolic 
solution, a hydration shell develops when the cyclodextrin is dissolved in aqueous 
media.42,47,64–67 When a guest is present, the hydrophobic cavity accommodates the 
hydrophobic guest molecules, thereby forming inclusion complexes and conferring a certain 
degree of solubility onto the guest molecule which would otherwise be insoluble in aqueous 
media.40 In this way, each cyclodextrin molecule can accommodate one or two guest 
molecules, or inversely, portions of a guest molecule can be entrapped by one, two or three 
cyclodextrins.40 The process of complex formation between cyclodextrin and a guest 
molecule is a dimensional fit between the host cavity and the guest, with the lipophilic 
cavity of each cyclodextrin molecule providing a microenvironment which can only 
accommodate appropriately sized guests.44 During this process, there are no covalent bonds 
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broken or formed and instead what occurs is the release of enthalpy-rich water molecules 
from the cavity which are included in the cyclodextrin cavity and are present in this part of 
the molecule in crystal structures due to crystallisation of the cyclodextrins from aqueous 
media.41 These are displaced as a result of the presence of more hydrophobic guest 
molecules. This is favoured because it reduces the cyclodextrin ring strain resulting in a 
more stable lower energy state due to the apolar-apolar association formed.48,68 
Although cyclodextrins are popular for their water solubility, this is dependent on 
temperature, and this means that they are usually not highly soluble under all conceivable 
circumstances. An obvious example is β-CDx which is less soluble than both α-CDx and γ-CDx 
at low temperatures, with their respective aqueous solubilities improving at higher 
temperatures.41 This temperature dependent solubility tends to be lost in inclusion 
complexes because if the guest is highly soluble in water, the solubility of the inclusion 
complex increases whereas the opposite is also true for poorly water-soluble guests.41 To 
improve the solubility, inclusion capacity/hydrophobic cavity volume, stability and other 
relevant properties observed in natural cyclodextrins, chemically modified cyclodextrin 
derivatives are usually synthesised.41,47,55,62,69,70 The low solubility of naturally occurring 
cyclodextrins is attributed to the relatively strong intramolecular hydrogen bonding in the 
crystal lattice and the most common modifications to increase solubility are aminations, 
esterifications or etherifications of primary and secondary hydroxyl groups of the 
cyclodextrins.40,42  
Toxicological considerations 
The application of cyclodextrins in the medical field has advanced to the point that there are 
multiple drug formulations on the market, based on both solid and solution-based 
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cyclodextrin complexes, wherein the cyclodextrins increase the aqueous solubility of poorly 
water-soluble drugs.42,71–76 In addition to being carriers for poorly soluble drugs, 
cyclodextrins are also used to reduce side effects such as gastrointestinal and ocular 
irritation, unpleasant smells and tastes and unwanted interactions between drugs.42,77,78 
Because of their large molecular weights ranging from about 1000 to 2000 Da; hydrophilicity 
with a significant number of H-donors and acceptors means that they are not easily 
absorbed from the gastrointestinal tract in their intact form and the inability of human 
salivary and pancreatic amylases to hydrolyse  α-CDx and β-CDx (unlike γ-CDx), they are 
highly suitable for the biological applications listed above.42,79 To this end, multiple toxicity 
studies have been performed, and it has been demonstrated that orally administered 
cyclodextrins are practically non-toxic due to the lack of absorption from the 
gastrointestinal tract.40,79 The cytotoxicity of each of the parent cyclodextrins is discussed 
below: 
A. α-Cyclodextrin 
α-Cyclodextrin is known to be relatively irritating both to the eyes and when administered 
intramuscularly. It also has the ability to bind with some lipids while possessing very low 
absorption after oral administration to rats (between 2 and 3%) with no metabolism in the 
upper intestinal tract, since it is only cleaved by intestinal flora in the caecum and 
colon.40,42,80  
B. β-Cyclodextrin 
β-Cyclodextrin is a common food additive and is less irritating than α-cyclodextrin. It binds 
cholesterol in very small amounts (1–2%) and is absorbed in the upper intestinal tract after 
oral administration albeit with no metabolism until the caecum and colon. This is the most 
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common cyclodextrin in pharmaceutical formulations in the form of topical, buccal and 
rectal drug formulations.42,47,81 Application of high doses may be harmful and is not 
recommended and is also only non-toxic when given orally and not parenterally. 42,47,81 
C. γ-Cyclodextrin 
Intramuscular administration does not result in significant irritation, but it is rapidly and 
completely degraded to glucose in the upper intestinal tract by intestinal enzymes. There is 
almost no absorption after oral administration (0.1%) and practically no metabolism, making 
it the least toxic of the three natural cyclodextrins although its complexes are typically 
aggregates with limited solubility in aqueous solutions.40,82 The main reason for it to have 
the lowest toxicity is that its metabolism is similar to that of starch and it is excreted 
unchanged when administered intravenously.83,84 
Preparation methods: complexation techniques, solution dynamics & temperature effects 
and complex drying and storage 
When in solution, more cyclodextrin molecules are available for complexation compared to 
when in crystalline form which only provides the surface molecules of the cyclodextrin. 
Water is the most commonly used solvent particularly because it is easier for water 
molecules to be displaced by a hydrophobic guest relative to organic media, to yield solvent-
free complexes.40 An important factor worth monitoring is the amount of water used since 
the solubility of both cyclodextrin and water-soluble guests increases with a fraction of 
increased water; when the medium becomes too dilute this minimises contact between the 
guest molecule and the cyclodextrin.40 Since not all guests are water-soluble, organic 
solvents are used to dissolve the guest but, as is the case with ethanol and diethyl ether, the 
solvent should not be complexed by the cyclodextrin and should be easily removed by 
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evaporation.40 Also, although heating tends to increase the solubility of the cyclodextrin and 
in some instances that of the guest and this can enhance complex formation,40 this can also 
destabilise the complex and result in its decomposition at 50–60 °C, although this is not the 
case for all, especially for strongly bound guests or the highly insoluble complexes.40 
Co-precipitation 
This method is the most widely used method in the laboratory, wherein the cyclodextrin is 
dissolved in water and the guest is added while stirring the cyclodextrin solution, typically 
with controlled heating, followed by cooling while stirring to form a precipitate.40,41,85 For 
the least soluble of the parent cyclodextrins (β-cyclodextrin), the cyclodextrin solution is 
heated to at least 60 °C to dissolve the β-cyclodextrin before adding the guest.52 The 
precipitate is usually collected by centrifugation or filtration and washed with a small 
amount of solvent such as water or other water-miscible solvents such as ethyl alcohol, 
methanol or acetone although this is not always safe since organic solvents may destabilise 
some complexes.40,41 On scaling up, the disadvantage is the large volumes of water used 
which requires large tank capacities, longer heating times and higher heating energies.40,86  
Slurry complexation and paste complexation 
With slurry complexation, it is not necessary to dissolve the cyclodextrin completely. The 
complex forms in media made up mostly of solids (50–60%) and water, and then stirred at 
ambient temperatures. As the cyclodextrin complex saturates the liquid phase, the complex 
crystallises or precipitates out and the complex can be collected like with the co-
precipitation method.40,41 Unlike with co-precipitation however, the amount of water used 
is far less.40 The difference with paste complexation is the small amount of water used to 
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form a paste which is then mixed with the cyclodextrin using a mortar and pestle or using a 
kneader at large scale.40  
Damp mixing and heating 
Minimal water is used and the guest and cyclodextrin are thoroughly mixed and placed in a 
sealed container follower by heating to about 100 °C and then the complex is removed and 
dried.40 
Extrusion 
Cyclodextrin, guest and water are added to an extruder and extruded to yield a complex 
which may dry as it cools or needs to be dried in an oven. The disadvantage of this method 
is the decomposition of heat-labile guest molecules.40 
Dry mixing 
Oily and liquid guests are added to the cyclodextrin and mixed over time, typically at 
ambient temperature. Although no water is used, caking on scale-up results in poor mixing 
thereby leading to incomplete complexation after long time periods.40 
Drying typically occurs in an oven, fluid bed dryer or other types of dryers, with care to 
avoid destroying the complex.40 Depending on the boiling temperature of the guest, lower 
temperatures may need to be used. Alternatively, complexes may be spray-dried or dried at 
low temperatures. During spray-drying, particles may become too large as a result of 
precipitation or the complex can be lost if the guest is volatile and heat labile.40 At low 
temperatures, a desiccator or freeze dryer may be used.40 
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Aims and objectives of cyclodextrin use: 
The basis of the use of the cyclodextrin compounds here is their water solubility and their 
history in the inclusion of organic compounds in their cavities to form inclusion complexes in 
aqueous solutions.87 These inclusion complexes, particularly those with porphyrin 
derivatives have been shown to modify the photochemical and photophysical properties of 
the included compounds.87–90 The photophysical properties of the BODIPY dyes to be used 
have been assessed in organic media and their ability to generate singlet oxygen molecules 
in this context clearly demonstrated, thereby making them potential photosensitizers for 
various singlet oxygen applications. Their inclusion in cyclodextrins here, therefore is an 
attempt to show that cyclodextrins can be used as carrier agents for the photosensitizers for 
delivery in applications, such as photodynamic antimicrobial chemotherapy (PACT), which 
may require the photosensitizer to be water soluble. 
3. Nonlinear optics (NLO) 
Nonlinear optics (NLO) focuses on the study of changes in the optical properties of materials 
upon interacting with incident light of different intensities. One aspect of NLO that has 
gained momentum over the past few decades is the development of optical limiter 
materials that are capable of significantly reducing light transmittance at high incident 
intensities while remaining transparent under ambient light conditions. This normally 
involves processes such as two-photon absorption (2PA) and excited state absorption (ESA). 
2PA is a third-order nonlinear process of materials wherein a molecule simultaneously 
absorbs two photons, whereas ESA is the absorption of a photon from a lower excited state 
to a higher excited state (Figure 4).91  
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Figure 4. Jablonski diagrams showing two-photon absorption (A) and excited state 
absorption (B). 
Optical limiting (OL) is characterised by a decrease of transmittance by a sample at high 
incident laser intensity. An ideal OL response shows constant transmittance of intensity or a 
decrease to a minimal value above a certain illumination intensity (Figure 5A), with a 
decrease of the initial linear transmittance above a threshold value (Figure 5B). This optical 
limiting process can occur via nonlinear absorption (NLA), nonlinear refraction (NR) or 
nonlinear light scattering (NLS) and the focus in this study is on NLA associated with 
molecular dyes. OL materials can be formed using organic dyes and other compounds that 
can be used to protect light-sensitive objects such as the human eye and optical sensors 
from intense incident laser beams.92–94 The second harmonic of the Nd:YAG laser at 532 nm 
is particularly important in the context of OL applications and the continuous study of 
compounds for their potential use as OL materials at this wavelength is important because 
of, amongst other reasons, the ever-growing irresponsible use of laser pointers and the 
implications this has on aviation safety.95,96 The organic compounds such as porphyrins and 
phthalocyanines that have been used as optical limiters typically have delocalised π-
conjugation systems which possess high polarisabilities when interacting with intense laser 
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light.97–100 BODIPYs have, however, seldom been studied for applications as OL materials. In 
order to study BODIPY dyes as OL materials at 532 nm, the optical properties of the dyes 
must be significantly modified to ensure their utility in this context, since this lies close to 
the main BODIPY spectral band. The structural versatility and stability of the highly robust 
BODIPY core and its facile structural modification for the enhancement of selected 
properties make it possible for these dyes to be studied as optical limiters. One of the most 
widely used methods to achieve a red-shift of the BODIPY main spectral band towards the 
NIR is to introduce styryl groups at the 3,5-positions.5,11,12 Dyes modified in this fashion have 
an extended degree of π-conjugation and this results in a shift of the main absorption and 
fluorescence bands to longer wavelengths, hence achieving two necessary requirements for 
NLO studies at 532 nm: a π-conjugation system that results in high polarisability and a main 
absorption band that lies at a significantly longer wavelength than the second harmonic 
wavelength at 532 nm, typically with minimal absorbance at 532 nm.  
 
Figure 5. Ideal behaviour of an optical limiter. The limiting intensity is shown by the 
deviation of transmittance from linearity, as marked by a dashed line. A: Transmitted 
intensity, Iout vs. incident intensity Iin, B: transmittance, T vs. incident intensity, Iin. Reprinted 
with permission from reference 96; Copyright Royal Society of Chemistry, 1998.  
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NLA and NLR can be studied using the single-beam z-scan technique (Figure 6A) to 
determine optical limiting parameters.93,101 During the scan, the sample is moved along the 
z-direction of a focussed Gaussian beam and an aperture can be optionally placed in front of 
D2.102 When the aperture is absent, the total transmitted energy is detected, and this gives 
the results for nonlinear absorption alone.102 When the aperture is present, the scan gives 
both nonlinear absorption and nonlinear refraction results. To derive the nonlinear 
refraction curve, the resultant z-scan curve obtained with an aperture is divided by the 
curve obtained in the absence of the aperture, hence eliminating nonlinear absorption. This 
curve, referred to as the divided z-scan curve, reveals the effect of nonlinear refraction 
alone.102 In this study the focus is on the use of non-aggregated BODIPY molecular dyes for 
NLA, so only open aperture z-scan measurements are analysed to determine the most 
important NLO parameters that are related to OL. 
 
Figure 6. A: Open-aperture z-scan setup. The sample is moved along the z-direction of a 
focussed Gaussian beam. D1 and D2 are photodetectors, and S is the sample. B: Typical 
reverse saturable absorption response obtained from the z-scan setup. 
Some optical limiters are known to strongly reduce the transmittance of light at high 
incident light intensities while remaining transparent at incident intensities, a phenomenon 
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known as reverse saturable absorption; this can be visualised by plotting the data obtained 
from the z-scan equipment (Figure 6B). The data is first analysed using the procedure 
described by Sheik-Bahae et al., Equation (1):103 
        (1) 
 
where q0(z) provides an indicator of the strength of the nonlinearity. For circular-shaped 
beams, the q0(z) value is provided by Equation (2):104 
          (2) 
where P0 and leff are the peak power of the laser pulse and the effective pathlength, given 
by Equation (3): 
 
           (3) 
where α and l are the linear absorption coefficient and the pathlength. The beam width as a 
function of sample position ω(z) in Equation (2) can be obtained from Equation (4): 
          (4) 
where ω0 is the beam waist at the focus (z = 0), which is the distance from the centre of the 
beam to a point where intensity decreases to 1/𝑒2 of its on-axis value. z0 and z are the 
Rayleigh length and the translation distance for the sample relative to the focus, 
respectively. The Rayleigh length is defined as πω02/λ with λ being the laser wavelength. 
The βeff value, the effective nonlinear absorption coefficient, can be extracted from the 
experimentally measured transmittance using Equations (1–4). In this study, a nanosecond 
pulsed laser is used, so it is not possible to measure the β value that arises solely from 2PA, 
since an RSA response can also be associated with ESA (Figure 4). Equation (1) is not well 
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suited to fit directly to the data, however, so a numerical version of this formula (Equation 
(5)) is normally used to derive q0(z) from the normalised transmittance values obtained 
experimentally: 
 (5) 
On substituting Equation (4) into Equation (2), q0(z) can be defined by Equation (6): 
            (6) 
where Q0 is given as: 
           (7) 
A Gaussian-shaped curve with Q0 as the maximum value at z = 0 can be obtained from 
Equation (7). The full width at half minimum and peak values derived from the plot provide 
values for z0 and Q0, respectively. Equation (8) is used to obtain the value of βeff, and this 
provides an important parameter for assessing the suitability of materials for OL 
applications: 
                         (8) 
The imaginary third-order susceptibility (Im[χ(3)]) is a measure of the speed of the response 
by an optical limiter to the perturbation induced by the incident laser pulse. The imaginary 
third-order susceptibility is directly proportional to the two-photon absorption coefficient, 
βeff and can be calculated using Equation (9): 
                            (9) 
where 𝜂 is the refractive index of the solvent, c is the speed of light, 𝜀0 is the permittivity of 
free space, and λ is the wavelength of the laser. 
 
 
β  
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The second-order hyperpolarizability (γ) measures the interaction of the incident photon 
with the permanent dipole moments of the molecule. This parameter describes NLA per 
mole of the compound and can be determined using Equation (10): 
                     (10) 
where Cmol is the molar concentration of the active species, f is the Lorentz local field 
enhancement factor defined as f = (𝜂2 + 2)/3 (where 𝜂 is the refractive index of the sample), 
and NA is the Avogadro constant. 
From the standpoint of optical limiting applications, the Im[χ(3)] value has an optimal range 
of 10-9 to 10-15 whereas that of γ is 10-29 to 10-34.104 
The threshold limit intensity (Ilim), is defined as the input fluence at which the nonlinear 
transmittance is reduced to 50% of the linear transmittance value. The International 
Commission on Non-Ionizing Radiation Protection has published a guideline for exposure 
limits to a variety of lasers.105 Equation (11) can be used to determine what the use of 10 ns 
laser pulses at 532 nm results in as an exposure limit: 
                 (11) 
where CA is a correction factor (= 1 for 400–700 nm), and t is the exposure time. This 
equation provides a limit of 0.95 J.cm−2 for a 0.25 s exposure time corresponding to the 
normal blink reflex for the human eye.106  
In this work, the suitability of a series of structurally diverse BODIPY dyes for optical limiting 
is assessed in a variety of organic solvents. These BODIPY dyes are structurally diverse in 
that some contain heavy atoms in the form of bromine whereas others contain electron 
γ  
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withdrawing and electron donating groups separated by a π-conjugation system. For heavy 
atom containing BODIPYs, an enhanced optical limiting response is expected as has been 
previously observed with phthalocyanines,107–109 as a result of intersystem crossing to the 
triplet state, which in turn, typically results in ESA in this triplet manifold. An enhanced 
optical limiting response is also expected for the dyes containing electron withdrawing and 
electron donating groups separated by a π-system as this creates a dipole moment due to 
their asymmetrical nature.110 These donor (D)–π–acceptor (A) or D–π–A systems, typically 
termed as push-pull systems, have been studied to better understand their nonlinear optical 
behaviour and are known to possess large second-order nonlinearities.110,111 In the dyes 
being studied here, the respective functional groups, as will be discussed in Chapter 4, will 
act as electron donors and as electron acceptors while the BODIPY core electronic system 
will provide the polarisable electrons, and it is therefore expected that when these 
polarisable electrons interact with an oscillating electric field of light they will selectively 
shift from the donor to the acceptor, thereby creating a single charge transfer 
direction.110,111 This is what drives the large second-order optical nonlinearities observed in 
asymmetric molecules.111 
4. Sensing 
One other widely studied application of BODIPY dyes is their use in sensing, as chemical 
sensors. During the sensing process, the chemical sensor which is composed of a receptor 
and a transducer provides analytical information about a species present in a chemical 
system.112,113 The receptor binds with the analyte of interest whereas the transducer reports 
the binding process which may be a chemical or biological process, in the form of a 
recognisable and detectable signal.112–115  
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The focus here is on chemosensors which are made up of a molecule or molecules of abiotic 
origin and are able to detect varying substrates.112 Using synthetic chemistry, organic 
molecules, inorganic metal complexes, macrocycles, polymers and nanomaterials, sensitive 
and selective sensors have been previously developed to detect not only biologically 
important materials but other substrates of environmental and medicinal importance, 
irrespective of size and charge. Examples of these include various heavy metals and 
explosives.112,116–119 Heavy metals such as copper and mercury which are prevalent in the 
environment need to be constantly monitored. Copper, for example, should be maintained 
within the correct levels within the human body because it is linked to neurodegenerative 
disorders such as Alzheimer’s disease while copper deficiency leads to anaemia and 
leukopenia.112,120–123 Explosive devices and their potential link to terrorist organisations and 
rogue states raise the need for devices which can detect these explosives, and a lot of 
research has been carried out in this regard.112,124,125 
The substrate-receptor binding process is typically detected as either an optical or 
electrochemical signal.112,126 The optical approach includes changes in the electronic 
absorption spectrum of the probe or a change in the fluorescence properties of the probe. 
These colourimetric and fluorometric changes can be visualised and studied using UV-visible 
absorption and fluorescence spectroscopies, respectively.126 The electrochemical signals are 
a result of changes in current or redox potential and voltammetry is the most common 
technique used to follow the electrochemical changes which occur as a result of the 
presence of an analyte.112,126 The fluorometric approach has become the most favourable as 
a result of advantages such as high sensitivity and specificity, minimal cell disruption in 
biological applications and easily monitored turn-off/turn-on fluorescence switching, and 
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these have created avenues for applications in various research fields including, but not 
limited to biochemistry, biology and in medicinal and drug-related research and 
applications.112,114,127,128 During these fluorescence sensing studies, the chemosensor can be 
modified structurally or otherwise to enhance either the selectivity of the receptor for the 
analyte of interest or the sensitivity and output of the transducer.112 
BODIPY dye based chemosensors have been previously reported and studied in 
colourimetric and fluorometric applications.129–133 These BODIPY based sensors, particularly 
the fluorometric ones are typically based on far-red and NIR absorbing dyes.114 The main 
sensing mechanisms in these dyes are photo-induced electron transfer (PET), intramolecular 
charge transfer (ICT), and Förster resonance energy transfer (FRET) or a combination of 
these and there are two general designs for a fluorescence sensor, namely the fluorophore-
spacer-receptor system and intrinsic fluorescent probes.112,114,127 In the intrinsic fluorescent 
probes the receptor is part of the π-electron system of the fluorophore whereas, in the 
fluorophore-spacer-receptor system, the π-electron systems of the fluorophore and the 
receptor are electronically disconnected by a spacer, typically an aliphatic group.114,127 The 
fluorophore-spacer-receptor system is the basis for PET, wherein the binding of an analyte 
to the sensor modifies either the fluorescence intensity or fluorescence wavelength.114,127,134 
The PET-based fluorescence probes do not show significant spectral shifts upon analyte 
binding. Instead, their fluorescence is either enhanced or quenched and as such are more 
often referred to as “off-on” and “on-off” fluorescent sensors, whereas ICT based probes 
possess changes in fluorescence wavelength.114,134 During the PET process, the fluorophore 
may be the electron donor or acceptor and the process may either be reductive or oxidative 
depending on the relationship between the molecular orbitals of the fluorophore and 
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receptor. In reductive PET the highest occupied molecular orbital (HOMO) of the 
fluorophore is lower than the HOMO of the receptor and as such the fluorophore accepts 
electron(s) from the receptor.114 In contrast, in oxidative PET the lowest unoccupied 
molecular orbital (LUMO) of the fluorophore lies higher than the LUMO of the receptor and 
the fluorophore is the electron donor.114 During the ICT process, fluorescence changes result 
from electronic interactions between electron donating and electron accepting groups. 
During this process, charge transfer or electron density redistribution from the electron 
donating group to the electron accepting group creates a dipole moment within the 
molecule and this dipole moment is disturbed by analyte binding which may either enhance 
or reduce it, thereby altering the fluorescence properties.112 What happens to the 
fluorescence spectrum depends on whether the dipole is enhanced or reduced, i.e. an 
enhanced dipole results in an increase in molar absorptivity and red-shifted absorbance and 
fluorescence.112 FRET, on the other hand, is as a result of an interaction between two 
fluorophores that are joined in the same molecule. These act as a donor and acceptor, with 
an energy donor emitting at shorter wavelengths and the acceptor emitting at a longer 
wavelength.114 The energy transfer process is non-radiative and is facilitated by a spectral 
overlap between the emission spectrum of the donor and the absorption spectrum of the 
acceptor.114 
Given BODIPY dyes have been studied for their potential as molecules which can be used in 
the design of fluorescent probes, some of the dyes synthesised in this work will also be 
tested to this effect. BODIPY dyes have been extensively studied based on their potential in 
sensing pH changes, cations and anions, metal ions, enzymes and reactive oxygen 
species.114,131,133,135 With this proliferation of potential applications, pH-sensitive fluorescent 
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probes have also been on the spotlight especially since pH is an indicator in many cellular 
events, e.g. abnormal cell growth, inflammation and cancer are all characterised by pH 
values lower than those of normal cells.136 These BODIPY based pH probes are mostly based 
on PET and ICT, and they typically contain the dimethylaminophenyl group which has the 
potential to act as a receptor.137 Under normal circumstances, dyes with this functional 
group have their fluorescence quenched in polar solvents due to the charge transfer 
process, but upon protonation, the fluorescence process is activated due to the inhibition of 
the process.112,132,133,135,137 
Aims 
The aim of this work is to synthesise a series of structurally modified BODIPY dyes that will, 
among other properties exhibit the following characteristics: i. pH-sensitivity, ii. ability to 
absorb in the NIR region, and iii. possess enhanced photophysical properties. The aims can 
thus be summarised as: 
1. Synthesis and photophysical study of a series of heavy atom containing BODIPY dyes. 
2. Study the pH-sensitivity of the dyes containing N(CH3)2 groups both at the meso-position 
and on the styryl groups of the extended π-system. 
3. Study the nonlinear optical behaviour of certain distyryl-BODIPY dyes in organic media. 
4. Study BODIPY dye-cyclodextrin inclusion complexes in aqueous solution using UV-visible 
absorption and circular dichroism spectroscopies; and in solid state using x-ray 
diffraction spectroscopy, infrared spectroscopy and scanning electron microscopy. 
31 
 
5. Perform molecular modelling of the BODIPY dyes synthesised to identify structure-
property relationships. 
The results for one of the dyes studied for nonlinear optical limiting have already been 
published: 
 May, A. K.; Stone, J.; Ngoy, B. P.; Mack, J.; Nyokong, T.; Kimura, M.; Kobayashi, N., 
accepted for publication in the Journal of Porphyrins and Phthalocyanines in 2018 [doi: 
10.1142/S1088424617500869] 
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Chapter 2:  
Experimental 
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2.1. Materials 
All reagents were used without further purification unless otherwise stated. Trifluoroacetic 
acid (TFA), 2,4-dimethylpyrrole, 3-ethyl-2,4-dimethylpyrrole, tetrachloro-1,4-benzoquinone 
(p-chloranil), 4-bromobenzaldehyde, 4-dimethylamino benzaldehyde, 4-nitrobenzaldehyde, 
methyl 4-formylbenzoate, Rhodamine-6-G, 1,3-diphenylisobenzofuran (DBPF), boron 
trifluoride diethyl etherate (BF3·Et2O), N-bromosuccinimide (NBS), sodium sulphate, 
triethylamine (TEA), anthracene-9,10-bis-methylmalonatepiperidine (ADMA) and glacial 
acetic acid were purchased from Sigma Aldrich. Rose Bengal was purchased from Fluka. 
Silica gel 60 for flash column chromatography was purchased from Merck. The cyclodextrins 
were purchased from Tokyo Chemical Industry Co., Ltd. All solvents were dried using 
molecular sieves before use. 
2.2. Instrumentation 
 Ultraviolet-visible (UV–vis) absorption spectra were measured at room temperature on 
a Shimadzu UV-2550 spectrophotometer. A 1 cm path length quartz cuvette was used. 
 Proton nuclear magnetic resonance (1H-NMR) spectra were recorded at room 
temperature in acetone-d6, chloroform-d3, tetrahydrofuran-d8 (THF-d8), N,N-
Dimethylformamide-d7 (DMF-d7) or dimethylsulfoxide-d6 (DMSO-d6) on Bruker AMX 600 
and 300 instruments operating at 600 and 300 MHz, respectively. 
 Fluorescence emission and excitation spectra were obtained using a Varian Cary Eclipse 
spectrofluorimeter. 
 Mass spectra (MS) data were collected on a Bruker AutoFLEX III Smart-beam matrix-
assisted laser desorption/ionisation-time of flight (MALDI-TOF) mass spectrometer using 
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an α-cyano-4-hydroxycinnamic acid matrix and positive mode of operation for BODIPYs 
2–10. 
 Fourier-transform infrared spectra (FT-IR) were recorded on a Perkin Elmer Spectrum 
100 FT-IR spectrometer. 
 Fluorescence lifetimes were measured using a time-correlated single photon counting 
(TCSPC) setup (FluoTime 200, Picoquant GmbH). For the brominated BODIPY cores, an 
LDH-P-C-485 laser head driven by PDL 800-B single channel driver and a 10 MHz 
repetition rate was used. For the di-styryl BODIPYs, an LDH-P-670 laser head with a 20 
MHz repetition rate was used. Fluorescence was detected under the magic angle with a 
Peltier cooled photomultiplier tube (PMT) (PMA-C 192-N M, Picoquant GmbH) and 
integrated electronics (PicoHarp 300E, Picoquant GmbH). A monochromator with a 
spectral width of about 4 nm was used to select the required emission wavelength 
band. The response function of the system, which was measured with a scattering Ludox 
solution (DuPont), had a full width at half maximum (FWHM) of about 300 ps. All 
fluorescence decay curves were measured at the emission peak maxima. The decay 
curves were analysed with the FluoFit program (Picoquant GmbH). 
 The irradiations for most of the singlet oxygen experiments were conducted using an 
Ekspla NT342B-20-AW – Nd:YAG laser (max output – 1J, pulse duration 3–6 ns) with 
parametric generation (max output – 50 mJ, pulse duration 3–5 ns, wavelength 400–
2400 nm). 
 All z-scan experiments were performed using a frequency doubled Nd:YAG laser 
(Quanta-Ray, 1.5 J/10 ns FWHM pulse duration) as the excitation source. The laser was 
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operated in a near Gaussian transverse mode at 532 nm (second harmonic), with a pulse 
repetition rate of 10 Hz and energy range of 0.1–0.1 mJ, limited by the energy detectors 
(Coherent J5-09). The low repetition rate of the laser prevents cumulative thermal 
nonlinearities. The beam was spatially filtered to remove the higher order modes and 
tightly focused with a 15 cm focal length lens. 
 Circular dichroism (CD) spectra were recorded on a Jasco J-720 spectrodichrometer in 
water at room temperature. All samples were prepared from aqueous stock solutions. 
The following conditions were used: bandwidth, 1.0 nm; slit width, 1.0 nm; auto, 
sensitivity, 10 mdeg; time constant, 1.0 s; step resolution, 0.2 nm; scan speed, 20 
nm.min-1; number of scans, 4. 
 The irradiations for the cyclodextrin inclusion complex singlet oxygen measurements 
were carried out using a Thorlabs mounted M530L3 LED as the light source for 530 nm 
light. The LED was mounted into the housing for a Modulight medical laser system that 
was equipped with a sample holder with a spot diameter of 5.5 cm. The LED provided an 
irradiance of 350 mW.cm-2 with spectral readings taken at various time intervals to 
monitor progress. 
 Imaging of the BODIPY dyes, cyclodextrins and their inclusion complexes were captured 
using a TESCAN Vega TS 5136LM scanning electron microscopy (SEM) (Jeol Quanta 200 F 
FE-SEM) at an accelerating voltage of 20 kV. Before SEM analysis, non-conductive 
samples were coated with gold using a sputter coater (Balzers Union SKD 030). 
 X-ray powder diffraction (XRD) patterns were recorded on a Bruker D8, Discover 
instrument equipped with a proportional counter, using Cu-Kα radiation (λ = 1.5405 Å, 
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nickel filter). Data were collected in the range from 2θ = 10 to 100o, scanning at 1o min-1 
with a filter time-constant of 2.5 s per step and a slit width of 6.0 mm. Samples were 
placed on a zero background silicon wafer. The X-ray diffraction data were treated using 
the freely-available EVA (evaluation curve fitting) software.138 Baseline correction was 
performed on each diffraction pattern by subtracting a spline fitted to the curved 
background. 
 The Gaussian 09 software package running on an Intel/Linux cluster was used to 
perform all calculations.139 Geometry optimisations were carried out at the B3LYP level 
of theory with 6-31G(d)basis sets. TD-DFT calculations employed the CAM-B3LYP level of 
theory with 6-31G(d) basis sets. Avogadro, an advanced molecule editor and visualiser 
was used for all visualisations of molecular orbitals.140 
2.3. Photophysical Properties of BODIPY dyes 
A. Fluorescence properties of BODIPY dyes 
BODIPY dye fluorescence properties have been extensively researched and applied in 
different fields.5 Typically, the fluorescence spectra of BODIPYs are mirror images of the S0 
to S1 absorption band since fluorescence only occurs from the lowest vibrational level of the 
S1 to the S0, following Kasha’s rule.17 The narrow emission bands of BODIPY cores lie in the 
500–550 nm region unless they are red-shifted after structural modification.5 The Stokes 
shift, which is the wavelength difference between the band maxima of the absorbed and 
emitted light for the S0 to S1 transition is typically small (approximately 10 nm) because the 
S0 and S1 states have similar geometries.17 
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The fluorescence quantum yield (φF) which is the number of photons emitted relative to the 
photons absorbed can be very high for some BODIPYs.17,141 Similar to the fluorescence 
emission spectra, the fluorescence quantum yield is also independent of the excitation 
wavelength because there is rapid deactivation from the populated excited state (Sn) to the 
fluorescent lowest excited state.17,141 To determine the quantum yield, the intensity of the 
BODIPY dye is compared with that of a standard.142 In this work, the quantum yield is 
determined using Equation (12): 
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               (12) 
where F and FStd are the areas under the fluorescence curves for the sample and standard 
respectively. A and AStd are the absorbance values of the sample and standard at the 
excitation wavelength, while η and ηstd are the respective refractive indices of the solvents 
in which the sample and standard were dissolved. Rhodamine 6G and zinc Pc (ZnPc) can be 
used as standards for the determination of fluorescence quantum yields in ethanol and 
DMSO, respectively, with φF = 0.95 and 0.20.143,144 
The other important fluorescence property is the fluorescence lifetime (ꚍF).21,137,145,146 This is 
a measure of the average amount of time an electron in the S1 state spends in this state 
before returning to the ground state via radiative emission of a photon. TCSPC is one 
technique which can be used to determine ꚍF.146 Here, a decay curve is plotted and then 
deconvoluted to give the fluorescence lifetime. 
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B. Singlet oxygen quantum yield of BODIPY dyes 
There are two methods that can be used to quantify the generation of singlet oxygen by a 
photosensitizer dye, namely the physical/luminescence method and a comparative chemical 
method. In this work, the comparative method was used. This method uses a singlet oxygen 
quencher such as 1,3-diphenylisobenzofuran (DPBF) which reacts with the produced singlet 
oxygen. Monitoring is done using UV-visible absorption spectroscopy because a decrease in 
the intensity of the main absorption peak of the quencher is expected. Equation (13), shown 
below, is used for calculating singlet oxygen quantum yields (ΦΔ).147,148 
                   (13) 
where (ΦΔstd) is the singlet oxygen quantum yield for the standard (Rose Bengal, ΦΔstd = 0.76 
in DMSO).149 Rsample and Rstd are the DPBF photobleaching rates in the presence of the 
sample under investigation and the standard, respectively. Isample and Istd are the rates of 
light absorption by the sample and the standard, respectively. 
2.4. Synthesis 
A series of BODIPY dyes were synthesised, as described below. 
BODIPY cores (Scheme 1) 
2,4-Dimethylpyrrole (2.0 mole eq) and the corresponding benzaldehyde (1.0 mole eq) were 
dissolved in dry dichloromethane (DCM) (50 ml) under argon. TFA (2–3 drops) was added, 
and the reaction mixture was stirred at room temperature. When the aldehyde was 
consumed (monitored by TLC), a solution of p-chloranil (1.2 mole eq) in dry DCM (10 ml) 
was added at 0 °C. The solution was allowed to warm up to room temperature while stirring 
for 30 min under argon. A deep purple colour was observed and TLC confirmed the 
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synthesis of the dipyrromethene. TEA (7 mole eq) and BF3·Et2O (11 mole eq) were added 
dropwise at 0 °C, and the mixture was left to stir at room temperature for 12 h. The mixture 
was then filtered and washed with water (100 ml), dried over anhydrous sodium sulphate 
and the residue purified by flash column chromatography eluting with ethyl 
acetate:petroleum ether (1:4). 
 
Scheme 1. Synthesis of BODIPYs 1(a–e). 
BODIPY 1a, 4,4’-difluoro-8-(4-dimethylaminophenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-
diaza-s-indacene, was obtained in 11% yield (0.27 g); FT-IR (cm-1): 2918 (C-H stretch), 2848 
(C-H stretch), 2773 (C-H stretch), 1499, 1357 (C-N stretch), 1185, 1055 (C-N stretch), 968 
(=C-H bend), 468 (C-H); 1H NMR (300 MHz, DMSO-d6) δ 7.11–7.08 (d, J = 8.9 Hz, 2H), 6.86–
6.83 (d, J = 8.8 Hz, 2H), 6.15 (s, 2H), 2.97 (s, 6H), 2.43 (s, 6H), 1.45 (s, 6H) ppm. 
BODIPY 1b, 4,4’-difluoro-8-(4-bromophenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene, was obtained in 16% yield (0.35 g); FT-IR (cm-1): 2920 (C-H stretch), 2859 (C-H 
stretch), 1502, 1404 (C-N stretch), 1191, 1040 (C-N stretch), 970 (=C-H bend), 470 (C-H); 1H 
NMR (300 MHz, DMSO-d6) δ 7.78–7.76 (d, J = 8.3 Hz, 2H), 7.38–7.35 (d, J = 8.3 Hz, 2H), 6.20 
(s, 2H), 2.44 (s, 6H), 1.37 (s, 6H) ppm. 
40 
 
BODIPY 1c,  4,4’-difluoro-8-(4-nitrophenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene, was obtained in 25.8% yield (0.63 g); FT-IR (cm-1): 2953 (C-H stretch), 2914(C-H 
stretch), 1712 (C=O), 1410 (C-N stretch), 1188, (C-N stretch), 1277, 1062 (C-O), 964 (=C-H 
bend), 465 (C-H); 1H NMR (300 MHz, DMSO-d6) δ 8.41–8.38 (d, J = 8.8 Hz, 2H), 7.77–7.74 (d, 
J = 8.8 Hz, 2H), 6.22 (s, 2H), 2.46 (s, 6H), 1.34 (s, 6H) ppm. 
BODIPY 1d, 4,4’-difluoro-8-(4-carbomethoxyphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-
diaza-s-indacene, was obtained in 39% yield (0.9 g); FT-IR (cm-1): 2953 (C-H stretch), 2914 
(C-H stretch), 1712 (C=O), 1277, 1062 (C-O), 1459, 1410 (C-N stretch), 1188, 1062 (C-N 
stretch), 1277, 1062 (C-O), 965 (=C-H bend), 465 (C-H); 1H NMR (300 MHz, DMSO-d6) δ 8.14–
8.11 (d, J = 8.4 Hz, 2H), 7.58–7.55 (d, J = 8.4 Hz, 2H), 6.20 (s, 2H), 3.90 (s, 3H), 2.45 (s, 6H), 
1.32 (s, 6H) ppm. 
BODIPY 1e, 4,4’-difluoro-8-(4-benzyloxyphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene, was obtained in 35% yield; FT-IR (cm-1): 2918 (C-H stretch), 2854 (C-H stretch), 
1455, 1408 (C-N stretch), 1188, 1070 (C-N stretch), 1102 (C-O-C), 969 (=C-H bend), 468 (C-
H); 1H NMR (600 MHz, CDCl3) δ 7.48 (d, J = 7.3 Hz, 2H), 7.43 (t, J = 7.4 Hz, 2H), 7.38 (t, J = 7.3 
Hz, 1H), 7.20–7.19 (d, J = 8.6 Hz, 2H), 7.12–7.10 (d, J = 8.6 Hz, 2H), 6.00 (s, 2H), 5.14 (s, 2H), 
2.14 (s, 6H), 1.45 (s, 6H) ppm. 
Brominated BODIPYs (Scheme 2) 
BODIPYs 1a, b, c, d and e (1 mole eq.) and NBS (3 mole eq.) were dissolved in DCM (20 mL). 
The mixture was left to stir under Ar/N2 at room temperature; the reaction was followed by 
thin layer chromatography to completion. The product was washed with water and the 
organic phase dried over sodium sulphate. Finally, purification was achieved via flash 
column chromatography with ethyl acetate:petroleum ether (1:4) as the eluent. 
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Scheme 2. Bromination of BODIPYs 1(a–d) to form 2(a–d). 
BODIPY 2a, 4,4’-difluoro-8-(3-bromo-4-dimethylaminophenyl)-1,3,5,7-tetramethyl-2,6-
dibromo-4-bora-3a,4a-diaza-s-indacene, was obtained in 72% yield (0.82 g); FT-IR (cm-1): 
2919 (C-H stretch), 2854 (C-H stretch), 2781 (C-H stretch), 1535, 1308 (C-N stretch), 1170, 
1088 (C-N stretch), 990 (=C-H bend), 522 (C-Br stretch); 1H NMR (300 MHz, acetone-d6) δ 
7.69 (s, 1H), 7.40–7.39 (d, J = 1.1 Hz, 2H), 2.89 (s, 6H), 2.56 (s, 6H), 1.50 (s, 6H) ppm. MALDI-
TOF Anal. calc. m/z 603.93; Found: [M + 1H]+ 605.9. 
BODIPY 2b, 4,4’-difluoro-8-(4-bromophenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-bora-
3a,4a-diaza-s-indacene was obtained in 92% yield (0.18 g); FT-IR (cm-1): 2917 (C-H stretch), 
2856 (C-H stretch), 1458, 1394 (C-N stretch), 1174, 1086 (C-N stretch), 994 (=C-H bend), 523 
(C-Br stretch); 1H NMR (300 MHz, DMSO-d6) δ 7.82–7.80 (d, J = 8.5 Hz, 2H), 7.44–7.41 (d, J = 
8.5 Hz, 2H), 2.52 (s, 6H), 1.37 (s, 6H) ppm. MALDI-TOF Anal. calc. m/z 560.86; Found: [M + 
1H]+ 562.63. 
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BODIPY 2c, 4,4’-difluoro-8-(4-nitrophenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-bora-3a,4a-
diaza-s-indacene, was obtained in 86.6% yield (0.68 g); FT-IR (cm-1): 2921 (C-H stretch), 2850 
(C-H stretch), 1526 (N=0), 1456, 1410 (C-N stretch), 1184, (C-N stretch), 997 (=C-H bend), 
531 (C-Br stretch); 1H NMR (600 MHz, CDCl3) δ 8.57–8.56 (d, J = 8.7 Hz, 2H), 7.68–7.66 (d, J = 
8.7 Hz, 2H), 2.76 (s, 6H), 1.50 (s, 6H) ppm. MALDI-TOF Anal. calc. m/z 526.97; Found: [M] 
526.2.  
BODIPY 2d, 4,4’-difluoro-8-(4-carbomethoxyphenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-
bora-3a,4a-diaza-s-indacene, was obtained in 92% yield (0.18 g); FT-IR (cm-1): 2995 (C-H 
stretch), 2951 (C-H stretch), 1724 (C=O), 1268, 1091 (C-O), 1458, 1399 (C-N stretch), 1188, 
1091 (C-N stretch), 1268, 1091 (C-O), 998 (=C-H bend), 532 (C-Br stretch); 1H NMR (300 
MHz, DMSO-d6) δ 8.16–8.14 (d, J = 8.5 Hz, 2H), 7.64–7.61 (d, J = 8.5 Hz, 2H), 3.91 (s, 3H), 
2.52 (s, 6H), 1.31 (s, 6H) ppm. MALDI-TOF Anal. calc. m/z 539.99; Found: [M + H]+ 541.271. 
BODIPY 2e, 4,4’-difluoro-8-(4-benzyloxyphenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-bora-
3a,4a-diaza-s-indacene, was obtained in 30% yield; FT-IR (cm-1): 2918 (C-H stretch), 2856 (C-
H stretch), 1457, 1395 (C-N stretch), 1085 (C-N stretch), 1178 (C-O-C), 866 (=C-H bend), 527 
(C-Br); 1H NMR (600 MHz, CDCl3) δ 7.48 (d, J = 7.3 Hz, 2H), 7.43–7.42 (t, J = 7.4 Hz, 2H), 7.4–
7.37 (m, 2H), 7.16–7.11 (dd, J = 20,8.6 Hz, 3H), 5.17 (s, 2H), 2.61 (s, 6H), 1.43 (s, 6H) ppm. 
MALDI-TOF Anal. calc. m/z 588.09; Found: [M] 588.29.  
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BODIPY 3: 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-1,5,7-trimethyl-2,6-dibromo-3-mono-
styryl-(4-dimethylamino)-4-bora-3a,4a-diaza-s-indacene (Scheme 3) 
BODIPY 2d (1 mole eq.), 4-dimethyl amino benzaldehyde (1.4 mole eq.) and glacial acetic 
acid (0.4 mL) were dissolved in dry benzene (20 mL) under Ar with stirring. Piperidine (0.4 
mL) was added slowly and the solution was heated to reflux for 48 h under Ar.  A Dean-Stark 
trap was deployed for the azeotropic removal of water formed during the condensation 
reaction.  The reaction was quenched with water and the organic phase was dried over 
sodium sulphate. Separation was by flash column chromatography with ethyl 
acetate:petroleum ether (1:4). BODIPY 3 was obtained in 16.1% yield (0.02 g); FT-IR (cm-1): 
2852 (C-H stretch), 1715 (C=O), 1291 (C-O), 1434, 1351 (C-N stretch), 1064 (C-N stretch), 
1163, 1106 (C-O), 937 (=C-H bend), 516 (C-Br stretch); 1H NMR (600 MHz, CDCl3) δ 8.19–8.14 
(dd, J = 18.0, 12.3 Hz, 4H), 7.55–7.50 (dd, J = 18.5, 12.6 Hz, 4H), 7.39–7.37 (d, J = 8.2 Hz, 2H), 
3.97 (s, 3H), 3.04 (s, 6H), 2.62 (s, 3H), 1.36 (s, 3H), 1.32 (s, 3H) ppm. MALDI-TOF Anal. calc. 
m/z 671.18; Found: [M + 2H]+ 673.96. 
 
Scheme 3. Synthesis of BODIPY 3. 
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BODIPY 4: 4,4’-Difluoro-8-(4-dimehtylamino)-1,7-dimethyl-2,6-dibromo-3,5-di-styryl-(4-
benzo-15-crown-5)-4-bora-3a, 4a-diaza-s-indacene (Scheme 4) 
The BODIPY dye was previously synthesised and characterised by another MSc student at 
Rhodes University.150 For this thesis, the nonlinear optical studies of the di-styryl crown 
ether dye were the main focus and limited structural and photophysical characterisation 
was also performed to supplement the data already recorded.150 1H NMR (600 MHz, THF-d8) 
δ 8.13–8.10 (d, J = 16.6 Hz, 2H), 7.66–7.63 (d, J = 15.6 Hz, 3H), 7.32–7.31 (d, J = 11.7 Hz, 3H), 
7.22–7.20 (d, J = 9.9 Hz, 4H), 6.97–6.95 (d, J = 8.0 Hz, 2H), 4.19–4.13 (d, J = 33.5 Hz, 8H), 
3.88–3.85 (d, J = 20.6 Hz, 8H), 3.69 (s, 16H), 2.89 (s, 6H), 1.55 (s, 6H) ppm; MALDI-TOF Anal. 
calc. m/z 1082.6; Found: [M + H]+ 1083.4.  
 
Scheme 4. Synthesis of the di-styryl crown ether BODIPY dye (BODIPY 4). 
BODIPY 5: 4,4’-Difluoro-8-(4-benzyloxyphenyl)-1,7-dimethyl-3,5-di-styryl-(4-
benzyloxyphenyl)-4-bora-3a,4a-diaza-s-indacene (Scheme 5) 
4,4’-Difluoro-8-(4-benzyloxyphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene (1 
mole eq.), 4-benzyloxy benzaldehyde (1.4 mole eq.) and glacial acetic acid (0.4 mL) were 
dissolved in dry benzene (20 mL) under Ar with stirring. Piperidine (0.4 mL) was added 
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slowly and the solution was heated to reflux for 48 h under Ar.  A Dean-Stark trap was 
deployed for the azeotropic removal of water formed during the condensation reaction.  
The reaction was quenched with water and the organic phase was dried over sodium 
sulphate. Separation was by flash column chromatography with ethyl acetate:petroleum 
ether (1:4). BODIPY 5 was obtained in 32% yield; FT-IR (cm-1): 2926 (C-H stretch), 2856 (C-H 
stretch), 1501, 1438 (C-N stretch), 1103 (C-N stretch), 1166 (C-O-C), 876 (=C-H bend), 453 (C-
H); 1H NMR (600 MHz, CDCl3) δ 7.60 (s, 4H), 7.47 (d, J = 8.2 Hz, 5H), 7.42 (s, 12H), 7.22–7.20 
(d, J = 15.3 Hz, 3H), 7.11 (s, 2H), 7.02 (s, 3H), 6.92 (s, 2H), 6.62 (s, 2H), 5.13 (s, 4H), 5.03 (s, 
2H), 1.59 (s, 6H) ppm. MALDI-TOF Anal. calc. m/z 818.35; Found: [M] 818.93. 
 
Scheme 5. Synthesis of BODIPY 5. 
BODIPY 6: 4,4’-Difluoro-8-(4-benzyloxyphenyl)-1,7-dimethyl-2,6-dibromo-3-di-styryl-(4-
benzyloxyphenyl)-4-bora-3a,4a-diaza-s-indacene (Scheme 6) 
BODIPY 2e (1 mole eq.), 4-benzyloxy benzaldehyde (1.4 mole eq.) and glacial acetic acid (0.4 
mL) were dissolved in dry benzene (20 mL) under Ar with stirring. Piperidine (0.4 mL) was 
added slowly and the solution was heated to reflux for 48 h under Ar.  A Dean-Stark trap 
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was deployed for the azeotropic removal of water formed during the condensation reaction.  
The reaction was quenched with water and the organic phase was dried over sodium 
sulphate. Separation was by flash column chromatography with ethyl acetate:petroleum 
ether (1:4). BODIPY 6 was obtained in 20% yield; FT-IR (cm-1): 2923 (C-H stretch), 2852 (C-H 
stretch), 1507, 1441 (C-N stretch), 1110 (C-N stretch), 1161 (C-O-C), 912 (=C-H bend), 522 (C-
Br stretch) 1H NMR (600 MHz, CDCl3) δ 8.14–8.11 (d, J = 16.6 Hz, 2H), 7.65–7.62 (d, J = 15.4 
Hz, 6H), 7.48 (s, 6H), 7.42 (s, 6H), 7.37 (s, 3H), 7.20 (s, 2H), 7.15 (s, 2H), 7.05 (s, 4H), 5.17 (d, J 
= 13.2 Hz, 6H), 1.49 (s, 6H) ppm. MALDI-TOF Anal. calc. m/z 976.17; Found: [M] 976.71. 
 
Scheme 6. Synthesis of BODIPY 6. 
BODIPY 7: 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-1,7-dimethyl-3,5-di(thiophen-2-
yl)vinyl-4-bora-3a,4a-diaza-s-indacene (Figure 7) 
BODIPY 7 was previously synthesised and fully characterised by another MSc student at 
Rhodes Univerity;95,151 the photophysical and optical limiting properties were revisited here. 
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Figure 7. Structure of BODIPY 7.  
BODIPY 8: 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,7-dimethyl-3,5-di-styryl-
(4-dimethylaminophenyl)-4-bora-3a,4a-diaza-s-indacene (Scheme 7) 
3-Ethyl-2,4-dimethylpyrrole (2.0 mole eq) and methyl 4-formylbenzoate (1.0 mole eq) were 
dissolved in dry DCM (50 ml) under argon. TFA (2–3 drops) was added and the reaction 
mixture was stirred at room temperature. When the aldehyde was consumed (monitored by 
TLC), a solution of p-chloranil (1.2 mole eq) in dry DCM (10 ml) was added at 0 °C. The 
solution was allowed to warm up to room temperature while stirring for 30 min under 
argon. A deep purple colour was observed and TLC confirmed the synthesis of the 
dipyrromethene. TEA (7 mole eq) and BF3·Et2O (11 mole eq) were added dropwise at 0 °C 
and the mixture was left to stir at room temperature for 12 h. The mixture was then filtered 
and washed with water (100 ml), dried over anhydrous sodium sulphate and the residue 
purified by flash column chromatography eluting with ethyl acetate:petroleum ether (1:4). 
The product, 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4-
bora-3a,4a-diaza-s-indacene was obtained in powder form subsequent to drying. 
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4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-
s-indacene (1 mole eq.) was then mixed with 4-dimethyl amino benzaldehyde (1.4 mole eq.) 
and glacial acetic acid (0.4 mL) in dry benzene (20 mL) under Ar with stirring. Piperidine (0.4 
mL) was added slowly and the solution was heated to reflux for 48 h under Ar.  A Dean-Stark 
trap was deployed for the azeotropic removal of water formed during the condensation 
reaction.  The reaction was quenched with water and the organic phase was dried over 
sodium sulphate. Separation was by flash column chromatography with ethyl 
acetate:petroleum ether (1:4). BODIPY 8 was obtained in 25–30% yield;  FT-IR (cm-1): 2916, 
2853 (C-H stretch), 1712 (C=O), 1436, 1353 (C-N stretch), 1044 (C-N stretch), 1162, 1101 (C-
O), 953 (=C-H bend); 1H NMR (600 MHz, DMF-d7) δ 8.40 (s, 2H), 8.26 (s, 3H), 7.71 (d, J = 40.1 
Hz, 3H), 7.58 (s, 3H), 7.38 (s, 2H), 6.86 (s, 3H), 4.08 (s, 3H), 3.07 (s, 12H), 1.98 (s, 4H), 1.38 (s, 
6H), 1.29 (s, 6H) ppm. MALDI-TOF Anal. calc. m/z 700.38; Found: [M] 700.94. 
 
Scheme 7. Synthesis of BODIPY 8. 
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BODIPY 9: 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,7-dimethyl-3,5-di-styryl-
(4-hydroxyphenyl)-4-bora-3a,4a-diaza-s-indacene (Scheme 8) 
3-Ethyl-2,4-dimethylpyrrole (2.0 mole eq) and methyl 4-formylbenzoate (1.0 mole eq) were 
dissolved in dry DCM (50 ml) under argon. TFA (2–3 drops) was added and the reaction 
mixture was stirred at room temperature. When the aldehyde was consumed (monitored by 
TLC), a solution of p-chloranil (1.2 mole eq) in dry DCM (10 ml) was added at 0 °C. The 
solution was allowed to warm up to room temperature while stirring for 30 min under 
argon. A deep purple colour was observed and TLC confirmed the synthesis of the 
dipyrromethene. TEA (7 mole eq) and BF3·Et2O (11 mole eq) were added dropwise at 0 °C 
and the mixture was left to stir at room temperature for 12 h. The mixture was then filtered 
and washed with water (100 ml), dried over anhydrous sodium sulphate and the residue 
purified by flash column chromatography eluting with ethyl acetate:petroleum ether (1:4). 
The product, 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4-
bora-3a,4a-diaza-s-indacene was obtained in powder form subsequent to drying. 
4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-
s-indacene (1 mole eq.) was then mixed with 4-hydroxybenzaldehyde (1.4 mole eq.) and 
glacial acetic acid (0.4 mL) in dry benzene (20 mL) under Ar with stirring. Piperidine (0.4 mL) 
was added slowly and the solution was heated to reflux for 48 h under Ar. A Dean-Stark trap 
was deployed for the azeotropic removal of water formed during the condensation reaction.  
The reaction was quenched with water and the organic phase was dried over sodium 
sulphate. Separation was by flash column chromatography with ethyl acetate:petroleum 
ether (1:4). BODIPY 9 was obtained in 25–30% yield; FT-IR (cm-1): 3250 (O-H stretch), 2923, 
2858 (C-H stretch), 1718 (C=O), 1437, 1373 (C-N stretch), 1048 (C-N stretch), 1169, 1107 (C-
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O), 966 (=C-H bend); 1H NMR (600 MHz, acetone-d6) δ 8.79 (s, 2H), 8.26 (d, J = 8.2 Hz, 2H), 
7.67 (dd, J = 20.2, 12.5 Hz, 4H), 7.56 (d, J = 8.5 Hz, 4H), 7.36 (d, J = 16.8 Hz, 2H), 6.95 (d, J = 
8.5 Hz, 4H), 3.98(s, 3H), 2.68 (m, 4H), 1.39 (s, 6H), 1.17 (t, J = 7.5 Hz, 6H) ppm. MALDI-TOF 
Anal. calc. m/z 646.28; Found: [M] 646.83. 
 
Scheme 8. Synthesis of BODIPY 9. 
BODIPY 10: 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,7-dimethyl-3,5-di-styryl-
(4-methoxyphenyl)-4-bora-3a,4a-diaza-s-indacene (Scheme 9) 
3-Ethyl-2,4-dimethylpyrrole (2.0 mole eq) and methyl 4-formylbenzoate (1.0 mole eq) were 
dissolved in dry DCM (50 ml) under argon. TFA (2–3 drops) was added and the reaction 
mixture was stirred at room temperature. When the aldehyde was consumed (monitored by 
TLC), a solution of p-chloranil (1.2 mole eq) in dry DCM (10 ml) was added at 0 °C. The 
solution was allowed to warm up to room temperature while stirring for 30 min under 
argon. A deep purple colour was observed and TLC confirmed the synthesis of the 
dipyrromethene. TEA (7 mole eq) and BF3·Et2O (11 mole eq) were added dropwise at 0 °C, 
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and the mixture was left to stir at room temperature for 12 h. The mixture was then filtered 
and washed with water (100 ml), dried over anhydrous sodium sulphate, and the residue 
purified by flash column chromatography eluting with ethyl acetate:petroleum ether (1:4). 
The product, 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4-
bora-3a,4a-diaza-s-indacene was obtained in powder form subsequent to drying. 
4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-
s-indacene (1 mole eq.) was then mixed with 4-methoxybenzaldehyde (1.4 mole eq.) and 
glacial acetic acid (0.4 mL) in dry benzene (20 mL) under Ar with stirring. Piperidine (0.4 mL) 
was added slowly, and the solution was heated to reflux for 48 h under Ar.  A Dean-Stark 
trap was deployed for the azeotropic removal of water formed during the condensation 
reaction.  The reaction was quenched with water and the organic phase was dried over 
sodium sulphate. Separation was by flash column chromatography with ethyl 
acetate:petroleum ether (1:4). BODIPY 10 was obtained in 25–30% yield; FT-IR (cm-1): 2920, 
2855 (C-H stretch), 1722 (C=O), 1446, 1328 (C-N stretch), 1099 (C-N stretch), 1162 (C-O), 
1027 (C-O-C stretch), 966 (=C-H bend) 529 (C-O-C bend); 1H NMR (600 MHz, CDCl3) δ 8.23 (d, 
J = 7.4 Hz, 2H), 7.71 (d, J = 16.8 Hz, 2H), 7.61 (d, J = 8.0 Hz, 4H), 7.50 (d, J = 7.5 Hz, 2H), 7.30 
(s, 2H), 6.99 (d, J = 8.0 Hz, 4H), 4.03 (s, 3H), 3.90 (s, 6H), 2.65 (q, J = 7.1 Hz, 4H), 1.36 (s, 6H), 
1.20 (t, J = 7.5 Hz, 6H) ppm. MALDI-TOF Anal. calc. m/z 674.31; Found: [M] 674.91. 
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Scheme 9. Synthesis of BODIPY 10. 
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Chapter 3:  
Synthesis and spectroscopic 
characterisation of BODIPY 
Dyes 
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The focus of this chapter is on the synthesis of a series of BODIPY cores and their respective 
2,6-dibrominated; and 3,5-substituted, red-shifted π-extended analogues. The BODIPY 
cores, 1a–e (Scheme 1) were prepared for use in further reactions, to produce BODIPY dyes 
with more complex structures. Bromination of these BODIPYs at the 2,6-positions (and on 
one carbon of the meso-phenyl ring for BODIPY 1a) yielded BODIPYs 2a–e (Scheme 2). 
BODIPY 1e was used as a starting reagent for BODIPY 5 (Scheme 5) and BODIPY 2e as a 
starting reagent for BODIPY 6 (Scheme 6), both intended for use in optical limiting 
applications. BODIPYs 2a–c were synthesised for application in the formation of cyclodextrin 
inclusion complexes, while BODIPY 2d was used as a starting reagent for BODIPY 3. Unlike 
the other dyes, BODIPYs 8, 9 and 10 were synthesised from 3-ethyl-2,4-dimethylpyrrole and 
were intended for application in optical limiting studies and in addition, pH-sensing in the 
case of BODIPY 8. Extending the π-conjugation of the BODIPY dyes results in significantly 
red-shifted main spectral bands; the photophysical properties of some of these dyes with an 
extended π-conjugation system were partially investigated to demonstrate singlet oxygen-
generating capability, particularly for those derived from the 2,6-dibrominated dyes.3 The 
singlet oxygen quantum yields of the brominated dyes before styryl extension were also 
investigated by using the comparative chemical method, with DPBF as a singlet oxygen 
quencher.147–151 
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3.1. 4,4’-Difluoro-8-(4-dimethylaminophenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene (1a) 
3.1.1. Synthesis of BODIPY 1a 
BODIPY 1a, a previously reported dye was synthesised both as a precursor for a more 
complex BODIPY dye intended for use in optical limiting applications and for the formation 
of cyclodextrin inclusion complexes.152 The synthesis route was the commonly-used “one-
pot three-step” trifluoroacetic acid-catalysed condensation of 2,4-dimethylpyrrole and 4-
dimethylaminobenzaldehyde using trifluoroacetic acid in DCM (Scheme 10). Unwanted 
polymerisation of the pyrrole unit is eliminated by the presence of the methyl groups on the 
pyrrole 2,4-positions. 
 
Scheme 10. Acid-catalysed one-pot synthesis of BODIPY 1a. 
3.1.2 Structural Analysis of BODIPY 1a 
The signals for all twenty-four protons can be identified in the 1H NMR spectrum. The 
doublets at 7.11–7.08 and 6.86–6.83 ppm each integrate to two protons can be assigned to 
the four phenyl protons. The twelve proton signals that lie at 1.45 and 2.43 ppm can be 
attributed to the twelve methyl protons on the pyrrole core. The singlet signal at 2.97 ppm 
integrates as six protons and can be assigned to the six methyl protons on the 
dimethylamino group. The signal at 6.15 ppm is for the protons at the 2,6-positions of the 
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BODIPY core. The FT-IR spectra contained the peaks anticipated for the BODIPY 
core.150,151,153 Between 2750 and 2950 cm-1 there are bands attributed to the C-H stretch of 
the terminal methyl groups, whereas the N-C stretch bands corresponding to the pyrrolic 
nitrogen atoms lie in the 1050–1360 cm-1 region. The C-H stretch for the bonds at the 2,6-
positions are observed at 468 cm-1 
3.1.3 Spectroscopic properties of BODIPY 1a 
The electronic absorption spectrum for BODIPY 1a is typical of that of a meso-substituted 
BODIPY, with no signs of aggregation and an absorbance maximum at 500 nm in DMSO. 
BODIPY 1a is soluble in both ethanol and DMSO with only a slight blue-shift (ca. 2 nm) 
observed on increased solvent polarity from ethanol to DMSO. It has been suggested that 
this blue-shift arises from the polarisability of the solvent as a similar effect has been 
reported in cyanine-based dyes.154 The absorption, excitation and emission band maxima 
values in the two solvents are summarised below (Table 1) in the absence and presence of 
TFA; the absorption (Abs), excitation (Exc) and emission (Em) spectra in DMSO in the 
presence of TFA are also provided (Figure 8). Additionally, the dye has an emission spectrum 
that is typical for a 1,3,5,7-tetramethyl BODIPY core. Upon protonation, both the absorption 
and emission spectra in DMSO exhibit a 4 nm red shift. As can be seen from the 
fluorescence quantum yield values (Table 1), BODIPY 1a is highly fluorescent in the presence 
of TFA as intense fluorescence emission is only observed when the nitrogen lone pairs in the 
dimethylamino group are protonated. This is due to the elimination of intramolecular 
charge transfer from the nitrogen lone pairs into the BODIPY core. The dye has a negligible 
singlet oxygen quantum yield; this was studied using the comparative method and the dye 
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could not degrade DPBF, as is expected since there are no heavy atoms on the BODIPY core, 
and hence there is no intersystem crossing to the triplet state. 
 
Figure 8. Normalised absorption (red), excitation (grey) and emission (orange) spectra of 
BODIPY 1a in DMSO in the presence of TFA. 
Table 1. Photophysical data for BODIPY 1a in different organic solvents. 
Solvent λAbs 
(nm) 
λExc 
(nm)* 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF log ε* 
DMSO 500 n.d 512 469 0.022 5.30 
Ethanol 498 505 511 511 0.02 NS 
DMSO + TFA 504 503 516 461 0.35 4.84 
Ethanol + TFA 502 501 515 503 0.29 NS 
*NS = not studied; n.d = not detected 
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3.2. 4,4’-Difluoro-8-(4-bromophenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene 
(1b) 
3.2.1. Synthesis of BODIPY 1b 
BODIPY 1b, a previously reported dye was synthesised for use in cyclodextrin inclusion 
complex formation.155–160 The synthesis route was similar to that of BODIPY 1a (Scheme 11). 
 
Scheme 11. Acid-catalysed one-pot synthesis of BODIPY 1b. 
3.2.2 Structural Analysis of BODIPY 1b 
The signals for all eighteen protons can be identified in the 1H NMR spectrum. The doublets 
at 7.78–7.76 and 7.38–7.35 ppm each integrate to two protons can be assigned to the four 
phenyl protons. The twelve proton signals that lie at 1.37 and 2.44 ppm can be attributed to 
the twelve methyl protons on the pyrrole core. The signal at 6.20 ppm arises from the 
protons at the 2,6-positions of the BODIPY core. The FT-IR spectra contained the peaks 
anticipated for the BODIPY core.150,151,153 Between 2850 and 2930 cm-1 there are bands 
attributed to the C-H stretch of the terminal methyl groups, whereas the N-C stretch bands 
corresponding to the pyrrolic nitrogen atoms lie in the 1040–1410 cm-1 region. The C-H 
stretch for the bonds at the 2,6-positions are observed at 470 cm-1 
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3.2.3 Spectroscopic properties of BODIPY 1b 
The electronic absorption spectrum for BODIPY 1b is typical of that of a meso-substituted 
BODIPY, with no signs of aggregation and with an absorbance maximum at 503 nm in 
DMSO, similar to a previously reported value.151 The absorption, excitation and emission 
band maxima values in three different solvents are summarised below (Table 2) and the 
absorption, excitation and emission spectra in DMSO are also provided (Figure 9); the dye 
has an emission spectrum that is typical for a 1,3,5,7-tetramethyl BODIPY core. As can be 
seen from the fluorescence quantum yield values (Table 2), BODIPY 1b is highly fluorescent 
as an intense fluorescence emission is observed. As with 1a, the dye has a negligible singlet 
oxygen quantum yield, since there are no heavy atoms on the BODIPY core. 
Table 2. Photophysical data for BODIPY 1b in different organic solvents. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF log ε* 
DMSO 503 503 516 501 0.83 4.52 
Ethanol 501 
(501# 
503 513 
(513)# 
467 0.94 NS 
Chloroform 504 504 516 461 0.83 NS 
*NS = not studied 
#Previously reported157 
60 
 
 
Figure 9. Normalised absorption (red), excitation (black) and emission (orange) spectra of 
BODIPY 1b in DMSO. 
3.3. 4,4’-Difluoro-8-(4-nitrophenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene (1c) 
3.3.1. Synthesis of BODIPY 1c 
BODIPY 1c, a previously reported dye was synthesised for use in cyclodextrin inclusion 
complex formation.152,161 The synthesis route was similar to that of BODIPYs 1a and 1b 
(Scheme 12). 
 
Scheme 12. Acid-catalysed one-pot synthesis of BODIPY 1c. 
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3.3.2 Structural Analysis of BODIPY 1c 
The signals for all eighteen protons can be identified in the 1H NMR spectrum. The doublets 
at 8.41–8.38 and 7.77–7.74 ppm each integrate to two protons can be assigned to the four 
phenyl protons. The twelve proton signals that lie at 1.34 and 2.46 ppm can be attributed to 
the twelve methyl protons on the pyrrole core. The signal at 6.22 ppm is for the protons at 
the 2,6-positions of the BODIPY core. The FT-IR spectra contained the peaks anticipated for 
the BODIPY core.150,151,153 Between 2850 and 2920 cm-1 there are bands attributed to the C-
H stretch of the terminal methyl groups, whereas the N-C stretch bands corresponding to 
the pyrrolic nitrogen atoms lie in the 1070–1410 cm-1 region. The C-H stretch for the bonds 
at the 2,6-positions are observed at 468 cm-1. 
3.3.3 Spectroscopic properties of BODIPY 1c 
The electronic absorption spectrum for BODIPY 1c is typical of that of a meso-substituted 
BODIPY, with no signs of aggregation and with an absorbance maximum at 505 nm in 
DMSO. The absorption, excitation and emission band maxima values in DMSO are 
summarised below (Table 3) and the absorption, excitation and emission spectra are also 
provided (Figure 10); the dye has an emission spectrum that is typical for a 1,3,5,7-
tetramethyl BODIPY core. As can be seen from the fluorescence quantum yield value (Table 
3), BODIPY 1c is not highly fluorescent and this can be attributed to the quenching effect of 
the nitro group which is known to strongly quench fluorescent dyes through what is 
suggested to be an electron-withdrawing effect.161 As with 1a, the dye has a negligible 
singlet oxygen quantum yield, since there are no heavy atoms on the BODIPY core. 
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Figure 10. Normalised absorption (red), excitation (grey) and emission (orange) spectra of 
BODIPY 1c in DMSO. 
Table 3. Photophysical data for BODIPY 1c in DMSO. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift   
(cm-1) 
ФF log ε 
DMSO 505 506 514 347 0.05 
 
4.77 
  
3.4. 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene (1d) 
3.4.1. Synthesis of BODIPY 1d 
BODIPY 1d, a previously reported dye was synthesised as a precursor for a more complex 
BODIPY dye.162–164 The synthesis route was similar to that of BODIPYs 1a, 1b and 1c (Scheme 
13). 
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Scheme 13. Acid-catalysed one-pot synthesis of BODIPY 1d. 
3.4.2 Structural Analysis of BODIPY 1d 
The signals for all twenty-one protons can be identified in the 1H NMR spectrum. The 
doublets at 8.14–8.11 and 7.58–7.55 ppm each integrate to two protons and can be 
assigned to the four phenyl protons. The twelve proton signals that lie at 1.32 and 2.45 ppm 
can be attributed to the twelve methyl protons on the pyrrole core. The signal at 6.20 ppm 
arises from the protons at the 2,6-positions of the BODIPY core. Finally, the signal at 3.90 
ppm corresponds to the methyl protons of the ester group. The FT-IR spectra contained the 
peaks anticipated for the BODIPY core.150,151,153 Between 2900 and 2960 cm-1 there are 
bands that can be attributed to the C-H stretch of the terminal methyl groups, whereas the 
N-C stretch bands corresponding to the pyrrolic nitrogen atoms lie in the 1180 cm-1 region. 
The C=O ester stretch is observed at 1712 cm-1, whereas the C-O-C antisymmetric stretches 
lie at ca. 1277 and 1062 cm-1. The C-H stretch for the bonds at the 2,6-positions is observed 
at 465 cm-1. 
3.4.3 Spectroscopic properties of BODIPY 1d 
The electronic absorption spectrum for BODIPY 1d is typical of that of a meso-substituted 
BODIPY, with no signs of aggregation and with an absorbance maximum at 503 nm in 
DMSO. The absorption, excitation and emission band maxima values in three different 
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solvents are summarised below (Table 4) and the absorption, excitation and emission 
spectra in DMSO are also provided (Figure 11); the dye has an emission spectrum that is 
typical for a 1,3,5,7-tetramethyl BODIPY core. As can be seen from the fluorescence 
quantum yield values (Table 4), BODIPY 1d is highly fluorescent as intense fluorescence 
emission is observed. As with 1a, the dye has a negligible singlet oxygen quantum yield, 
since there are no heavy atoms on the BODIPY core. 
Table 4. Photophysical data for BODIPY 1d in DMSO and ethanol. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift    
(cm-1) 
ФF log ε* 
DMSO 503 503 518 576 0.59 4.42 
Ethanol 501 500 514 505 0.39 NS 
*NS = not studied 
 
Figure 11. Normalised absorption (red), excitation (black) and emission (orange) spectra of 
BODIPY 1d in DMSO. 
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3.5. 4,4’-Difluoro-8-(4-benzyloxyphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene (1e) 
3.5.1. Synthesis of BODIPY 1e 
BODIPY 1e was synthesised as a precursor for two more complex BODIPY dyes intended for 
use in optical limiting applications. The synthesis route was similar to that of BODIPYs 1a, 
1b, 1c and 1d (Scheme 14) 
 
Scheme 14. Acid-catalysed one-pot synthesis of BODIPY 1e. 
3.5.2 Structural Analysis of BODIPY 1e 
All twenty-five protons can be identified in the 1H NMR spectrum of BODIPY 1e. The protons 
of the benzyloxy phenyl ring appear as a doublet at 7.49 ppm, a triplet at 7.38 ppm and 
another triplet at 7.43 ppm, integrating to two, one and two protons, respectively. The two 
CH2 protons adjacent to the oxygen atom of the benzyloxy group appear at 5.14 ppm. The 
doublet signal at 7.20–7.19 ppm integrates to two protons and represents two of the meso-
phenyl ring protons, with the remaining meso-phenyl ring protons appearing as a doublet 
integrating to two protons, at 7.12–7.10 ppm. The two protons at the 2,6-positions appear 
as a singlet at 6.0 ppm. The singlets at 2.14 and 1.45 ppm each integrate to six protons, 
representing the four methyl groups on the BODIPY core. The FT-IR spectrum of BODIPY 1e 
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contained the peaks anticipated for the BODIPY core.150,151,153 Between 2920 and 2850 cm-1 
there are bands attributed to the C-H stretch of the terminal methyl groups, whereas the N-
C stretch bands corresponding to the pyrrolic nitrogen atoms lie in the 1070–1460 cm-1 
region. The C-O-C stretch for the benzyloxy ether group is observed at 1102 cm-1. The C-H 
stretch for the bonds at the 2,6-positions lies at 468 cm-1. 
3.5.3 Spectroscopic properties of BODIPY 1e 
Spectroscopic characterisation of BODIPY 1e was not carried out, as for the purposes of this 
thesis, there was no intended application for it but it was only used as a starting reagent in 
the syntheses of BODIPYs 2e and 5. 
3.6. 4,4’-Difluoro-8-(3-bromo-4-dimethylaminophenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-
bora-3a,4a-diaza-s-indacene (2a) 
3.6.1. Synthesis of BODIPY 2a 
Halogenation has long been known to be employed in red-shifting the main spectral band of 
BODIPY dyes, with the 2,6-positions of the tetramethyl BODIPY core being the most 
vulnerable to electrophilic attack. BODIPY 2a, a new BODIPY dye was synthesised from 
BODIPY 1a using NBS (Scheme 15). 
 
Scheme 15. Synthesis of the brominated BODIPY 2a. 
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BODIPY 1a and NBS were stirred together in DCM under argon and the reaction monitored 
by TLC. The duration of the reaction was very short due to the high reactivity of NBS. The 
aim was to brominate the 2,6-positions only but upon structural characterisation, an 
additional bromine was found to be present in the meso-phenyl ring.  
3.6.2 Structural Analysis of BODIPY 2a 
All twenty-one protons can be identified in the 1H NMR spectrum of BODIPY 2a (Figure 12). 
The doublet at 7.40–7.39 ppm integrates as two protons and is attributed to two phenyl 
protons; whereas the singlet at 7.69 ppm is representative of the remaining phenyl proton. 
The singlet at 2.89 ppm is attributed to the six methyl group protons of the dimethylamino 
group. The singlets at 2.56 and 1.50 ppm each integrate to six protons, representing the four 
methyl groups on the BODIPY core. The absence of a singlet at 6.22 ppm confirms that the 
hydrogen atoms at the 2,6-positions of BODIPY 1a have been replaced with bromine atoms. 
In the FT-IR spectrum of BODIPY 2a, similar vibrations to that of BODIPY 1a are observed. 
The appearance of a peak at 522 cm-1 confirms bromination, since the peak can be 
attributed to the C-Br stretch associated with bromination of the 2,6-positions of the 
BODIPY core. The predicted molecular mass of 603.93 amu for BODIPY 2a was confirmed by 
MALDI-TOF mass spectrometry as the primary peak occurred at 605.9 amu (+ 1H+) (Figure 
13). 
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Figure 12. 1H NMR spectrum of BODIPY 2a in acetone-d6. 
 
Figure 13. Mass spectrum of BODIPY 2a with the primary peak at 605.9 (2a + 1H+). 
3.6.3 Spectroscopic properties of BODIPY 2a 
The electronic absorption spectrum for BODIPY 2a is typical of that of a tetramethyl 
substituted BODIPY containing heavy atoms at the 2,6-positions, as can be seen in the 
absorbance maximum at 534 nm in DCM. The absorption, excitation and emission band 
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maxima values in different solvents are summarised below (Table 5) in the absence and 
presence of TFA; the absorption, excitation and emission spectra in DMSO in the presence 
of TFA are also provided and show no signs of aggregation (Figure 14). Upon protonation, 
the absorption and emission spectra in DCM exhibit 4 and 14 nm red shifts, respectively.  
Table 5. Photophysical data for BODIPY 2a in different organic solvents.  
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns)* 
log ε* Ф∆* 
DCM 534 537 546 412 0.04 2.23 NS NS 
DCM + TFA 538 540 560 730 0.22 2.42 NS NS 
DMSO 529 532 552  788 0.19 1.98 5.30 NS 
DMSO + TFA 528 532 552 824 0.19 1.37 5.34 0.81 
Ethanol 527 531 549 760 0.29 NS NS  NS 
Ethanol + TFA 530 531 549 653 0.27 NS NS 0.64 
*NS = not studied 
As can be seen from the fluorescence quantum yield values (Table 5), BODIPY 2a only 
fluoresces in the presence of TFA in the less polar DCM but in the more polar ethanol and 
DMSO it is significantly fluorescent even when no TFA is added to eliminate intramolecular 
charge transfer from the nitrogen lone pairs into the BODIPY core (albeit possessing lower 
fluorescence than BODIPY 1a due to the presence of bromines as heavy atoms). The dye has 
significant singlet oxygen quantum yield values; this was studied using the comparative 
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method and the dye degraded the singlet oxygen quencher DPBF, as is expected since there 
are heavy atoms on the BODIPY core, thereby increasing the rate of intersystem crossing to 
the triplet manifold. 
 
Figure 14. Normalised absorption (red), excitation (black) and emission (orange) spectra of 
BODIPY 2a in DCM. 
3.7. 4,4’-Difluoro-8-(4-bromophenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-bora-3a,4a-diaza-
s-indacene (2b) 
3.7.1. Synthesis of BODIPY 2b 
In a similar manner to BODIPY 2a, BODIPY 2b, a previously reported dye was synthesised 
from BODIPY 1b (Scheme 16) by using NBS.160,165 
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Scheme 16. Synthesis of the 2,6-dibrominated BODIPY 2b. 
3.7.2 Structural Analysis of BODIPY 2b 
All sixteen protons can be identified the 1H NMR spectrum of BODIPY 2b. The doublets at 
7.82–7.80 and 7.44–7.41 ppm each integrate as two protons and can be attributed to the 
four phenyl protons. The singlets at 2.52 and 1.37 ppm each integrate to six protons, 
representing the four methyl groups on the BODIPY core. The absence of the singlet at 6.20 
ppm confirms that the hydrogen atoms at the 2,6-positions of BODIPY 1b have been 
replaced with bromine atoms. In the FT-IR spectrum of BODIPY 2b, similar vibrations to that 
of BODIPY 1b are observed. The appearance of a peak at 523 cm-1 confirms bromination, 
since this peak can be attributed to the C-Br stretch associated with bromination of the 2,6-
positions of the BODIPY core. The predicted molecular mass of 560.86 amu for BODIPY 2b 
was confirmed by MALDI-TOF mass spectrometry as the primary peak occurred at 562.63 
amu (+ 1H+). 
3.7.3 Spectroscopic properties of BODIPY 2b 
The electronic absorption spectrum for BODIPY 2b is typical of that of a tetramethyl 
substituted BODIPY containing heavy atoms, as can be seen in the absorbance maximum at 
529 nm in DMSO. The absorption, excitation and emission band maxima values in different 
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solvents are summarised below (Table 6) and the absorption, excitation and emission 
spectra in ethanol are also provided and show no signs of aggregation (Figure 15).  
Table 6. Photophysical data for BODIPY 2b in different organic solvents.  
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns)* 
log ε* Ф∆* 
DCM 
531   
(528) # 
530 547 
(551) # 
 551 0.44 
 
(0.08)# 
 
1.48 NS NS 
DMSO 529 529 548 655 0.25 
 
1.44 4.65 0.57 
Ethanol 528 526 544 557 0.36 
 
1.48 NS NS 
*NS = not studied 
#Previously reported165 
 
Figure 15. Normalised absorption (red), excitation (green) and emission (orange) spectra of 
BODIPY 2b in ethanol. 
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BODIPY 2b has moderately high fluorescence quantum yields albeit with a lower quantum 
yield than BODIPY 1b due to the presence of the heavy atoms. As with 2a, the dye has a 
significant singlet oxygen quantum yield value, since there are heavy atoms on the BODIPY 
core and this enhances the rate of intersystem crossing to the triplet manifold. 
3.8. 4,4’-Difluoro-8-(4-nitrophenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-bora-3a,4a-diaza-s-
indacene (2c) 
3.8.1. Synthesis of BODIPY 2c 
In a similar manner to BODIPYs 2a and 2b, BODIPY 2c was synthesised from BODIPY 1c 
(Scheme 17) by using NBS. 
 
Scheme 17. Synthesis of the 2,6-dibrominated BODIPY 2c. 
3.8.2 Structural Analysis of BODIPY 2c 
All sixteen protons can be identified in the 1H NMR spectrum of BODIPY 2c. The doublets at 
8.57–8.56 and 7.68–7.66 ppm each integrate as two protons and can be attributed to the 
four phenyl protons. The singlets at 2.76 and 1.50 ppm each integrate to six protons, 
representing the four methyl groups on the BODIPY core. The absence of the singlet at 6.22 
ppm confirms that the hydrogen atoms present at the 2,6-positions of BODIPY 1c have been 
replaced with bromine atoms. In the FT-IR spectrum of BODIPY 2c, similar vibrations to that 
of BODIPY 1c are also observed. The appearance of a peak at 531 cm-1 confirms 
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bromination; the peak can be attributed to the C-Br stretch associated with bromination of 
the 2,6-positions of the BODIPY core. The predicted molecular mass of 526.97 amu for 
BODIPY 2c was confirmed by MALDI-TOF mass spectrometry as the primary peak occurred 
at 526.2 amu. 
3.8.3 Spectroscopic properties of BODIPY 2c 
The electronic absorption spectrum for BODIPY 2c is typical of that of a tetramethyl 
substituted BODIPY containing heavy atoms, as can be seen in the absorbance maximum at 
532 nm in DMSO. The absorption, excitation and emission band maxima values in different 
solvents are summarised below (Table 7) and the absorption, excitation and emission 
spectra in DCM are also provided and show no signs of aggregation (Figure 16). BODIPY 2c 
has moderately high fluorescence quantum yields in DCM and ethanol, while in the more 
polar DMSO the low fluorescence quantum yield value is not significantly different to that of 
BODIPY 1c. As with 2a, the dye has a significant singlet oxygen quantum yield value in 
DMSO, since there are heavy atoms on the BODIPY core. 
Table 7. Photophysical data for BODIPY 2c in different organic solvents.  
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns)* 
log ε* Ф∆* 
DCM 535 534 555 674 0.33 1.3 NS NS 
DMSO 532 n.d 556 811 0.04 
 
0.56 5.30 0.64 
Ethanol 530 530 551 719 0.23 
 
n.d NS NS 
*NS = not studied; *n.d = not detected 
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Figure 16. Normalised absorption (red), excitation (green) and emission (orange) spectra of 
BODIPY 2c in DCM. 
3.9. 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-bora-
3a,4a-diaza-s-indacene (2d) 
3.9.1. Synthesis of BODIPY 2d 
In a similar manner to BODIPYs 2a, 2b and 2c, BODIPY 2d was synthesised from BODIPY 1d 
(Scheme 18) by using NBS. 
 
Scheme 18. Synthesis of the 2,6-dibrominated BODIPY 2d. 
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3.9.2 Structural Analysis of BODIPY 2d 
All nineteen protons can be identified in the 1H NMR spectrum of BODIPY 2d. The doublets 
at 8.16–8.14 and 7.64–7.61 ppm each integrate as two protons and can be attributed to the 
four phenyl protons. The signal at 3.91 integrates to three protons, representing the three 
methyl group protons on the ester group. The singlets at 2.52 and 1.31 ppm each integrate 
to six protons, representing the four methyl groups on the BODIPY core. The absence of the 
singlet at 6.20 ppm confirms that the hydrogen atoms present at the 2,6-positions of 
BODIPY 1d have been replaced with bromine atoms. In the FT-IR spectrum of BODIPY 2d, 
similar vibrations to that of BODIPY 1d are observed. The appearance of a peak at 532 cm-1 
confirms bromination, since the peak can be attributed to the C-Br stretch associated with 
bromination of the 2,6-positions of the BODIPY core. The predicted molecular mass of 
539.99 amu for BODIPY 2d was confirmed by MALDI-TOF mass spectrometry as the primary 
peak occurred at 541.27 amu (+ 1H+). 
3.9.3 Spectroscopic properties of BODIPY 2d 
The electronic absorption spectrum for BODIPY 2d is typical of that of a tetramethyl 
substituted BODIPY containing heavy atoms, as can be seen in the absorbance maximum at 
530 nm in DMSO. The absorption, excitation and emission band maxima values in different 
solvents are summarised below (Table 8) and the absorption, excitation and emission 
spectra in ethanol are also provided and show no signs of aggregation (Figure 17). BODIPY 
2d has moderately high fluorescence quantum yields. As with 2a, the dye has a significant 
singlet oxygen quantum yield value, since there are heavy atoms on the BODIPY core. 
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Table 8. Photophysical data for BODIPY 2d in different organic solvents. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns)* 
log ε* Ф∆* 
DCM 531 530 548 584 0.36 1.78 NS NS 
DMSO 530 530 549 653 0.20 
 
1.33 5.0 0.4 
Ethanol 528 527 546 624 0.26 
 
NS NS 0.73 
*NS = not studied 
 
Figure 17. Normalised absorption (red), excitation (green) and emission (orange) spectra of 
BODIPY 2d in ethanol. 
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3.10. 4,4’-Difluoro-8-(4-benzyloxyphenyl)-1,3,5,7-tetramethyl-2,6-dibromo-4-bora-3a,4a-
diaza-s-indacene (2e) 
3.10.1. Synthesis of BODIPY 2e 
In a similar manner to BODIPYs 2a, 2b, 2c and 2d, BODIPY 2e was synthesised from BODIPY 
1e (Scheme 19) using NBS. 
 
Scheme 19. Synthesis of the 2,6-dibrominated BODIPY 2e. 
3.10.2 Structural Analysis of BODIPY 2e 
All twenty-three protons can be identified in the 1H NMR spectrum of BODIPY 2e. The 
protons of the benzyloxy phenyl ring appear as a doublet of doublets at 7.16–7.11 ppm and 
a triplet at 7.43–7.42 ppm, integrating to three and two protons, respectively. The two CH2 
protons adjacent to the oxygen atom of the benzyloxy group lie at 5.17 ppm. The doublet 
signal at 7.48 ppm integrates to two protons and represents two of the meso-phenyl ring 
protons, with the remaining meso-phenyl ring protons appearing as a multiplet integrating 
to two protons, at 7.4–7.37 ppm. The singlets at 2.61 and 1.43 ppm each integrate to six 
protons, representing the four methyl groups on the BODIPY core. The predicted molecular 
mass of 588.09 amu for BODIPY 2e was confirmed by MALDI-TOF mass spectrometry as the 
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primary peak occurred at 588.3 amu. In the FT-IR spectrum of BODIPY 2e, similar vibrations 
to that of BODIPY 1e are observed. The appearance of a peak at 527 cm-1 confirms 
bromination, since the peak can be attributed to the C-Br stretch associated with 
bromination of the 2,6-positions of the BODIPY core. 
3.10.3 Spectroscopic properties of BODIPY 2e 
Spectroscopic characterisation of BODIPY 2e was not carried out for the purposes of this 
thesis, since there was no intended applications for it but it was only used as a starting 
reagent in the synthesis of BODIPY 6. 
3.11. 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-1,5,7-trimethyl-2,6-dibromo-3-mono-styryl-
(4-dimethylamino)-4-bora-3a,4a-diaza-s-indacene (3) 
Substitution at any of the acidic methyl groups typically red-shifts the main absorption 
bands of the BODIPY dye due to delocalisation of the π-system. Additionally, the 
dimethylamino group used here was intended for use in pH sensing applications. 
3.11.1. Synthesis of BODIPY 3 (Scheme 20) 
BODIPY 3 was synthesised using a modified Knoevenagel condensation reaction. BODIPY 2d 
and 4-dimethylaminobenzaldehyde were dissolved in dry benzene with piperidine added to 
initiate the condensation; the reaction was heated to reflux for 48 h and allowed to 
continue under argon with stirring, with constant monitoring using TLC. A Dean-Stark trap 
was used for the azeotropic removal of water formed as a by-product during the 
condensation reaction. The solution changed colour from orange-red to semi-dark green. A 
di-styryl-BODIBPY was expected to form but when left for longer, the product decomposed 
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into a dark brown mixture. BODIPY 3 was obtained by column chromatography by using 
ethyl acetate:petroleum ether (1:4) as the eluent. 
 
Scheme 20. Knoevenagel condensation to form BODIPY 3. 
3.11.2 Structural Analysis of BODIPY 3  
All twenty-eight protons can be identified in the 1H NMR spectrum of BODIPY 2d (Figure 18). 
The doublet of doublets at 8.19–8.14 ppm integrates as four protons and can be attributed 
to the four phenyl protons of the styryl group. The doublet of doublets at 7.55–7.50 ppm 
integrates as four protons and can be attributed to the four phenyl protons of meso-
substituent. The signal at 7.39–7.37 is a doublet and integrates to the two protons of the 
bridging alkene between the styryl group and the core. The signal at 3.97 ppm integrates to 
three protons, representing the three methyl group protons on the ester group. The signal 
at 3.04 ppm integrates to six protons, representing the six dimethylamino group protons on 
the styryl ring. The singlets at 2.62, 1.36 and 1.32 ppm each integrate to three protons, 
representing the three methyl groups on the BODIPY core. The predicted molecular mass of 
671.18 amu for BODIPY 3 was confirmed by MALDI-TOF mass spectrometry as the primary 
peak occurred at 673.96 amu (+ 2H+) (Figure 19). The FT-IR spectra were as expected for the 
BODIPY skeleton.150,151,153 At ca. 2850 cm-1 there are bands attributed to the C-H stretch of 
81 
 
the terminal methyl groups attached to the BODIPY core, whereas the N-C stretch bands 
corresponding to both the pyrrolic nitrogen atoms and the styryl dimethylamino moiety lie 
in the 1060–1435 cm-1 region. The C=O ester stretch is observed at ca. 1715 cm-1, whereas 
the C-O-C antisymmetric stretches are observed at 1163 and 1106 cm-1. The C-Br stretch for 
the bonds at the 2,6-positions lie at 516 cm-1. 
 
Figure 18. 1H NMR spectrum of BODIPY 3 in CDCl3. 
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Figure 19. Mass spectrum of BODIPY 3 with the primary peak at 673.96 (3 + 1H+). 
3.12. 4,4’-Difluoro-8-(4-benzyloxyphenyl)-1,7-dimethyl-3-di-styryl-(4-benzyloxyphenyl)-4-
bora-3a,4a-diaza-s-indacene (5) 
As previously mentioned, the substitution of any of the acidic methyl groups typically red-
shifts the main absorption bands of the BODIPY dye due to delocalisation of the π-system 
and this is helpful in the intended application of BODIPY 5 which is optical limiting.  
3.12.1. Synthesis of BODIPY 5 (Scheme 21) 
BODIPY 5 was synthesised from BODIPY 1e using a modified Knoevenagel condensation 
reaction. The solution changed colour from orange-red to deep ink-blue and when left for 
longer periods, the colour changes to green indicating the formation of a di-styryl-BODIPY 
from the blue mono-styryl. BODIPY 5 was obtained by column chromatography by using 
ethyl acetate:petroleum ether (1:4) as the eluent. 
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Scheme 21. Knoevenagel condensation to form BODIPY 5. 
3.12.2 Structural Analysis of BODIPY 5  
All forty-five protons can be identified in the 1H NMR spectrum of BODIPY 5. The singlet at 
7.60 ppm integrates as four protons and can be attributed to four protons from the phenyl 
of the benzyloxy on the styryl group. The doublet at 7.47 ppm integrates as five protons and 
can be attributed to the five protons of the benzyloxy group. The singlet at 7.42 ppm 
integrates as twelve protons and can be attributed to the three phenyl rings of the 
benzyloxy group, each with four protons and close to the BODIPY core. The doublet at 7.22–
7.20 ppm integrates as three protons and can be attributed to three protons on one of the 
phenyl rings of the benzyloxy group; these are the furthest protons from the BODIPY core. 
The singlet at 7.11 ppm integrates as two protons and can be attributed to one of the 
bridging alkenes between the styryl group and the core; with the second set integrating as 
two protons at 6.92 ppm. The singlet at 7.02 ppm integrates as three protons and can be 
attributed to the remaining three protons on one of the phenyl rings of the benzyloxy 
group. The protons at the 2,6-positions appear as a singlet which integrates to two protons, 
at 6.62 ppm. The singlet signal at 5.13 ppm integrates to four protons and is assigned to the 
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CH2 protons adjacent to the oxygen atoms of the benzyloxy groups on the styryls; while the 
third CH2 group which is of the benzyloxy group appears as a singlet integrating to two 
protons, at 5.03 ppm. The final signal at 1.59 ppm is a singlet which integrates to six 
protons, representing the two methyl groups on the BODIPY core. The predicted molecular 
mass of 818.35 amu for BODIPY 5 was confirmed by MALDI-TOF mass spectrometry as the 
primary peak occurred at 818.93 amu. In the FT-IR spectrum of BODIPY 5, similar vibrations 
to that of BODIPY 1e are also observed. 
3.12.3 Spectroscopic properties of BODIPY 5 
The electronic absorption spectrum for BODIPY 5 is typical of that of a di-styryl substituted 
BODIPY, as can be seen in the absorbance maximum at 649 nm in DMSO. The absorption, 
excitation and emission band maxima values in different solvents are summarised below 
(Table 9) and the absorption, excitation and emission spectra in DMSO are also provided 
and show no signs of aggregation (Figure 20). The relatively intense absorption bands in the 
300–400 nm region are believed to be associated with the benzyloxy substituents.  
Table 9. Photophysical data for BODIPY 5 in DCM and DMSO. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns) 
log ε 
DCM 643 644 657 331 0.15 3.23 4.68 
DMSO 649 649 665 371 0.13 3.74 5.23 
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BODIPY 5 has a relatively low but significant fluorescence quantum yield value. No singlet 
oxygen generation was observed when the comparative method was used with DPBF as the 
scavenger, due to the absence of heavy atoms to promote intersystem crossing. 
 
Figure 20. Normalised absorption (red), excitation (green) and emission (orange) spectra of 
BODIPY 5 in DMSO. 
3.13. 4,4’-Difluoro-8-(4-benzyloxyphenyl)-1,7-dimethyl-2,6-dibromo-3-di-styryl-(4-
benzyloxyphenyl)-4-bora-3a,4a-diaza-s-indacene (6) 
As previously mentioned, the substitution of any of the acidic methyl groups typically red-
shifts the main absorption bands of the BODIPY dye due to delocalisation of the π-system 
and this is useful in the intended application of BODIPY 6 which is optical limiting. Also, it 
should be noted that the presence of the bromines as heavy atoms serves a function in 
studying the optical limiting applications (Chapter 4). 
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3.13.1. Synthesis of BODIPY 6 (Scheme 22) 
BODIPY 6 was synthesised from BODIPY 2e by using a modified Knoevenagel condensation 
reaction. The solution changed colour from orange-red to deep ink-blue and when left for 
longer periods, the colour changes to green indicating the formation of a di-styryl-BODIPY 
from the blue mono-styryl dye. BODIPY 6 was obtained by column chromatography by using 
ethyl acetate:petroleum ether (1:4) as the eluent. 
 
Scheme 22. Knoevenagel condensation to form BODIPY 6. 
3.13.2 Structural Analysis of BODIPY 6  
All forty-three protons can be identified in the 1H NMR spectrum of BODIPY 6. The three 
phenyl rings closest to the BODIPY core have their protons appearing as two sets, combined; 
at 7.65–7.62 ppm and 7.48 ppm there is a doublet and a singlet, respectively, each 
integrating to six protons and thereby totalling twelve protons with four on each ring. The 
doublet at 8.14–8.11 ppm integrates as two protons and can be attributed to the two 
protons of the benzyloxy group closest to the linking oxygen. The furthest protons from the 
BODIPY core for both styryl groups appear as a singlet integrating to six protons at 7.42 
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ppm, arising from three protons on each ring. The singlet at 7.37 ppm integrates as three 
protons and can be attributed to three protons on the phenyl rings of the benzyloxy group; 
these are the furthest protons from the BODIPY core for the meso-substituent. The singlet 
at 7.15 ppm integrates as two protons and can be attributed to one set of benzyloxy group 
phenyl protons furthest from the core; the second set is observed at 7.20 ppm. The singlet 
at 7.05 ppm integrates as four protons and can be attributed bridging alkenes between the 
styryl group and the core. The doublet signal at 5.17 ppm integrates to six protons and is 
assigned to the CH2 protons adjacent to the oxygen atoms of the benzyloxy groups on both 
the styryls and the benzyloxy group. The final signal at 1.49 ppm is a singlet which integrates 
to six protons, representing the two methyl groups on the BODIPY core. The predicted 
molecular mass of 976.17 amu for BODIPY 6 was confirmed by MALDI-TOF mass 
spectrometry as the primary peak occurred at 976.71 amu. In the FT-IR spectrum of BODIPY 
6, similar vibrations to that of BODIPY 5 are also observed. The appearance of a peak at 522 
cm-1 confirms bromination; the peak can be attributed to the C-Br stretch associated with 
bromination of the 2,6-positions of the BODIPY core.  
3.13.3 Spectroscopic properties of BODIPY 6 
The electronic absorption spectrum for BODIPY 6 is typical of that of a di-styryl substituted 
BODIPY, as can be seen in the absorbance maximum at 667 nm in DMSO which is more red-
shifted than BODIPY 5 due to the presence of heavy atoms at the 2,6-positions. The 
absorption, excitation and emission band maxima values in different solvents are 
summarised below (Table 10) and the absorption, excitation and emission spectra in DMSO 
are also provided and show no signs of aggregation (Figure 21). The absorption bands in the 
300–400 nm region are associated with the benzyloxystyryl substituents. BODIPY 6 exhibits 
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moderate fluorescence. Due to the presence of heavy atoms, 6 has a significant singlet 
oxygen quantum yield value in DMSO. 
Table 10. Photophysical data for BODIPY 6 in different organic solvents. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns) 
log ε Ф∆* 
DCM 663 665 685 484 0.16 3.98 4.93 NS 
DMSO 667 669 700 707 0.13 
 
3.56 4.50 0.30 
*NS = not studied 
 
Figure 21. Normalised absorption (red), excitation (green) and emission (orange) spectra of 
BODIPY 6 in DMSO. 
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3.14. 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,7-dimethyl-3,5-di-styryl-(4-
dimethylaminophenyl)-4-bora-3a,4a-diaza-s-indacene (8) 
The substitution of any of the acidic methyl groups on the BODIPY core typically red-shifts 
the main absorption bands of the BODIPY dye due to delocalisation of the π-system and this 
is helpful in optical limiting, one of the intended applications of BODIPY 8.  
3.14.1. Synthesis of BODIPY 8 (Scheme 23) 
BODIPY 8 was synthesised from 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene by using a modified Knoevenagel condensation 
reaction. The solution changed colour from orange-red to light brown-red indicating the 
formation of a di-styryl-BODIPY. BODIPY 8 was obtained by column chromatography by 
using ethyl acetate:petroleum ether (1:4) as the eluent. 
 
 
Scheme 23. Knoevenagel condensation to form BODIPY 8. 
3.14.2 Structural Analysis of BODIPY 8  
All forty-seven protons can be identified in the 1H NMR spectrum of BODIPY 8.  The singlet 
at 8.40 ppm integrates as two protons and can be attributed to two protons from one of the 
phenyl rings on the styryls, while the singlet at 8.26 ppm integrates as three protons and can 
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be attributed to three protons from the other phenyl ring on the styryls. The rest of the 
styryl phenyl protons appear as a doublet which integrates as three protons, at 7.71 ppm. 
The singlet at 7.58 ppm integrates as three protons and can be attributed to three protons 
from the meso-phenyl ring, with the remaining proton found in the singlet at 7.38 ppm 
(notwithstanding the fact that the singlet integrates to two protons). The singlet at 6.86 
ppm integrates as three protons and can be attributed to three protons from the bridging 
alkenes between the styryl group and the core, with the remaining proton of the bridging 
alkenes found at 7.38 ppm. The ester group protons appear as a singlet integrating to three 
protons, at 4.08 ppm. The dimethylamino protons from the styryls are found as a singlet 
integrating to twelve protons, at 3.07 ppm. At 1.98 ppm, a singlet integrating to four 
protons appears and it represents the two CH2 groups of the ethyl groups at the 2,6-
positions, with the CH3 groups of the same group appearing as a singlet which integrates to 
six protons at 1.29 ppm. The final signal at 1.38 ppm is a singlet which integrates to six 
protons, representing the two methyl groups on the BODIPY core. The predicted molecular 
mass of 700.38 amu for BODIPY 8 was confirmed by MALDI-TOF mass spectrometry as the 
primary peak occurred at 700.94 amu. The FT-IR spectrum, with bands attributed to the C-H 
stretch of the terminal methyl groups attached to the BODIPY core found at 2916 and 2853 
cm-1. The C=O ester stretch is observed at 1712 cm-1, whereas the C-O-C antisymmetric 
stretches are at 1162 and 1101 cm-1. The N-C stretch bands corresponding to both the 
pyrrolic nitrogen atoms and the styryl dimethylamino moiety lie in the 1044–1436 cm-1 
region.  
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3.14.3 Spectroscopic properties of BODIPY 8 
The electronic absorption spectrum for BODIPY 8 in the presence of an acid is typical of that 
of a di-styryl substituted BODIPY, as can be seen in the absorbance maximum at 730 nm in 
DMSO which is more red-shifted than all the other BODIPYs previously mentioned in this 
thesis. The absorption, excitation and emission band maxima values in different solvents are 
summarised below (Table 11) and the absorption, excitation and emission spectra in 
benzene with excess TFA are also provided and show no signs of aggregation (Figure 22). 
BODIPY 8 exhibits moderate fluorescence in the presence of acid due to the elimination of 
charge transfer. 
 
Figure 22. Normalised absorption (red), excitation (green) and emission (black) spectra of 
BODIPY 8 in benzene in the presence of TFA. 
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Table 11. Photophysical data for BODIPY 8 in different organic solvents in the 
presence and absence of TFA. 
Solvent λAbs 
(nm) 
λExc 
(nm)* 
λEm 
(nm)* 
Stokes shift 
(cm-1) 
ФF τF 
(ns)* 
log ε* 
Benzene 714 660 680; 
754 
743 0.09 2.63 5.07 
Benzene + TFA 638 639 658 476 0.27 4.60 NS 
DCM 715 657 673; 
761 
845 0.04 2.05 4.25 
DCM + TFA 636 641 660 572 0.16 4.60 NS 
Acetonitrile 711 717 794 1470 0.02 NS 4.60 
Acetonitrile + 
TFA 
622 633 655 810 0.02 NS NS 
DMSO 730  n.d  n.d  - 0.02 0.75 
(97%) 
3.301 
(3.2%) 
4.05 
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DMSO + TFA 633 633 662 692 0.03 0.26 
(73%) 
1.99 
(27.1%) 
NS 
*NS = not studied; *n.d =not detected 
3.15. 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,7-dimethyl-3,5-di-styryl-(4-
hydroxyphenyl)-4-bora-3a,4a-diaza-s-indacene (9) 
The substitution of any of the acidic methyl groups on the BODIPY core typically red-shifts 
the main absorption bands of the BODIPY dye due to delocalisation of the π-system and this 
is helpful in the intended application of BODIPY 9, which is optical limiting.  
3.15.1. Synthesis of BODIPY 9 (Scheme 24) 
BODIPY 9 was synthesised from 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene using a modified Knoevenagel condensation 
reaction. The solution changed colour from orange-red to a deep green colour indicating the 
formation of a di-styryl-BODIPY. BODIPY 9 was obtained by column chromatography by 
using ethyl acetate:petroleum ether (1:4) as the eluent. 
 
Scheme 24. Knoevenagel condensation to form BODIPY 9. 
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3.15.2 Structural Analysis of BODIPY 9  
All thirty-seven protons can be identified in the 1H NMR spectrum of BODIPY 9. The singlet 
at 8.79 ppm integrates as two protons and can be attributed to two protons from the meso-
phenyl ring, while the doublet at 8.26 ppm integrates as two protons and can be attributed 
to the two remaining protons of the meso-phenyl ring. The styryl phenyl protons appear as 
two doublets, each integrating as four protons, at 7.67 and 7.56 ppm. The doublet at 7.36 
ppm integrates as two protons and can be attributed to the two protons from the hydroxyl 
groups on the styryls. At 6.95 ppm, the doublet integrates to four protons and can be 
attributed to the four protons of the bridging alkenes. The ester group protons appear as a 
singlet integrating to three protons, at 3.98 ppm. At 2.68 ppm, a multiplet integrating to 
four protons appears and it represents the two CH2 groups of the ethyl groups at the 2,6-
positions, with the CH3 groups of the same ethyl groups appearing as a triplet which 
integrates to six protons at 1.17 ppm. The final signal at 1.39 ppm is a singlet which 
integrates to six protons, representing the two methyl groups on the BODIPY core. The 
predicted molecular mass of 646.28 amu for BODIPY 9 was confirmed by MALDI-TOF mass 
spectrometry as the primary peak occurred at 646.83 amu. The FT-IR spectrum contained 
the anticipated peaks, with bands attributed to the C-H stretch of the terminal methyl 
groups attached to the BODIPY core found at 2923 and 2858 cm-1. The C=O ester stretch is 
observed at 1718 cm-1, whereas the C-O-C antisymmetric stretches are at 1169 and 1107 
cm-1. The N-C stretch bands corresponding to the pyrrolic nitrogen atoms lie in the 1048–
1437 cm-1 region. The O-H stretch from the styryls is found at ca. 3250 cm-1. 
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3.15.3 Spectroscopic properties of BODIPY 9 
 
Figure 23. Normalised absorption (red), excitation (green) and emission (black) spectra of 
BODIPY 9 in DCM. 
Table 12. Photophysical data for BODIPY 9 in different organic solvents. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns) 
log ε 
Benzene 658 659 676 405 0.18 3.49 4.50 
DCM 653 653 674 477 0.19 3.73 4.56 
Acetonitrile 651 657 680 655 0.14 3.66 5.40 
The electronic absorption spectrum for BODIPY 9 is typical of that of a di-styryl substituted 
BODIPY, as can be seen in the absorbance maximum at 653 nm in DCM. The absorption, 
excitation and emission band maxima values in different solvents are summarised above 
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(Table 12) and the absorption, excitation and emission spectra in DCM are also provided 
and show no signs of aggregation (Figure 23). BODIPY 9 exhibits moderate fluorescence. The 
quantum yield and lifetime values are also recorded. 
3.16. 4,4’-Difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,7-dimethyl-3,5-di-styryl-(4-
methoxyphenyl)-4-bora-3a,4a-diaza-s-indacene (10) 
The substitution of any of the acidic methyl groups on the BODIPY core typically red-shifts 
the main absorption bands of the BODIPY dye due to delocalisation of the π-system and this 
is helpful in the intended application of BODIPY 10 which is optical limiting.  
3.16.1. Synthesis of BODIPY 10 (Scheme 25) 
BODIPY 10 was synthesised from 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-
1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene by using a modified Knoevenagel 
condensation reaction. The solution changed colour from orange-red to a deep green colour 
indicating the formation of a di-styryl-BODIPY. BODIPY 10 was obtained by column 
chromatography by using ethyl acetate:petroleum ether (1:4) as the eluent. 
 
Scheme 25. Knoevenagel condensation to form BODIPY 10. 
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3.16.2 Structural Analysis of BODIPY 10  
All forty-one protons can be identified in the 1H NMR spectrum of BODIPY 10. The doublet 
at 8.23 ppm integrates as two protons and can be attributed to two styryl phenyl protons, 
with the second set of two protons appearing as a doublet at 7.71 ppm. At 7.61 ppm, the 
doublet integrates as four protons and can be attributed to the four phenyl protons from 
the second styryl. The four meso-phenyl ring protons are represented by two different 
signals; a doublet at 7.50 ppm and a singlet at 7.30 ppm, each integrating to two protons. At 
6.99 ppm, the doublet integrates to four protons and can be attributed to the four protons 
of the bridging alkenes.  The ester group protons appear as a singlet integrating to three 
protons, at 4.03 ppm. The singlet at 3.90 ppm integrates as six protons and can be 
attributed to the six protons from the CH3 groups of the methoxy groups on the styryls. At 
2.65 ppm, a quartet integrating to four protons appears and it represents the two CH2 
groups of the ethyl groups at the 2,6-positions, with the CH3 groups of the same ethyl 
groups appearing as a triplet which integrates to six protons at 1.20 ppm. The final signal at 
1.36 ppm is a singlet which integrates to six protons, representing the two methyl groups on 
the BODIPY core. The predicted molecular mass of 674.31 amu for BODIPY 10 was 
confirmed by MALDI-TOF mass spectrometry as the primary peak occurred at 674.91 amu. 
The FT-IR spectrum contained the anticipated peaks, with bands attributed to the C-H 
stretch of both the terminal methyl groups attached to the BODIPY core and those of the 
methyl groups of the styryl methoxy moieties found at ca. 2920 and 2855 cm-1. The C=O 
ester stretch is observed at 1722 cm-1, whereas the C-O-C antisymmetric stretch of the ester 
group lies at 1162 cm-1. The N-C stretch bands corresponding to the pyrrolic nitrogen atoms 
are observed in the 1099–1446 cm-1 region. The C-O-C stretch from the methyl groups of 
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the styryl methoxy moieties is found at 1027 cm-1, whereas the corresponding C-O-C bend 
lies at 529 cm-1. 
3.16.3 Spectroscopic properties of BODIPY 10 
The electronic absorption spectrum for BODIPY 10 is typical of that of a di-styryl substituted 
BODIPY, as can be seen in the absorbance maximum at 654 nm in DCM. The absorption, 
excitation and emission band maxima values in benzene and DCM are summarised below 
(Table 13) and the absorption, excitation and emission spectra in benzene are also provided 
and show no signs of aggregation (Figure 24). BODIPY 10 exhibits moderate fluorescence. 
The quantum yield and lifetime values are also recorded. 
 
Figure 24. Normalised absorption (red), excitation (green) and emission (black) spectra of 
BODIPY 10 in benzene. 
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Table 13. Photophysical data for BODIPY 10 in benzene and DCM. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns) 
log ε 
Benzene 662 664 680 400 0.20 3.97 4.73 
DCM 654 659 680 585 0.19 2.50 
(46.2%) 
4.89 
(53.8%) 
4.73 
3.17. Spectroscopic characterisation of previously synthesised BODIPY Dyes 
3.17.1 Spectroscopic properties of BODIPY 4, 4,4’-difluoro-8-(4-dimethylamino)-1,7-
dimethyl-2,6-dibromo-3,5-di-styryl-(4-benzo-15-crown-5)-4-bora-3a, 4a-diaza-s-indacene 
The electronic absorption spectrum for BODIPY 4 is typical of that of a di-styryl substituted 
BODIPY, as can be seen in the absorbance maximum at 681 nm in DMSO which is highly red-
shifted relative to BODIPY 1a due to the presence of the bromines as heavy atoms at the 
2,6-positions and the crown-ether-substituted styryl moieties at the 3,5-positions. The 
absorption, excitation and emission band maxima values in different solvents are 
summarised below (Table 14) and the absorption, excitation and emission spectra in DCM 
are also provided and show no signs of aggregation (Figure 25). The relatively intense 
absorption bands in the 300–400 nm region are believed to be associated with the crown 
ether substituents. 
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Figure 25. Normalised absorption (red), excitation (green) and emission (orange) spectra of 
BODIPY 4 in DCM. 
Table 14. Photophysical data for BODIPY 4 in different organic solvents. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns) 
log ε 
Benzene 682 683 708 539 0.12 3.52 4.61 
DCM 675 675 707 671 0.14 3.57 4.65 
THF 676 678 709 689 0.11 3.41 4.80 
Acetonitrile 676 676 707 649 0.05 2.02 4.97 
DMSO 681 688 721 815 0.02 2.59 5.0 
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3.17.2 Spectroscopic properties of BODIPY 7, 4,4’-difluoro-8-(4-carbomethoxyphenyl)-1,7-
dimethyl-3,5-di(thiophen-2-yl)vinyl-4-bora-3a,4a-diaza-s-indacene 
The electronic absorption spectrum for BODIPY 7 is typical of that of a di-styryl substituted 
BODIPY, as can be seen in the absorbance maximum at 660 nm in DMSO which is red-shifted 
due to the presence of the thienylvinylene substituents at the 3,5-positions. The absorption, 
excitation and emission band maxima values in different solvents are summarised below 
(Table 15) and the absorption, excitation and emission spectra in DMSO are also provided 
and show no signs of aggregation (Figure 26). The relatively intense absorption bands in the 
300–400 nm region are believed to be associated with the thienylvinylene groups. 
Table 15. Photophysical data for BODIPY 7 in different organic solvents. 
Solvent λAbs 
(nm) 
λExc 
(nm) 
λEm 
(nm) 
Stokes shift 
(cm-1) 
ФF τF 
(ns) 
log ε 
Benzene 659 659 672 294 0.56 2.99 4.13 
DCM 654 656 667 298 0.50 2.95 4.89 
THF 651 653 664 301 0.46 2.95 5.29 
Acetonitrile 646 646 661 351 0.46 3.01 5.36 
DMSO 660 661 677 381 0.13 2.80 5.44 
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Figure 26. Normalised absorption (red), excitation (green) and emission (orange) spectra of 
BODIPY 7 in DMSO. 
Concluding remarks 
Five BODIPY cores, 1a–1e, were synthesised using the classic “one-pot three-step” acid-
catalysed condensation reaction and structurally characterised using various techniques. 
The only structural difference between these BODIPY dyes is the functional groups present 
on the para-position of the meso-phenyl ring. In addition to structural characterisation, 
photophysical characterisation were performed for 1a–1d, which have broadly similar 
absorption properties as is typical from BODIPY dyes derived from 2,4-dimethylpyrrole, 
since the meso-aryl ring lies orthogonal to the BODIPY cores. The dyes do, however, differ 
significantly when it comes to fluorescence properties, although both the lifetimes and 
quantum yields lie in the range generally expected for BODIPY dyes.5 BODIPY 1a is only 
highly fluorescent in the presence of acid to eliminate charge transfer between the 
dimethylamino moiety and the BODIPY core, while BODIPY 1c also possessed weak 
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fluorescence due to the quenching effect of the nitro group which is known to strongly 
quench fluorescent dyes through what is suggested to be an electron-withdrawing effect.161 
BODIPYs 1b and 1d are highly fluorescent in a manner that is independent of solvent 
polarity, since the absorption maximum was not significantly altered by changing the 
solvent. BODIPYs 1a–1e were brominated at the 2,6-positions (and BODIPY 1a on one of the 
carbons of the meso-phenyl ring), yielding BODIPYs 2a–2e whose absorption spectra are red 
shifted by ca. 30 nm relative to their parent dyes (particularly BODIPYs 2a–2d which were of 
spectroscopic interest here). BODIPYs 2a–2d possessed significant singlet oxygen quantum 
yields. It is worth noting that BODIPYs 1a–1d and 2b–2d were not novel and have been 
previously reported in literature. To the best of our knowledge, the only novelty in this 
regard was the detailed photophysical characterisation undertaken herein. 
BODIPY 2d was used to synthesise BODIPY 3, a new mono-styryl BODIPY dye whose 
structural characterisation was also successful. Five novel di-styryl BODIPYs, BODIPYs 5, 6, 8, 
9 and 10 were synthesised from BODIPYs 1e and 2e for BODIPYs 5 and 6, respectively and 
from 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4-bora-3a,4a-
diaza-s-indacene which was synthesised using the classic “one-pot three-step” acid-
catalysed condensation reaction, for BODIPYs 8, 9 and 10 . BODIPYs 3, 5, 6, 8, 9 and 10 were 
synthesised using a modified version of the Knoevenagel condensation reaction from their 
respective starting BODIPYs. These dyes were characterised using 1H-NMR, MALDI-TOF mass 
spectrometry and FT-IR. Their main absorption band maxima are significantly red-shifted far 
beyond 532 nm, the second harmonic of the Nd:YAG laser which is used to study the optical 
limiting properties of these dyes, as discussed in Chapter 4. BODIPY 6 was red-shifted into 
the therapeutic window, with absorption maxima at 663 in DCM and 667 nm in DMSO; this 
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red-shift coupled with the ability of the dye to generate singlet oxygen species (as is evident 
with the quantum yield of 0.3 in DMSO) makes the dye a potential photosensitizer for 
singlet oxygen applications such as PDT. In addition to studying the optical limiting 
properties of BODIPY 8, this dye was also designed for study as a pH-sensitive fluorescent 
probe for potential biomedical applications, as discussed in Chapter 6. 
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Chapter 4:  
Nonlinear optical (NLO) limiting 
properties of BODIPY dyes in 
solution  
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The goal of this chapter is to investigate the NLO properties of a series of 3,5-divinylene-
substituted BODIPY dyes (Figure 27), some of which contain electron withdrawing and 
electron donating groups separated by a π-conjugation system to form D-π-A type systems. 
BODIPY 4 contains the electron donating dimethylaminophenyl group at the meso-position 
and crown ether moieties on the styryl rings and was studied in benzene, DCM, THF, 
acetonitrile and DMSO solutions to assess the effects of differences in solvent polarity. 
BODIPYs 5 and 6 were studied in DCM solutions and as is evident from their somewhat 
identical structures (Figure 27), the motivation for studying these compounds was to look at 
the effect of the presence of heavy atoms in the form of bromine. BODIPY 7 was studied in 
DCM, THF, acetonitrile and DMSO solutions to assess the effects of differences in solvent 
polarity with the added effect of the absence of heavy atoms to promote intersystem 
crossing which is known to enable ESA in the triplet manifold. BODIPYs 8, 9 and 10 are 2,6-
diethyl-substituted BODIPY dyes containing a moderately electron withdrawing ester group 
on the meso-phenyl ring and strongly electron donating groups at the 3,5-positions. This 
creates a strong permanent dipole moment in the ground state. All seven dyes possess an 
extended π-system and BODIPYs 4 and 6 contain bromine heavy atoms and as such an 
enhanced optical limiting response is expected since optical limiter materials with heavy 
atoms incorporated have previously shown to perform better in the context of 
phthalocyanines.107–109 During the z-scan measurements on these compounds, there was a 
consistent effort to ensure that the dye being studied was not aggregated in solution by 
carefully checking the UV-visible absorption spectra before and after measurement, since 
aggregation could lead to significant NLS and as such interfere with the NLA results. 
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Figure 27. BODIPY dyes used for the NLO studies. 
It is worth noting that the z-scan setup being used employs nanosecond and not 
femtosecond laser pulses, hence the RSA responses observed as the focal point is 
approached during the z-scan measurements are expected not to be strictly due to 2PA. This 
means that the 2PA intrinsic β value cannot be measured and instead, the effective 
nonlinear absorption coefficient (βeff) is determined, since ESA that occurs on a nanosecond 
timescale can also result in an RSA response.166,97 When ESA is more intense than ground 
state absorption, there is a positive nonlinear absorption coefficient and a decrease in 
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transmittance as the material approaches the zero position of the z-scan instrument at high-
intensity incident light levels.166 
I. Optical limiting properties of BODIPY 4 
The optical limiting ability of the di-styryl crown ether BODIPY was assessed in benzene, 
DCM, THF, acetonitrile and DMSO and in all solvents the main absorption band lies ca. 145 
nm to the red of the Nd:YAG laser’s second harmonic wavelength at 532 nm with minimal 
absorbance at this wavelength (Figure 28), and this provides the possibility of a good NLO 
response. 
 
Figure 28. Normalised absorption spectra of the di-styryl crown ether BODIPY (4) in different 
organic solvents. 
To study the effects of the amount of dye present, two different concentrations were 
studied for each solvent. NLO responses can be studied by following the reduction in 
transmittance along the z-axis, which shows a positive nonlinear absorption. The responses 
in this study were characteristic of RSA.167–169 The studies were conducted at four energies 
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in terms of each incident laser pulse, in all solvents, but the z-scan plots (Figure 29–Figure 
33) are limited only to two energies in terms of each incident laser pulse, i.e. a comparative 
study between a lower and a higher energy. The results for the other incident laser pulse 
intensities are included in the tables (Table 16–Table 20). 
 
Figure 29. Characteristic open-aperture z-scans of the di-styryl crown ether BODIPY (4) in 
benzene at A: input intensity of 10 µJ for each laser pulse and a concentration of 3.35 × 10−6 
M, B: input intensity of 40 µJ and a concentration of 3.35 × 10−6 M, C: input intensity of 10 µJ 
and a concentration of 6.85 × 10−6 M and D: input intensity of input intensity of 40 µJ and a 
concentration of 6.85 × 10−6 M. 
The open-aperture z-scan plots obtained at both dye concentrations studied in benzene 
were able to reduce transmittance below 50% and an increase in dye concentration 
significantly reduces transmittance by the BODIPY solution (Figure 29A and Figure 29C). The 
transmittance is also reduced more when higher energy incident laser pulses are used at 
each concentration. 
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In order to study the efficiency of this dye as an OL material, the main OL parameters were 
studied. These parameters include the nonlinear absorption coefficient (βeff), imaginary 
third-order susceptibility (Im[χ(3)]), second order hyperpolarizability (γ) and the limiting 
intensity (Ilim). The parameters that will be discussed here are limited only to those solutions 
which were able to reduce transmittance by at least 50%, since this is viewed as a 
prerequisite for a good optical limiter (Table 16). The βeff value provides a measure of the 
effective degree of nonlinear absorptivity when measurements are made on a nanosecond 
timescale. A positive nonlinear absorption coefficient is an indication that the optical limiter 
being studied possesses reverse saturable absorption and as a result is characterised by a 
high transmittance at normal light intensities and a decrease in transmittance under high 
intensity.93 The Im[χ(3)] value is a measure of the rapidity of response by an optical limiter to 
the perturbation induced by incident laser pulses, whereas the γ value provides a measure 
of the interaction of the incident photon with the permanent dipole moments of the OL 
material. The Ilim value is defined as the threshold input energy or fluence at which a 
decrease to 50% transmittance is achieved.93 The lower the optical limiting threshold, the 
better the optical limiting material. As described in Chapter 1, to avoid damage to the 
human eye, the limiting threshold should be 0.95 J.cm−2 or lower for 10 ns laser pulses at 
532 nm.168,105,106 
For BODIPY 4, the OL parameters are tabulated and are ordered according to increasing 
solvent polarity (Table 16–Table 20). In each case, the Im[χ(3)] and γ values lie in the optimal 
range that has been reported for these parameters (see Chapter 1) and this clearly 
demonstrates that this dye is potentially useful as an optical limiting material and merits 
further study in this regard. This was not unexpected, since similar results were recently 
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obtained by Harris et al.95 and Kubheka et al.96 for BODIPY dyes and an aza-BODIPY dye, 
respectively.  
In the optical limiting parameters for the benzene solutions (Table 16), a better optical 
limiting response is observed for the lower energy laser pulses, since the general trend is a 
decrease in βeff, Im[χ(3)] and γ values with an increase in pulse energy. Also, an increase in 
the concentration of the dye present in solution seems to give a significantly better optical 
limiting response, as seen with βeff and Im[χ(3)] values increasing with an increase in 
concentration. The γ values, however, follow an opposite trend with higher values observed 
for the lower concentration. The limiting intensity values were determined experimentally 
at 50% transmittance and a lower threshold response is obtained with an increase in 
concentration and a decrease in the laser pulse energy (Table 16). 
Table 16. NLO parameters for the di-styryl crown ether BODIPY (4) in benzene.  
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3)] 
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
3.35 × 10-6 
~10 
1.26 
343.1 8.29 × 10-10 1.02 × 10-28 0.46 
~20 277.7 6.71 × 10-10 8.23 × 10-29 0.56 
~30 249.3 6.03 × 10-10 7.39 × 10-29 0.87 
~40 209.6 5.07 × 10-10 6.21 × 10-29 1.02 
6.85 × 10-6 
~10 
2.41 
563.7 1.36 × 10-9 8.18 × 10-29 0.40 
~20 440.9 1.07 × 10-9 6.40 × 10-29 0.47 
~30 369.0 8.92 × 10-10 5.35 × 10-29 0.57 
~40 270.5 6.54 × 10-10 3.92 × 10-29 0.78 
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The open-aperture z-scan plots obtained using DCM show that both concentrations studied 
were able to reduce transmittance far below 50%, demonstrating the ability of the dye to 
perform as an optical limiter. It was observed that an increase in concentration significantly 
reduces transmittance by the BODIPY solution (Figure 30A and Figure 30C). Additionally, the 
transmittance is reduced more for the higher energy at each concentration (Figure 30C and 
Figure 30D), as was the case in benzene solution. 
 
Figure 30. Characteristic open-aperture z-scans of the di-styryl crown ether BODIPY (4) in 
DCM at A: input intensity of 10 µJ for each laser pulse and a concentration of 2.22 × 10−5 M, 
B: input intensity of 40 µJ and a concentration of 2.22 × 10−5 M, C: input intensity of 10 µJ 
and a concentration of 5.54 × 10−5 M and D: input intensity of input intensity of 40 µJ and a 
concentration of 5.54 × 10−5 M. 
In DCM, a better optical limiting response in terms of the βeff and Im[χ(3)] values is observed 
at higher concentrations and for the lower energy laser pulses in a similar manner to what 
was observed in benzene (Table 17). The γ values, however, did not follow any specific 
trend with somewhat similar values observed for both concentrations, but were generally 
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higher for the lower concentration. Lower Ilim values are obtained with an increase in 
concentration and a decrease in laser pulse energy (Table 17). 
Table 17. NLO parameters for the di-styryl crown ether BODIPY (4) in DCM. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3) ]  
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
2.22 × 10-5 
~10 
0.77 
232.5 5.06 × 10-10 1.17 × 10-29 0.73 
~20 151.4 3.30 × 10-10 7.60 × 10-30 0.95 
~30 188.1 4.09 × 10-10 9.44 × 10-30 0.95 
~40 111.5 2.43 × 10-10 5.59 × 10-30 1.55 
5.54 × 10-5 
~10 
2.42 
584.1 1.27 × 10-9 1.17 × 10-29 0.34 
~20 307.1 6.68 × 10-10 6.16 × 10-30 0.60 
~30 353.2 7.69 × 10-10 7.09 × 10-30 0.65 
~40 283.1 6.16 × 10-10 5.68 × 10-30 0.85 
 
 
Figure 31. Characteristic open-aperture z-scans of the di-styryl crown ether BODIPY (4) in 
THF at A: input intensity of 10 µJ for each laser pulse and a concentration of 3.02 × 10−5 M, 
B: input intensity of 40 µJ and a concentration of 3.02 × 10−5 M, C: input intensity of 10 µJ 
and a concentration of 4.77 × 10−5 M and D: input intensity of input intensity of 40 µJ and a 
concentration of 4.77 × 10−5 M. 
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In THF solution, in contrast with the two previous solvents, an increase in concentration 
failed to significantly reduce transmittance by the BODIPY solution (Figure 31A and Figure 
31C), but the anticipated trend of a decrease in transmittance with higher laser pulse 
energies was observed at each concentration. A better optical limiting response is again 
observed at lower laser pulse energies as is evident from the decrease in the βeff, Im[χ(3)] 
and γ values with increasing pulse energies (Table 18), and there is an increase in the values 
with an increase in dye concentration. Lower Ilim values were again obtained when there is 
an increase in the dye concentration and a decrease in laser pulse energy (Table 18). 
Table 18. NLO parameters for the di-styryl crown ether BODIPY (4) in THF. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im [χ(3)] 
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
3.02 × 10-5 
~10 
2.02 
274.6 5.81 × 10-10 1.04 × 10-29 0.73 
~20 240.2 5.08 × 10-10 9.09 × 10-30 0.90 
~30 209.3 4.43 × 10-10 7.92 × 10-30 1.05 
~40 193.7 4.10 × 10-10 7.33 × 10-30 1.42 
4.77 × 10-5 
 
~10 
2.95 
581.2 1.23 × 10-9 1.39 × 10-29 0.40 
~20 537.9 1.14 × 10-9 1.29 × 10-29 0.42 
~30 405.0 8.57 × 10-10 9.71 × 10-30 0.55 
~40 466.1 9.86 × 10-10 1.12 × 10-29 0.57 
In acetonitrile, both concentrations studied were able to reduce transmittance below 50% 
and an increase in laser pulse energy significantly reduces transmittance by the BODIPY 
solution (Figure 32A and Figure 32C). Unlike in the previous three solvents, however, there 
was significant trend observed related to an increase in dye concentration.  
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Figure 32. Characteristic open-aperture z-scans of the di-styryl crown ether BODIPY (4) in 
acetonitrile at A: input intensity of 10 µJ for each laser pulse and a concentration of 1.95 × 
10−5 M, B: input intensity of 40 µJ and a concentration of 1.95 × 10−5 M, C: input intensity of 
10 µJ and a concentration of 2.93 × 10−5 M and D: input intensity of input intensity of 40 µJ 
and a concentration of 2.93 × 10−5 M. 
In acetonitrile solution, a better optical limiting response is observed at lower laser pulse 
energies since the general trend is a decrease in βeff, Im[χ(3)] and γ values with an increase in 
energy (Table 19), and an increase in the dye concentration gives a significantly better 
optical limiting response as would normally be anticipated. The γ values follow the trend of 
having higher values at lower concentration as was observed in benzene and DCM. Lower 
Ilim values were again obtained at the higher concentration and at lower laser pulse energies 
(Table 19).   
 
 
116 
 
Table 19. NLO parameters for the di-styryl crown ether BODIPY (4) in acetonitrile. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3)] 
(esu) 
γ  
(esu) 
Ilim (J.cm−2) 
1.95 × 10-5 
~10 
1.48 
365.0 7.07 × 10-10 2.32 × 10-29 0.45 
~20 229.3 4.44 × 10-10 1.46 × 10-29 0.93 
~30 193.8 3.76 × 10-10 1.23 × 10-29 0.95 
~40 173.1 3.35 × 10-10 1.10 × 10-29 1.06 
2.93 × 10-5 
~10 
1.95 
422.5 8.19 × 10-10 1.79 × 10-29 0.41 
~20 293.1 5.68 × 10-10 1.24 × 10-29 0.47 
~30 249.0 4.83 × 10-10 1.06 × 10-29 0.82 
~40 238.9 4.63 × 10-10 1.01 × 10-29 0.85 
In the DMSO solutions, only the higher concentration solution studied was able to reduce 
transmittance below 50% (Figure 33B and Figure 33D). Additionally, the transmittance is 
reduced more for the higher energy laser pulses at each concentration (Figure 33C and 
Figure 33D).  
The results in Table 20 are limited to the higher dye concentration of 2.50 × 10-5 M in DMSO, 
since only this concentration was able to reduce the transmittance by at least 50%. An 
increase in laser pulse energy seems to result in a poorer optical limiting response as can be 
seen in the decrease in βeff, Im[χ(3)] and γ values at higher laser pulse energies. A limiting 
threshold of below 0.95 J.cm-2 was only obtained at the lowest laser pulse energy of 20 µJ. 
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Figure 33. Characteristic open-aperture z-scans of the di-styryl crown ether BODIPY (4) in 
DMSO at A: input intensity of 10 µJ for each laser pulse and a concentration of 1.0 × 10−5 M, 
B: input intensity of 40 µJ and a concentration of 1.0 × 10−5 M, C: input intensity of 10 µJ and 
a concentration of 2.5 × 10−5 M and D: input intensity of input intensity of 40 µJ and a 
concentration of 2.5 × 10−5 M. 
Table 20. NLO parameters for the di-styryl crown ether BODIPY (4) in DMSO. 
Concentration 
(M) 
α 
(cm-1) 
Energy 
(µJ) 
βeff 
(cm.GW-1) 
Im[χ(3)] 
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
2.50 × 10-5 3.94 
~20 250.0 5.87 × 10-10 1.03 × 10-29 0.93 
~30 218.1 5.12 × 10-10 8.96 × 10-30 1.23 
~40 181.4 4.26 × 10-10 7.45 × 10-30 1.42 
 
A comparison for the response by the dye in each solvent was made by overlaying the z-
scan responses at 20 µJ together with a plot of output fluence vs input fluence showing the 
extent of deviation from linear transmittance. Following the reduction in transmittance, 
benzene seems to perform best followed by DCM, THF and acetonitrile and then DMSO 
(Figure 34).  
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Figure 34. A: Characteristic open-aperture z-scans, B: plots of output fluence (I0ut) vs input 
fluence (I0) and C: normalised transmittance vs input fluence curves. Plots for the di-styryl 
crown ether BODIPY (4) were obtained at 20 µJ and the following concentrations: benzene-
6.85 × 10−6 M, DCM-2.22 × 10−5 M, THF-3.02 × 10−5 M, acetonitrile-2.93 × 10−5 M and DMSO-
2.5 × 10−5 M.  
According to the parameters, the benzene solution, despite having the lowest concentration 
performs better than any other solvent followed by acetonitrile, THF, DMSO and then DCM 
as the poorest. There appears to be no clear relationship between the OL ability and both 
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the fluorescence quantum yield and lifetime for this dye, despite the fact that the lowest 
fluorescence lifetimes are obtained for the most polar solvents, acetonitrile and DMSO 
(Table 14). Kubheka et al.96 have previously observed for the aza-BODIPY studied therein 
that the NLO responses obtained demonstrated strong solvent dependence and that this 
was consistent with differences in the fluorescence lifetimes and quantum yields. This 
mechanism was attributed to the absence of significant ground state absorbance and 
intersystem crossing, meaning that the 2PA-assisted ESA which causes an RSA response on 
the nanosecond timescale is dependent on the population of the S1 state which is linked to 
both the fluorescence properties and solvent dependent population of this S1 state.96 For 
BODIPY 4, this was not the case, however, and this is thought to be as a result of both the 
nonzero values for the linear absorption coefficient, α (Table 16–Table 20), and the 
presence of bromine heavy atoms to promote intersystem crossing which enables ESA in the 
triplet manifold. 
II. Optical limiting properties of BODIPYs 5 and 6 
The NLO studies for BODIPYs 5 and 6 were performed in DCM, and as is typical for styryl-
extended BODIPY dyes the main absorption band lies well to the red of the Nd:YAG laser’s 
second harmonic wavelength at 532 nm with minimal absorbance at this wavelength (Figure 
35). Five different concentrations were studied for each compound. Strong RSA responses 
were observed in the z-scan plots (Figure 36 and Figure 37) and the NLO parameters (Table 
21 and Table 22) will be discussed in the context of two laser pulse energies. 
120 
 
 
Figure 35. Normalised absorption spectra of BODIPYs 5 and 6 in DCM. 
The open-aperture z-scan plots for BODIPY 5 show that all of the solution concentrations 
studied were able to reduce transmittance far below 50% and this provides a strong 
indication that the dye is able to perform highly favourably as an optical limiter (Figure 36). 
It was observed that an increase in concentration does not give any significant trend in 
relation to reduction in transmittance. The observations are generally similar for BODIPY 6 
(Figure 37). As would normally be anticipated, the transmittance is reduced more for the 
higher energy laser pulse at each concentration for both compounds (Figure 36 and Figure 
37). 
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Figure 36. Characteristic open-aperture z-scans of BODIPY 5 in DCM at A: input intensity of 
15 µJ for each laser pulse and a concentration of 2.31 × 10-5 M, B: input intensity of 35 µJ 
and a concentration of 2.31 × 10-5 M, C: input intensity of 15 µJ and a concentration of 3.35 
× 10−5 M, D: input intensity of input intensity of 35 µJ and a concentration of 3.35 × 10−5 M, 
E: input intensity of 15 µJ and a concentration of 4.15 × 10−5 M, F: : input intensity of 35 µJ 
and a concentration of 4.15 × 10−5 M , G: input intensity of 15 µJ and a concentration of 5.24 
× 10−5 M, H: input intensity of 35 µJ and a concentration of 5.24 × 10−5 M, I: input intensity of 
15 µJ and a concentration of 6.91 × 10-5 M and J: input intensity of 35 µJ and a concentration 
of 6.91 × 10-5 M. 
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Figure 37. Characteristic open-aperture z-scans of BODIPY 6 in DCM at A: input intensity of 
15 µJ for each laser pulse and a concentration of 1.19 × 10−5 M, B: input intensity of 35 µJ 
and a concentration of 1.19 × 10−5 M, C: input intensity of 15 µJ and a concentration of 1.9 × 
10−5 M, D: input intensity of input intensity of 35 µJ and a concentration of 1.9 × 10−5 M, E: 
input intensity of 15 µJ and a concentration of 2.49 × 10−5 M, F: input intensity of 35 µJ and a 
concentration of 2.49 × 10−5 M, G: input intensity of 15 µJ and a concentration of 3.08 × 10−5 
M, H: input intensity of 35 µJ and a concentration of 3.08 × 10−5 M, I: input intensity of 15 µJ 
and a concentration of 3.67 × 10−5 M and J: input intensity of 35 µJ and a concentration of 
3.67 × 10−5 M. 
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The main OL parameters were studied and a better optical limiting response was observed 
for the lower energy laser pulses, since an increase in energy gives lower βeff, Im[χ(3)] and γ 
values (Table 21 and Table 22). For both dyes, the Im[χ(3)] and γ values lie in the optimal 
range that has been previously reported for these parameters and this clearly demonstrates 
that these dyes are potentially useful as optical limiting materials, warranting further study 
in this regard.  
Table 21. NLO parameters for BODIPY 5 in DCM. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3) ] 
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
2.31 × 10-5 
~15 
0.71 
173 3.77 × 10-10 8.34 × 10-30 1.74 
~35 135 2.94 × 10-10 6.51 × 10-30 1.35 
3.35 × 10-5 
~15 
1.27 
219.5 4.78 × 10-10 7.27 × 10-30 0.74 
~35 191.4 4.17 × 10-10 6.34 × 10-30 0.90 
4.19 × 10-5 
~15 
1.62 
294.8 6.42 × 10-10 7.82 × 10-30 0.67 
~35 214.5 4.67 × 10-10 5.69 × 10-30 0.66 
5.24 × 10-5 
~15 
1.59 
305.1 6.64 × 10-10 6.47 × 10-30 0.59 
~35 216.8 4.72 × 10-10 4.60 × 10-30 0.95 
6.91 × 10-5 
~15 
0.98 
385.8 8.40 × 10-10 6.20 × 10-30 0.44 
~35 249 5.42 × 10-10 4.00 × 10-30 0.92 
For both dyes, an increase in dye concentration results in a significantly better OL response, 
as can be observed in the increase in the values of βeff and Im[χ(3)]. The γ values, however, 
follow an opposite trend with significantly higher values observed at lower concentrations 
for both compounds. Differences in this regard are not unexpected, since γ is defined to 
factor in concentration, while the other parameters are not.151 The Ilim values at the lowest 
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concentration were above 0.95 J.cm−2 for both BODIPYs, but lower values were observed 
with an increase in dye concentration and a decrease in the energy of the incident laser 
pulses.  
Table 22. NLO parameters for BODIPY 6 in DCM. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3)] 
 (esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
1.19 × 10-5 
~15 
0.3 
185.0 4.03 × 10-10 1.7 × 10-29 0.96 
~35 117.0 2.55 × 10-10 1.1 × 10-29 1.47 
1.9 × 10-5 
~15 
0.62 
203.0 4.42 × 10-10 1.2 × 10-29 0.74 
~35 171.1 3.72 × 10-10 1 × 10-29 0.89 
2.49 × 10-5 
~15 
0.63 
219.9 4.79 × 10-10 9.8 × 10-30 0.64 
~35 168.3 3.66 × 10-10 7.5 × 10-30 0.94 
3.08 × 10-5 
~15 
1.05 
274.4 5.97 × 10-10 9.9 × 10-30 0.49 
~35 223.8 4.87 × 10-10 8.1 × 10-30 0.89 
3.67 × 10-5 
~15 
0.93 
323.5 7.04 × 10-10 9.8 × 10-30 0.37 
~35 220.6 4.80 × 10-10 6.7 × 10-30 0.87 
BODIPY 6 was found to perform somewhat better as an optical limiter than BODIPY 5 when 
studied in DCM. This is evident in both the increased reduction in transmittance at the focal 
point of the z-scan instrument and the enhanced NLO parameter values that were obtained 
at comparable concentrations (Table 21 and Table 22). This is consistent with previous 
observations with phthalocyanines that optical limiters with heavy atoms have the ability to 
perform better as optical limiters,107–109 and suggests that halogenation may be a useful 
strategy for enhancing the OL properties of BODIPY dyes. 
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Figure 38. A: plots of output fluence (I0ut) vs input fluence (I0) for BODIPY 5, B: plots of 
output fluence (I0ut) vs input fluence (I0) for BODIPY 6, C: transmittance (T) vs input fluence 
curve for BODIPY 5 and D: transmittance (T) vs input fluence curve for BODIPY 6. Data 
obtained at an input intensity of 15 µJ and concentrations of 6.91 × 10−5 M for BODIPY 5 and 
3.67 × 10−5 M for BODIPY 6. 
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III. Optical limiting properties of BODIPY 7 
The optical limiting ability of BODIPY 7 was assessed in DCM, THF, acetonitrile and DMSO 
and in all solvents the main absorption band lies well above the second harmonic 
wavelength at 532 nm and there is minimal absorbance at 532 nm and there is minimal 
absorbance at this wavelength (Figure 39). 
 
Figure 39. Normalised absorption spectra of BODIPY 7 in different organic solvents. 
The optical limiting studies for BODIPY 7 were carried out using two different concentrations 
for each solvent and strong RSA responses167–169 were observed in the z-scan plots in each 
solvent (Figure 40–Figure 43) at two different laser pulse energies. 
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Figure 40. Characteristic open-aperture z-scans of BODIPY 7 in DCM at A: input intensity of 
20 µJ for each laser pulse and a concentration of 2.0 × 10−5 M, B: input intensity of 40 µJ and 
a concentration of 2.0 × 10−5 M, C: input intensity of 20 µJ and a concentration of 3.12 × 
10−5M and D: input intensity of input intensity of 40 µJ and a concentration of 3.12 × 10−5M. 
Table 23. NLO parameters for BODIPY 7 in DCM. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3)] 
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
2.00 × 10-5 
~20 
0.86 
141.2 3.07 × 10-10 7.84 × 10-30 1.20 
~30 136.9 2.98 × 10-10 7.60 × 10-30 1.25 
3.12 × 10-5 
 
~10 
1.19 
290.8 6.33 × 10-10 1.04 × 10-29 0.65 
~20 223.4 4.86 × 10-10 7.96 × 10-30 0.87 
~30 186.4 4.06 × 10-10 6.64 × 10-30 1.40 
~40 125.8 2.74 × 10-10 4.48 × 10-30 1.34 
In DCM, the βeff and Im[χ(3)] values increase with dye concentration. For both 
concentrations, an increase in incident laser pulse energy gives poorer/lower βeff, Im[χ(3)] 
and γ values (Table 24). The Ilim values appear to be lower at higher dye concentration as 
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would normally be anticipated and some of the values lie below the desired 0.95 J.cm−2 
threshold for 10 ns laser pulses at 532 nm. 
 
Figure 41. Characteristic open-aperture z-scans of BODIPY 7 in THF at A: input intensity of 20 
µJ for each laser pulse and a concentration of 1.1 × 10−5 M, B: input intensity of 40 µJ and a 
concentration of 1.1 × 10−5 M, C: input intensity of 20 µJ and a concentration of 1.6 × 10−5 M 
and D: input intensity of input intensity of 40 µJ and a concentration of 1.6 × 10−5 M. 
In THF, transmittance was consistently reduced below 50 % at the focal point of the z-scan 
instrument at all laser pulse energies studied except at 10 µJ for the low concentration of 
1.32 × 10-4 M. An increase in both laser pulse energy and dye concentration reduces 
transmittance by the BODIPY solution, albeit only slightly with the pulse energy increases 
(Figure 41C and Figure 41D). The βeff and Im[χ(3)] values increase with the dye concentration, 
whereas the γ value decreases. For both concentrations, an increase in incident laser pulse 
energy results in poorer/lower βeff, Im[χ(3)] and γ values (Table 24). Lower Ilim values were 
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obtained at high concentration and low laser pulse energies. Some of the values lie above 
the desired value of 0.95 J.cm−2. 
Table 24. NLO parameters for BODIPY 7 in THF. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3)] 
(esu) 
γ 
(esu) 
Ilim 
(J.cm−2) 
1.10 × 10-5 
 
~20 
1.08 
215.1 4.55 × 10-10 2.23 × 10-29 0.78 
~30 156.9 3.32 × 10-10 1.63 × 10-29 0.97 
~40 125.2 2.65 × 10-10 1.30 × 10-29 1.55 
1.60 × 10-5 
~10 
1.45 
313.8 6.64 × 10-10 2.24 × 10-29 0.71 
~20 268.3 5.67 × 10-10 1.92 × 10-29 0.74 
~30 205.2 4.34 × 10-10 1.47 × 10-29 0.80 
~40 171.4 3.63 × 10-10 1.22 × 10-29 1.10 
 
 
Figure 42. Characteristic open-aperture z-scans of BODIPY 7 in acetonitrile at A: input 
intensity of 20 µJ for each laser pulse and a concentration of 7.84 × 10−6 M, B: input intensity 
of 40 µJ and a concentration of 7.84 × 10−6 M, C: input intensity of 20 µJ and a concentration 
of 1.09 × 10−5 M and D: input intensity of input intensity of 40 µJ and a concentration of 1.09 
× 10−5 M. 
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In acetonitrile, the transmittance was consistently reduced below 50% except for the 
studies at 10 µJ for both concentrations, and an increase in both laser pulse energy and dye 
concentration reduces transmittance by the BODIPY solution (Figure 42). 
Table 25. NLO parameters for BODIPY 7 in acetonitrile.  
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3)]  
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
7.84 × 10-6 
~20 
1.16 
173.9 3.37 × 10-10 2.76 × 10-29 1.08 
~30 118.5 2.30 × 10-10 1.88 × 10-29 1.75 
~40 108.5 2.10 × 10-10 1.72 × 10-29 1.70 
1.09 × 10-5 
 
~20 
1.46 
194.3 3.77 × 10-10 2.22 × 10-29 0.80 
~30 214.6 4.16 × 10-10 2.45 × 10-29 0.70 
~40 185.9 3.60 × 10-10 2.12 × 10-29 0.83 
The βeff and Im[χ(3)] values in acetonitrile increase with dye concentration (Table 25). An 
increase in incident laser pulse results in lower βeff, Im[χ(3)] and γ values observed with an 
increase in energy. The three parameters reach their highest values at 30 µJ for the higher 
concentration (Table 25). The Ilim values were lower at higher concentration and the values 
lie above 0.95 J.cm−2 for the lower concentration solutions. The lowest Ilim value was 
obtained at 30 µJ, which appears to be the optimal energy for the OL response in this 
solvent.  
The open-aperture z-scan plots of the DMSO solutions at a concentration of 6.46 × 10-6 M, 
at 10 and 20 µJ do not dip below 50% transmittance, in contrast with the other scans for this 
dye. As would normally be anticipated, an increase in both energy and concentration 
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significantly reduces transmittance by the BODIPY solution in this solvent (Figure 43C and 
Figure 43D). 
 
Figure 43. Characteristic open-aperture z-scans of BODIPY 7 in DMSO at A: input intensity of 
20 µJ for each laser pulse and a concentration of 6.46 × 10−6 M, B: input intensity of 40 µJ 
and a concentration of 6.46 × 10−6 M, C: input intensity of 20 µJ and a concentration of 1.13 
× 10−5 M and D: input intensity of input intensity of 40 µJ and a concentration of 1.13 × 10−5 
M. 
Table 26. NLO parameters for BODIPY 7 in DMSO. 
Concentration 
(M) 
Energy 
(µJ) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im[χ(3)] 
(esu) 
γ  
(esu) 
Ilim 
(J.cm−2) 
6.46 × 10-6 
~30 
0.85 
114.2 2.68 × 10-10 1.82 × 10-29 1.52 
~40 102.6 2.41 × 10
-10 1.63 × 10-29 1.74 
1.13 × 10-5 
~10 
1.28 
291.2 6.83 × 10-10 2.64 × 10-29 0.87 
~20 213.7 5.02 × 10
-10 1.94 × 10-29 0.79 
~30 191.6 4.50 × 10
-10 1.74 × 10-29 0.87 
~40 192.4 4.52 × 10
-10 1.75 × 10-29 0.82 
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In DMSO, as is the case with THF and acetonitrile, a better optical limiting response is 
observed for the lower laser pulse energy, since there is a decrease in the βeff, Im[χ(3)] and γ 
values (Table 26) with increasing laser pulse energy, and the OL response is enhanced by an 
increase in the dye concentration. The Ilim value in the higher concentration solutions lie 
below 0.95 J.cm−2, while those of the low concentration solutions do not. 
To make a comparison for the response by the dye in each solvent, an overlay of the z-scan 
responses at 30 µJ was made together with a plot of output fluence vs input fluence 
showing the extent of deviation from linear transmittance. Following the reduction in 
transmittance, DMSO seems to perform best followed by acetonitrile, and then DCM and 
THF (Figure 44). According to the parameters βeff, Im[χ(3)], γ and Ilim, acetonitrile and DMSO 
perform better followed by THF while DCM seems to possess the poorest optical limiting 
parameters. This is despite the acetonitrile solution having the lowest concentration.  
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Figure 44. A: Characteristic open-aperture z-scans, B: plots of output fluence (I0ut) vs input 
fluence (I0) and C: normalised transmittance vs input fluence curves. Plots for BODIPY 7 
were obtained at 30 µJ and the following concentrations: DCM-2.0 × 10−5 M, THF-1.1 × 10−5 
M, acetonitrile-1.09 × 10−5 M and DMSO-1.13 × 10−5 M.  
For BODIPY 7, the OL parameters Im[χ(3)] and γ values lie in the optimal range that has been 
reported for these parameters. This clearly demonstrates that this dye is potentially useful 
as an optical limiting material and merits further study in this regard. This was similar to 
results recently obtained by Harris et al.95 and Kubheka et al.96 for BODIPY dyes and an aza-
BODIPY dye, respectively. As previously mentioned in the context of BODIPY 4, Kubheka et 
al.96 observed NLO responses with a strong solvent dependence for an aza-BODIPY dye, due 
to an 2PA-assisted ESA which causes an RSA response on the nanosecond timescale that is 
dependent on the population of the S1 state which is linked to both the fluorescence 
properties and solvent dependent population of this S1 state.96 This was initially expected to 
also be the case for BODIPY 7 since the dye does not contain any heavy atoms to promote 
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intersystem crossing and ESA in the triplet manifold. The observations were not consistent 
with this, however, since there is no clear relationship between the OL responses, solvent 
polarity, and both the fluorescence quantum yields and lifetimes for this dye (Table 15). The 
difference in mechanism can be attributed to the nonzero values for the linear absorption 
coefficient, α (Table 23–Table 26). This suggests that the main mechanism for the RSA 
response of this dye results from an ESA mechanism which depends primarily on population 
of the S1 state via linear absorption. 
IV. Optical limiting properties of BODIPYs 8, 9 and 10. 
This section focuses on the optical limiting ability of three 2,6-diethyl-substituted BODIPY 
dyes, 8, 9 and 10, which contain an electron withdrawing ester group on the meso-phenyl 
position and strongly electron donating styryl groups at the 3,5-positions to study the effect 
of the D-π-A type structure of these dyes on the OL properties. The main absorption band 
lies well above the Nd:YAG laser’s second harmonic wavelength at 532 nm in benzene, DCM 
and acetonitrile and there is minimal absorbance at this wavelength (Figure 45) making the 
dye potentially suitable for use as an OL material. 
 
Figure 45. Normalised absorption spectra of BODIPYs 8, 9 and 10 in benzene. 
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Figure 46. Characteristic open-aperture z-scans of BODIPY 8 in different organic solvents at 
an input intensity of 25 µJ for each laser pulse and a concentration of 3.0 × 10−5 M. A: 
benzene, B: DCM and C: acetonitrile. 
BODIPY 8 was studied at a concentration of 3.0 × 10−5 M in all solvents. The benzene 
solution was able to reduce the transmittance by 79% at the focal point of the laser, 
followed by the acetonitrile solution with a 64% reduction and DCM with a 24% reduction 
(Figure 46). When the concentration was doubled in DCM, the OL response improved 
significantly and the transmittance was reduced by 79% (Figure 47). A comparison of the 
βeff, Im[χ(3)] and γ values shows that the best optical limiting response is observed for the 
benzene solution at a concentration of 3.0 × 10−5 M (Table 27). This is also evident in the 
plots showing the extent of deviation from linearity (Figures 48A and 49A). 
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Figure 47. Open-aperture z-scan of BODIPY 8 in DCM at an input intensity of 25 µJ for each 
laser pulse and a concentration of 6.2 × 10−5 M. 
 
Figure 48. Overlayed data for BODIPY 8. A: Plots of output fluence (I0ut) vs input fluence (I0) 
and B: normalised transmittance vs input fluence curves. Data obtained at input intensity of 
25 µJ for each laser pulse and a concentration of 3.0 × 10−5 M in all solvents. 
Only the Ilim values in benzene at 3.0 × 10−5 M (Figure 48B) and in DCM at 6.2 × 10−5 M 
(Figure 49B) lie below 0.95 J.cm−2. Overall, BODIPY 8 proved to be more effective as an 
optical limiter in the less polar benzene solvent, as is evident in both the z-scan plots 
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showing the extent of reduction in transmittance and in the OL parameters that were 
obtained (Table 28). 
 
Figure 49. The optical limiting ability of BODIPY 8 at a higher concentration. A: Plot of output 
fluence (I0ut) vs input fluence (I0) and B: normalised transmittance vs input fluence curve. 
Data obtained at input intensity of 25 µJ and a concentration of 6.2 × 10−5 M in DCM. 
BODIPY 9 was studied at a concentration of 1.5 × 10−5 M in all solvents. Acetonitrile was able 
to reduce the transmittance by 80% at the focal point of the z-scan instrument, followed by 
DCM with a 74% reduction and benzene with a 59% reduction (Figure 50).  When the 
concentration was increased to 8.0 × 10−5 M in benzene and DCM, the OL response 
improved significantly for benzene but not for DCM as the transmittance was reduced by 
71% and 65%, respectively (Figure 52). The optical limiting parameters show that a better 
optical limiting response is observed for the acetonitrile solution at a concentration of 1.5 × 
10−5 M, followed by DCM and then benzene (Table 27). The enhanced OL responses in 
acetonitrile and DCM are also evident in the plots showing the extent of deviation from 
linearity (Figure 51A). 
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Figure 50. Characteristic open-aperture z-scans of BODIPY 9 in different organic solvents at 
an input intensity of 25 µJ for each laser pulse and a concentration of 1.5 × 10−5 M. A: 
benzene, B: DCM and C: acetonitrile. 
The Ilim values were lowest in acetonitrile followed by the sample studied in DCM (Figure 
51B), and the value obtained in benzene at higher concentration was also well below 0.95 
J.cm−2 (Figure 53B). Overall, BODIPY 9 proved to be a more effective optical limiter in the 
more polar acetonitrile solvent followed by DCM as is evident in the OL parameters that 
were derived from the z-scan data (Table 27). 
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Figure 51. Overlayed data for BODIPY 9. A: Plots of output fluence (I0ut) vs input fluence (I0) 
and B: normalised transmittance vs input fluence curves. Data obtained at input intensity of 
25 µJ for each laser pulse and a concentration of 1.5 × 10−5 M in all solvents. 
 
Figure 52. Characteristic open-aperture z-scans of BODIPY 9 at an input intensity of 25 µJ for 
each laser pulse and a concentration of 8.0 × 10−5 M. A: benzene and B: DCM. 
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Figure 53. Overlayed data for BODIPY 9 at a higher concentration. A: Plots of output fluence 
(I0ut) vs input fluence (I0) and B: normalised transmittance vs input fluence curves. Data 
obtained at input intensity of 25 µJ for each laser pulse and a concentration of 8.0 × 10−5 M 
in both solvents. 
BODIPY 10 was studied at a concentration of 5.9 × 10−5 M in benzene and DCM, but not in 
acetonitrile due to poor solubility. The benzene solution was able to reduce the 
transmittance by 79% while DCM had an 83% reduction (Figure 54).   
 
Figure 54. Characteristic open-aperture z-scans of BODIPY 10 at an input intensity of 25 µJ 
for each laser pulse and a concentration of 5.9 × 10−5 M. A: benzene and B: DCM. 
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Figure 55. Overlayed data for BODIPY 10. A: Plots of output fluence (Iout) vs input fluence (I0) 
and B: normalised transmittance vs input fluence curves. Data obtained at input intensity of 
25 µJ and a concentration of 5.9 × 10−5 M in both solvents 
Table 27. NLO parameters for the 2,6-diethyl BODIPYs (8, 9 and 10) in different organic 
solvents at an input energy of ~25 µJ. 
BODIPY Solvent Conc. 
(M) 
α 
(cm-1) 
βeff 
(cm.GW-1) 
Im [χ(3)] 
(esu) 
γ 
(esu) 
Ilim (J.cm-2) 
8 
benzene 
3.0 × 10-5 
6.98 471.9 1.14 × 10-9 1.56 × 10-29 0.82 
DCM 1.35 24.9 5.42 × 10-11 9.30 × 10-31 N/A 
acetonitrile 3.42 149.0 2.89 × 10-10 6.19 × 10-30 1.31 
DCM 
6.2 × 10-5 
2.76 357.9 7.79 × 10-10 6.44 × 10-30 0.85 
9 
benzene 
1.5 × 10-5 
0.16 43.9 1.06 × 10-10 2.91 × 10-30 N/A 
DCM 0.35 89.2 1.94 × 10-10 6.61 × 10-30 1.01 
acetonitrile 1.83 350.9 6.80 × 10-10 2.90 × 10-29 0.80 
benzene 
8.0 × 10-5 
0.87 202.5 4.89 × 10-10 2.52 × 10-30 0.61 
DCM 1.33 71.9 1.57 × 10-10 1.00 × 10-30 1.72 
10 
benzene 
5.9 × 10-5 
1.10 148.8 3.60 × 10-10 2.51 × 10-30 1.11 
DCM 1.38 426.8 9.29 × 10-10 8.05 × 10-30 0.57 
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The parameters βeff, Im[χ(3)] and γ for BODIPY 10 show that there is a better optical limiting 
response for the DCM solution (Table 27). The Ilim values were also lower in DCM (Figure 
55B). 
For all three BODIPYs, 8, 9 and 10, the values for the OL parameters Im[χ(3)] and γ (Table 27) 
lie in the optimal range that has been previously reported for these parameters and this 
clearly demonstrates that these dyes are potentially useful as optical limiting materials and 
merit further study in this regard. There is no clear trend or relation between the 
fluorescence properties and the NLO responses for all the dyes (Table 11, Table 12 and 
Table 13) and there was no significant solvent dependence of the NLO responses obtained. 
Also, the dyes did not contain heavy atoms to promote intersystem crossing which enables 
ESA in the triplet manifold, and it can therefore be concluded that an ESA mechanism which 
depends on population of the S1 state via linear absorption is likely to be the main 
mechanism of interest, since each of the dyes possessed nonzero values for the linear 
absorption coefficient, α, in all solvents at 532 nm (Table 27). 
Concluding remarks 
The βeff, Im[χ(3)], Ilim and γ values that were derived from the z-scan studies clearly 
demonstrate that BODIPYs 4, 5, 7, 8, 9 and 10 are potentially suitable for use in OL 
applications and merit further study in this regard, as was expected since the main spectral 
bands associated with the polarisable π-system lie beyond 600 nm with relatively weak 
absorbance at 532 nm, the second harmonic of Nd:YAG lasers that was used in these 
studies. The trends in the OL parameters are consistent with a positive nonlinear absorption 
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coefficient coupled with a decrease in transmittance as the material approaches the focal 
point of the z-scan instrument and high laser light intensity.166 
BODIPY 4 was studied in five different solvents of differing polarity, while BODIPY 7 was 
studied in four solvents of differing polarity. For both dyes, there is no clear relationship 
between the OL ability and the fluorescence quantum yields and lifetime values. It was 
recently reported by Kubheka et al.96 that there was significant solvent dependence in the 
NLO response for an aza-BODIPY dye containing no heavy atoms that was consistent with 
differences in the fluorescence lifetimes and quantum yields. In the absence of significant 
ground state absorbance and intersystem crossing to 2PA-assisted ESA which causes an RSA 
response on the nanosecond timescale, the mechanism was attributed to solvent 
dependent population of the S1 state which is linked to the fluorescence properties.96 These 
trends were initially expected to also be the observed for BODIPY 7 but the experimental 
data were not consistent with this. This can be attributed to the nonzero values for the 
linear absorption coefficient, α, which provides scope for significant ground-state 
absorption. In the context of BODIPY 4, the presence of bromine heavy atoms to promote 
intersystem crossing which enables ESA from the triplet manifold is also likely to be a 
significant factor. Despite the absence of significant intersystem crossing, BODIPY 7 
possesses favourable OL properties at 532 nm, providing further evidence that an ESA 
mechanism from the S1 state can account for the OL properties of non-halogenated BODIPY 
dyes.19,20,32,170-173170,171,20,172,32,19,173  
BODIPYs 5 and 6 were studied in DCM at five different concentrations. BODIPY 6 contains 
bromine heavy atoms, hence for BODIPY 5 it is expected that the mechanism will involve 
ESA from the S1 state due to the absence of intersystem crossing to the triplet state while 
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for BODIPY 6 the triplet manifold is likely to be involved. This sheds light on the relative 
efficiency of the OL mechanism for these BODIPY dyes, since dyes which undergo 
intersystem crossing are known to possess OL responses related to ESA from the T1 state. 
Overall, BODIPY 6 performs better as an optical limiter when studied in DCM, thereby 
suggesting that optical limiters with heavy atoms can perform better as optical limiters due 
to ESA from the longer-lived T1 state,107–109 and that halogenation may prove to be a useful 
strategy for enhancing the OL properties of the BODIPY chromophore. BODIPYs 8, 9 and 10 
were also investigated in different solvents, with 8 and 9 studied in benzene, DCM and 
acetonitrile, while 10 was studied in benzene and DCM. For all three dyes, there is no 
significant trend between the OL responses observed and both solvent polarity and 
fluorescence lifetimes and quantum yields (Table 11, Table 12 and Table 13). As with 
BODIPY 7, this can again be attributed to the nonzero values for the linear absorption 
coefficient, α, since there are no heavy atoms, and an ESA mechanism which depends on 
the population of the S1 state by linear absorption is the main mechanism. 
In drawing all these conclusions, it is worth noting that BODIPY dyes have still not been 
extensively studied for their optical limiting ability at 532 nm. Within our research group, 
some articles have been published on the study of π-extended BODIPY dyes as nonlinear 
optical limiters.95,96,171,174 Of all the studies undertaken both in this thesis and within the 
group, the optical limiting parameters Im[χ(3)] and γ lie within the ranges that are normally 
viewed as being suitable for optical limiting, as tabulated above for the studies conducted 
herein, and this demonstrates that further research in this area is merited. A final point 
worth noting is that the di-styryl crown-ether-substituted BODIPY (4) is predicted to have an 
unusually large permanent dipole moment introduced by the benzo-fused crown ether and 
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4-dimethylaminophenyl substituents and it has been experimentally demonstrated that the 
dye possesses good optical limiting properties at 532 nm, as is evident from the enhanced 
RSA profiles that are observed. The results for BODIPY 4 have been published,174 and it is 
expected that highly favourable results for other D-π-A type BODIPY dyes studied in this 
thesis, such as BODIPYs 8, 9 and 10, will also be published soon. D-π-A type structures 
provide an obvious opportunity for further studies on the use of BODIPY dyes as optical 
limiters on the nanosecond timescale at 532 nm, and this approach could be extended in 
future to the other possible laser wavelengths of interest. 
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Chapter 5:  
BODIPY-cyclodextrin 
inclusion complex formation 
and characterisation 
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As mentioned in Chapter 1, the main factors responsible for cyclodextrin inclusion complex 
formation are non-covalent forces such as Van der Waals and hydrophobic interactions 
which stabilise the complex.41,44 Since the three parent cyclodextrins have a different 
number of glucopyranose units, they have different sizes and molecular dimensions and this 
enables them to include different guests. For example, α-cyclodextrin tends to complex low 
molecular weight molecules and compounds with aliphatic side chains while β-cyclodextrin 
complexes aromatic and heterocyclic compounds, while γ-cyclodextrin typically complexes 
larger molecules in the size range of macrocycles and steroids.41,47 The inclusion complexes 
formed tend to be of a [guest]/[cyclodextrin] molar ratio of 1:1 but this is not always the 
case as higher or lower molar ratios are possible depending on how the guest and 
cyclodextrin relate when it comes to size and steric factors.41,175 Another point worth noting 
is the fact that the inclusion of guest molecules in the cyclodextrin cavity is not fixed or 
permanent but is a dynamic equilibrium and the strength of the interaction depends on 
both the complementarity of how well the guest and cyclodextrin fit with each other and 
also the intermolecular interactions between surface atoms.47 When included in the 
cyclodextrins, the physicochemical properties of the guest are usually modified or 
enhanced, depending on the conformation adopted by the guest within the cavity. This 
inclusion tends to protect the guest from specific properties which would otherwise render 
the guest incapable of performing its function. These include conferring solubility on 
insoluble guest molecules, protection and stabilisation of labile guests against the 
degradative effects of oxidation, visible or UV light and heat, and a decrease in and control 
of volatility and sublimation.40 
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The dyes used here contain various functional groups, particularly at the meso-position and 
it has been shown previously that cyclodextrins can encapsulate a wide range of functional 
groups and compounds within their cavity. These include but are not limited to straight or 
branched chain aliphatic compounds, aldehydes, ketones, alcohols, organic acids, fatty 
acids, aromatics, gases, and polar compounds such as halogens, oxyacids and amines.40,176 
These functional groups (present on the guest) serve two purposes; one is steric and the 
other one thermodynamic. Sterically, when the size of the guest molecule or its functional 
groups matches with the requirements of the cyclodextrin cavity, the guest is included in 
the cavity; and the same principle applies to the thermodynamic interactions between the 
different components of the system, i.e. guest-host interactions in a given solvent must pull 
the guest into the cyclodextrin cavity.40 Energetically, there are four favourable interactions 
that promote the formation of the inclusion complex:40 
 The displacement of polar water molecules from the apolar cyclodextrin cavity. 
 The increased number of hydrogen bonds formed as the displaced water leaves the 
cavity. 
 A reduction of the repulsive interactions between the hydrophobic guest and the 
aqueous environment as a result of inclusion into the hydrophobic cavity.  
 An increase in the hydrophobic interactions as the guest inserts itself into the apolar 
cyclodextrin cavity. 
For the studies in this thesis, conferring aqueous solubility on insoluble heavy atom 
containing BODIPY dyes is the main goal; the dyes are only soluble in organic media, and this 
is not suitable for most biological and green applications. The main aim, therefore, is to 
create suitable conditions for the BODIPY dyes to generate singlet oxygen in aqueous media. 
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5.1. Inclusion complex preparation 
Following literature methods, the inclusion complexes of BODIPYs 2a, 2b and 2c were 
studied.41,177,178 This was carried out by following the co-precipitation method. Standard 
BODIPY-cyclodextrin solutions with total concentrations of 2.54 × 10-3 M, 2.38 × 10-3 M and 
2.53 × 10-3 M for BODIPYs 2a, 2b and 2c, respectively, were prepared as follows: the 
respective cyclodextrin, α or β, was dissolved in deionised water maintained at ca. 75 °C 
with stirring; the temperature was dropped to ca. 28 °C and the respective BODIPY dye, 
dissolved in ethanol, was added dropwise and after overnight with continuous stirring at 
room temperature, the precipitate was filtered and dried. 
There are different techniques which can be used to study and characterise cyclodextrin 
complexes, both in solution and in the solid state.41 Among these, the most referenced in 
literature are: phase solubility, high-performance liquid chromatography (HPLC), circular 
dichroism, NMR, (XRD), differential scanning calorimetry (DSC), thermogravimetric analysis 
(TGA), UV-visible absorption spectroscopy, FT-IR, and FT-Raman Spectroscopy.45,52,179–184 
The following were employed in this study: 
Fourier-transform infrared spectroscopy (FT-IR) 
With FT-IR spectroscopy, when the guest is complexed with the cyclodextrin, there are shifts 
or changes in the spectrum relative to that of the uncomplexed guest, and there are 
typically interferences from the cyclodextrin.52,183 These changes and shifts tend to be very 
small hence each spectrum needs to be carefully studied and analysed.52 The typical method 
carefully following changes in the spectra is recording the spectrum of the guest alone, 
cyclodextrin alone, a physical mixture made by mixing the guest and cyclodextrin in the 
absence of a solvent and then finally that of the inclusion complex.41,52,183 
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Circular dichroism  
Marconi and Mayer45 have studied the conformational and circular dichroism responses of 
cyclodextrin inclusion complexes and were able to “elucidate different geometrical 
configurations and to gain insight into the relationship between structural and dynamic 
properties of the complexes”.41,45 
X-ray powder diffraction analysis (XRD)  
XRD is a technique used to study the crystal arrangement and geometry of materials. 
Osadebe et al., 178 have used this technique to study the diffraction patterns of piroxicam 
and β-cyclodextrin inclusion complexes. A sample in powder or crystalline form is usually 
used and the absence or presence of peaks in the respective diffractograms of the guest, 
cyclodextrin, physical mixture or complex are carefully analysed. The diffractogram of the 
physical mixture is usually a superimposition of the patterns of the guest and host, while 
that of the inclusion complex does not correspond to those of both the guest and host.184 
UV-visible absorption spectroscopy 
UV-visible absorption spectroscopy is not only useful in studying changes in the guest 
spectra when complexed, but can also be used to determine complex stoichiometries.41,42 
Scanning electron microscopy (SEM)  
The SEM technique enables the visualization of surface morphological changes of the 
physical mixture and inclusion complex relative to those of the guest and cyclodextrin.184–186 
Similar to the superimposition usually observed in FT-IR and XRD analyses, the physical 
mixture tends to show a combined morphology of the guest and cyclodextrin, with the 
complex not showing the original morphologies and instead forming a new one.184 
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5.2. Results and discussion 
5.2.1. UV-visible absorption studies 
The UV-visible absorption spectra recorded in deionised water were observed to be more 
broadened for the inclusion complexes (Figure 56 and Figure 57) relative to the sharp bands 
observed for the BODIPY dyes in organic media. Although this is thought to be the effect of 
aggregation of the inclusion complexes in water, it is not conclusive as the dyes were 
completely insoluble in water before complexation and as such no direct comparisons can 
be drawn between inclusion complex spectra in water and BODIPY dye spectra in water. As 
a result of this aggregation, fluorescence studies were not successful, which was expected 
because aggregates are known not to fluoresce. 
 
Figure 56. Normalised absorption spectra of BODIPY-(α-cyclodextrin) inclusion complexes 
in deionised water.(a) BODIPY 2a-(α-cyclodextrin), (b) BODIPY 2b-(α-cyclodextrin) and (c) 
BODIPY 2c-(α-cyclodextrin). 
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Figure 57. Normalised absorption spectra of BODIPY-(β-cyclodextrin) inclusion complexes 
in deionised water.(a) BODIPY 2a-(β-cyclodextrin), (b) BODIPY 2b-(β-cyclodextrin) and (c) 
BODIPY 2c-(β-cyclodextrin). 
Table 28. Differences in the spectra of BODIPY dyes in organic media and when 
included in α-cyclodextrin, in water. 
Sample Absorption maximum λ 
(Ethanol) (nm) 
Absorption maximum λ 
(water) (nm) 
BODIPY 2a 531 N/A 
α + BODIPY 2a incl. comp N/A 547 
BODIPY 2b 521 N/A 
α + BODIPY 2b incl. comp N/A 542 
BODIPY 2c 531 N/A 
α + BODIPY 2c incl. comp N/A 522 
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In addition to being broadened, the spectra show changes in the wavelength of the main 
transition bands of the respective BODIPY dyes and inclusion complexes (Table 28 and Table 
29). Red-shifts in the 11–20 nm range were observed, except when BODIPY 2c was included 
in α-cyclodextrin, since this resulted in a 9 nm blue shift (Table 28 and Table 29). 
Table 29. Differences in the spectra of BODIPY dyes in organic media and when 
included in β-cyclodextrin, in water. 
Sample Absorption maximum λ 
(Ethanol) (nm) 
Absorption maximum λ 
(water) (nm) 
BODIPY 2a 531 N/A 
α + BODIPY 2a incl. 
comp 
N/A 542 
BODIPY 2b 521 N/A 
α + BODIPY 2b incl. 
comp 
N/A 538 
BODIPY 2c 531 N/A 
α + BODIPY 2c incl. 
comp 
N/A 545 
 
The complex stoichiometries of inclusion complexes can also be determined. The most 
common method to determine these complex stoichiometries is the continuous 
variation/Job plot method using changes in a quantitative spectroscopic property such as 
absorbance.187–189 To obtain the Job plots, absorbance is plotted against mole fraction, r (r = 
m/m + n), where m represents the proportion of BODIPY dye present in solution and n 
represents that of cyclodextrin; for the equimolar solutions with varying molar ratios i.e. 
(BODIPYm:CYCLODEXTRINn). The plot is then used to infer the stoichiometric ratio at the 
maximum absorbance value; for example, if maximum absorbance occurs at r = 0.33, this 
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implies a ratio of 1BODIPY:2CYCLODEXTRINS (m = 1 and n = 2). In this study, a series of 
inclusion complex aqueous solutions with a fixed final concentration for each BODIPY dye 
inclusion complex (2a-2.54 × 10-3 M, 2b-2.38 × 10-3 M and 2c-2.53 × 10-3 M), were prepared 
by varying the molar ratios of BODIPYm:CYCLODEXTRINn. The results indicated different mole 
ratios (Table 30) but a representative job plot is included (Figure 58); the other complexes 
were also studied following similar procedures. 
 
Figure 58. Continuous variation plot of the BODIPY 2b-(β-cyclodextrin) inclusion complex. 
Table 30. Inclusion complex stoichiometric ratios 
Sample Stoichiometric ratio 
(BODIPY:CYCLODEXTRIN) 
BODIPY 2a α incl. comp 1:1 
BODIPY 2b α incl. comp 1:1 
BODIPY 2c α incl. comp 1:1 
BODIPY 2a β incl. comp 1:1 
BODIPY 2b β incl. comp 1:2 
BODIPY 2c β incl. comp 1:2 
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5.2.2. Fourier-transform infrared spectroscopy (FT-IR) 
The infrared spectra were recorded for the BODIPY dyes, cyclodextrins, physical mixtures 
and for the inclusion complexes. The IR plots are displayed (Figure 59 and Figure 60) below 
and the characteristics of each spectrum discussed (Table 31 and Table 32). The spectra 
provide the evidence for significant spectral differences that is required to infer inclusion of 
the BODIPY dyes into cyclodextrins; this is evident from the changes in the characteristic 
peaks which change subsequent to inclusion. 
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Figure 59. FT-IR spectra of BODIPY 2a, BODIPY 2b and BODIPY 2c with α-cyclodextrin. 
Coloured boxes used to highlight changes in the respective characteristic peaks of the 
BODIPY and cyclodextrin upon formation of the inclusion complex. 
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Table 31. Discussion of FT-IR spectra of BODIPY dyes included in α-cyclodextrin. 
Sample Characteristics 
α alone 
500–1650 cm-1: cis RCH=CHR, =CH and =CH2 stretch, C-H 
bend, O-H, C-O, C-C-C bend, O-H bend, CH2 deformation, O-C 
and C=O bands. At ca. 3300 cm-1, there is an OH stretch. 
BODIPY 2a 
alone 
C-Br stretch at 522 cm-1. 550–1600 cm-1: multiple CH and CH2 
bands; C-N stretch. Ca. 2900 cm-1: C-H stretches. 
α + BODIPY 2a 
PM 
500–1800 cm-1: C-Br stretch, combined and superimposed 
BODIPY and CDx peaks, with broadening of the peak at ca. 
1000 cm-1. BODIPY C-H stretch at ca. 2918 cm-1 is maintained, 
but is less intense and characteristic shape lost. The O-H 
stretch of the CDx at 3261 cm-1 is maintained. Overall, the 
spectrum is a combination of CDx and BODIPY spectra. 
α + BODIPY 2a 
incl. comp 
500–600 cm-1: All BODIPY stretches disappear, while those of 
the CDx are maintained. CDx O-H and C-O bands maintained 
at 1022 cm-1. The C-C-C CDx bend at ca. 1150 cm-1 is 
drastically reduced in intensity but still maintained, whereas 
between 1150–1650 cm-1 the CDx and BODIPY spectra 
combine and peaks become less intense.  At ca. 2921 cm-1, 
the C-H stretch of the BODIPY is maintained, but loses the 
shape seen in the dye alone and is not significantly different 
to that of the physical mixture. Finally, the O-H stretch of the 
CDx at ca. 3289 cm-1 is maintained. 
BODIPY 2b 
alone 
C-Br stretch at 523 cm-1. 550–1600 cm-1: multiple CH and CH2 
stretches. Ca. 2900 cm-1: C-H stretches. 
α + BODIPY 2b 
PM 
500–1600 cm-1: BODIPY C-Br stretch maintained; CDx and 
BODIPY spectra maintained with some bands superimposed 
and most of the BODIPY peaks exhibiting decreased intensity. 
BODIPY C-H stretch at ca. 2918 cm-1 is maintained, but the 
characteristic shape is lost. The O-H stretch of the CDx at 
3257 cm-1 is also maintained. Overall, the spectrum is a 
combination of CDx and BODIPY spectra. 
α+ BODIPY 2b 
incl. comp 
500–1600 cm-1: Both BODIPY and CDx stretches are 
maintained. CDx O-H and C-O bands at 1022 cm-1 are 
combined and superimposed with the BODIPY spectrum, 
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hence changing frequency to ca. 998 cm-1. In the 2855–2925 
cm-1 region, the C-H stretches of the BODIPY are maintained, 
but the characteristic shape is lost but not as drastically as in 
the physical mixture. Also, the O-H stretch of the CDx at ca. 
3276 cm-1 is maintained. 
BODIPY 2c 
alone 
C-Br stretch at 531 cm-1. 550–1700 cm-1: multiple CH and CH2 
stretches; N=O band lies at 1526 cm-1. Ca. 2850–2925 cm-1: C-
H stretches. 
α+ BODIPY 2c 
PM 
500–1800 cm-1: C-Br stretch maintained; other BODIPY and 
CDx peaks are combined and superimposed, with significant 
broadening observed for the C=O/OH although it maintains 
the original frequency of 1026 cm-1. N=O band is maintained 
at 1533 cm-1. The BODIPY C-H stretch at 2919 cm-1 is 
maintained, but the characteristic shape is lost. The O-H 
stretch of the CDx at ca. 3300 cm-1 is fully maintained. 
Overall, the spectrum is a combination of the CDx and 
BODIPY spectra. 
α+ BODIPY 2c 
incl. comp 
500–1700 cm-1: Most BODIPY stretches disappear, while 
those of the CDx are maintained. CDx O-H and C-O bands 
maintained and change frequency to 1023 cm-1 as a result of 
superimposition with BODIPY peaks. The C-C-C CDx bend at 
ca. 1150 cm-1 is fully maintained. The N=O band which was 
observed at ca. 1530 cm-1 in the BODIPY and physical mixture 
spectra is lost in that of the complex. This may indicate 
inclusion of the meso-phenyl ring which contains the nitro 
group inside the cyclodextrin cavity.  At ca. 2900 cm-1, the C-H 
stretches of the BODIPY are maintained and the characteristic 
shape is fully lost, more than in the physical mixture. Finally, 
the O-H stretch of the CDx at ca. 3260 cm-1 is maintained. 
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Figure 60. FT-IR spectra of BODIPY 2a, BODIPY 2b and BODIPY 2c with β-cyclodextrin. 
Coloured boxes used to highlight changes in the respective characteristic peaks of the 
BODIPY and cyclodextrin upon formation of the inclusion complex. 
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Table 32. Discussion of FT-IR spectra of BODIPY dyes included in β-cyclodextrin. 
Sample Characteristics 
β alone 
500–1650 cm-1: cis RCH=CHR, =CH and =CH2 stretch, C-H 
bend, OH, C-O, C-C-C bend, O-H bend, CH2 deformation, 
O-C and C=O. At ca. 3300 cm-1, there is an O-H stretch.  
BODIPY 2a 
alone 
C-Br stretch at 522 cm-1. 550–1600 cm-1: multiple CH and 
CH2; C-N stretch. Ca. 2900 cm-1: C-H stretches. 
β+ BODIPY 2a 
PM 
The O-H stretch of the CDx at ca. 3350 cm-1 is maintained. 
500–1800 cm-1: C-Br stretch; combined and superimposed 
BODIPY and CDx peaks, with broadening of the peak at 
996 cm-1. BODIPY C-H stretch at 2918 cm-1 maintained, 
but characteristic shape lost. Overall, the spectrum is a 
combination of the CDx and BODIPY spectra. 
β+ BODIPY 2a 
incl. comp 
500–600 cm-1: All BODIPY stretches disappear, with those 
of the CDx maintained, but are markedly less obvious, i.e. 
decreased intensity. CDx OH and C-O bands maintained, 
but shift from 1022 cm-1 in the CDx spectrum to 1031 cm-1 
in that of the complex. The C-C-C CDx bend at ca. 1150 
cm-1 is maintained, whereas around 1150–1650 cm-1, the 
CDx spectrum combines with the less intense BODIPY 
peaks.  At ca. 2900 cm-1, the BODIPY C-H stretch is 
maintained, but it loses the shape seen in the dye alone. 
Finally, the O-H stretch of the CDx at 3290 cm-1 is 
maintained. 
BODIPY 2b 
alone 
C-Br stretch at 523 cm-1. 550–1600 cm-1: multiple C-H and 
CH2 stretches. Ca. 2900 cm-1: C-H stretches. 
β+ BODIPY 2b  
PM 
500–1100 cm-1: BODIPY C-Br stretch maintained; other 
CDx and BODIPY bands superimposed with the CDx 
spectrum being more prominent. 1100–1600 cm-1: the 
BODIPY spectrum is the only one maintained but with 
decreased intensity. BODIPY C-H stretch at 2919 cm-1 is 
maintained, but the characteristic shape is lost. The O-H 
stretch of the CDx at 3300 cm-1 is also maintained. 
Overall, the spectrum is a combination of CDx and BODIPY 
spectra. 
161 
 
β+ BODIPY 2b 
incl. comp 
500–1600 cm-1: BODIPY C-Br stretch disappears together 
with both the BODIPY and CDx stretches below 1000 cm-1, 
while those around 1250–1600 cm-1 are maintained. CDx 
O-H and C-O bands are maintained and superimposed 
with those of BODIPY, and as such the peak shifts from 
1022 to 1036 cm-1. The C-C-C CDx bend at ca. 1160 cm-1 is 
drastically reduced in intensity but still maintained.  In the 
2905–2975 cm-1 region, the C-H stretch of the BODIPY is 
fully maintained. Finally, the O-H stretch of the CDx at ca. 
3270 cm-1 is maintained. 
BODIPY 2c 
alone 
C-Br stretch at 531 cm-1. 550–1700 cm-1: multiple CH and 
CH2 stretches; N=O band lies at 1526 cm-1. 2850–2925 cm-
1: C-H stretches. 
β+ BODIPY 2c 
PM 
500–1800 cm-1: C-Br stretch maintained, while other 
BODIPY and CDx peaks are combined and superimposed, 
with broadening of the C=O/OH band and change in 
frequency to ca. 1008 cm-1. The N=O band is maintained 
at ca. 1530 cm-1. The BODIPY C-H stretch at 2918 cm-1 is 
maintained, but the characteristic shape is lost. The O-H 
stretch of the CDx at ca. 3300 cm-1 is fully maintained. 
Overall, the spectrum is a combination of the CDx and 
BODIPY spectra. 
β+ BODIPY 2c 
incl. comp 
500–900 cm-1: All BODIPY stretches disappear, while those 
of the CDx are maintained. CDx O-H and C-O bands 
maintained at 1023 cm-1. The C-C-C CDx bend at ca. 1150 
cm-1 is drastically reduced although still visible. Between 
1150–1650 cm-1 the CDx and BODIPY spectra combine and 
peaks become the less intense. The N=O band at ca. 1530 
cm-1 in the BODIPY and physical mixture spectra is lost in 
that of the complex. This may indicate inclusion of the 
meso-phenyl ring which contains the nitro group inside 
the cyclodextrin cavity.  At ca. 2900 cm-1, the C-H 
stretches of the BODIPY are maintained, and the 
characteristic shape becomes more pronounced than in 
the physical mixture. Finally, the O-H stretch of the CDx at 
ca. 3260 cm-1 is maintained but loses significant intensity. 
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5.2.3. Scanning electron microscopy (SEM) 
The SEM images for the BODIPY dyes, cyclodextrins, physical mixtures and inclusion 
complexes were recorded (Figure 61–Figure 66) and they are discussed below (Table 33 and 
Table 34). 
 
Figure 61. SEM micrographs of BODIPY 2a with α-cyclodextrin: (a) α-cyclodextrin, (b) BODIPY 
2a, (c) BODIPY 2a-(α-cyclodextrin physical mixture and (d) BODIPY 2a-(α-cyclodextrin) 
inclusion complex. 
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Figure 62. SEM micrographs of BODIPY 2b with α-cyclodextrin: (a) α-cyclodextrin, (b) 
BODIPY 2b, (c) BODIPY 2b-(α-cyclodextrin physical mixture and (d) BODIPY 2b-(α-
cyclodextrin) inclusion complex. 
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Figure 63. SEM micrographs of BODIPY 2c with α-cyclodextrin: (a) α-cyclodextrin, (b) BODIPY 
2c, (c) BODIPY 2c-(α-cyclodextrin physical mixture and (d) BODIPY 2c-(α-cyclodextrin) 
inclusion complex. 
Table 33. Discussion of SEM images of BODIPY dyes included in α-cyclodextrin. 
Sample Characteristics 
α alone Cubic, well-defined structures. 
BODIPY 2a alone 
Some fibrous structures, coupled with aggregated 
amorphous to cubic shape. 
α+ BODIPY 2a 
PM 
Mixed morphology. 
α+BODIPY 2a 
incl. comp 
Aggregated and amorphous. Different from both 
parent shapes. 
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BODIPY 2b alone Aggregated/close-lying with a semi-cylindrical shape. 
α+BODIPY 2b PM Mixed morphology. 
α+ BODIPY 2b 
incl. comp 
New morphology. The dendrous and amorphous nature 
of the BODIPY is completely lost. 
BODIPY 2c alone Amorphous aggregates. 
α+ BODIPY 2c PM Mixed morphology, with CDx being more prominent. 
α+ BODIPY 2c 
incl. comp 
New morphology. Pore-like structures also present. 
 
 
Figure 64. SEM micrographs of BODIPY 2a with β-cyclodextrin: (a) β-cyclodextrin, (b) BODIPY 
2a, (c) BODIPY 2a-(β-cyclodextrin physical mixture and (d) BODIPY 2a-(β-cyclodextrin) 
inclusion complex. 
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Figure 65. SEM micrographs of BODIPY 2b with β-cyclodextrin: (a) β-cyclodextrin, (b) BODIPY 
2b, (c) BODIPY 2b-(β-cyclodextrin physical mixture and (d) BODIPY 2b-(β-cyclodextrin) 
inclusion complex. 
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Figure 66. SEM micrographs of BODIPY 2c with β-cyclodextrin: (a) β-cyclodextrin, (b) BODIPY 
2c, (c) BODIPY 2c-(β-cyclodextrin physical mixture and (d) BODIPY 2c-(β-cyclodextrin) 
inclusion complex. 
Table 34. Discussion of SEM images of BODIPY dyes included in β-cyclodextrin. 
Sample Characteristics 
β alone Somewhat amorphous. 
BODIPY 2b alone Aggregated/close-lying with a semi-cylindrical shape. 
β+ BODIPY 2b PM Combined amorphous and semi-cylindrical. 
β+ BODIPY 2b incl. 
comp 
Both CDx alone and BODIPY alone shapes were lost. New 
flaky, amorphous morphologies observed, combined 
with some fibrous structures. 
168 
 
BODIPY 2a alone 
Some fibrous structures, coupled with aggregated 
amorphous to cubic shape. 
β+ BODIPY 2a PM 
Both CDx amorphous and BODIPY cubic to amorphous 
morphologies maintained, with the BODIPY losing the 
aggregated nature and fibrous structures.   
β+ BODIPY 2a incl. 
comp 
New flaky structure observed. Increased aggregation, 
losing original shapes. 
BODIPY 2c alone Amorphous aggregates. 
β+ BODIPY 2c PM 
Both CDx and BODIPY morphologies maintained, with the 
CDx being more prominent. 
β+ BODIPY 2c incl. 
comp 
New morphologies: flaky and rod-like, coupled with 
aggregated amorphous ball-like structures. 
5.2.4. X-ray powder diffraction analysis (XRD) 
The X-ray diffraction patterns of the BODIPY dyes, cyclodextrins, physical mixtures and 
inclusion complexes have also been analysed (Figure 67 and Figure 68). The α-cyclodextrin 
was crystalline (Figure 67) whereas the β-cyclodextrin was amorphous (Figure 68). The 
BODIPY dyes were all observed to be amorphous, with BODIPY 2a exhibiting minimal 
crystallinity. The physical mixtures obtained with α-cyclodextrin were a superimposition of 
the diffraction patterns of the respective BODIPY dye and α-cyclodextrin, with the 
cyclodextrin being more prominent for BODIPYs 2a and BODIPY 2b, whereas for the BODIPY 
2c-(α-cyclodextrin) physical mixture the BODIPY pattern was more pronounced. Upon 
inclusion of the respective dyes into α-cyclodextrin, all diffraction patterns were mainly 
amorphous with a minor degree of crystallinity, albeit being different from the parent ones.  
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Figure 67. X-ray diffraction patterns of BODIPY 2a, BODIPY 2b and BODIPY 2c with α-
cyclodextrin. 
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Figure 68. X-ray diffraction patterns of BODIPY 2a, BODIPY 2b and BODIPY 2c with β-
cyclodextrin. 
171 
 
In the β-cyclodextrin studies, the physical mixtures obtained were also a superimposition of 
the diffraction patterns of the respective BODIPY dye and β-cyclodextrin, with no parent 
pattern being more prominent for the BODIPY 2a- and 2b-(β-cyclodextrin) physical mixtures 
while the BODIPY diffraction pattern is more prominent for 2c. When included in β-
cyclodextrin, new patterns of a mixed amorphous and crystalline nature are observed and 
these are different from those of the BODIPY alone, cyclodextrin alone and the physical 
mixtures except for the 2b-(β-cyclodextrin) complex which exhibits some similarities to the 
BODIPY diffraction pattern. 
5.2.5. Circular dichroism 
In essence, circular dichroism spectroscopy is used to identify both chromophore 
orientation and the direction of the electric dipole transition moment. The sign of the 
induced CD (ICD) spectrum shows the type of inclusion which has occurred, and this is based 
on the electronic transitions taking place.45,87,190–192  A positive ICD signal shows that the 
electronic transitions occur parallel to the molecular axis of the cyclodextrin (axial inclusion) 
while a negative one shows that the electronic transitions occur parallel to the molecular 
axis of the cyclodextrin (equatorial inclusion). When the ICD signals of the short and long 
axis polarised transitions are both negative in sign, a third type of inclusion, the lid-type has 
occurred.45,87,190–192 Attempts were made to obtain the CD spectra in deionised water but 
for all the complexes studied here, the CD spectra did not give satisfactory results as there 
was no clearly detectable induced signal. This was most probably due to the BODIPY and 
cyclodextrin forming the inclusion complexes not possessing strong enough interactions to 
generate ICD and/or the relatively large energy separation between the main BODIPY 
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spectral band in the 520–540 nm region and those of the cyclodextrin that lie below 300 
nm. 
5.2.6. Fluorescence spectroscopy 
Another spectroscopic technique that is typically used in the assessment of guest inclusion 
into the cyclodextrin cavity is fluorescence spectroscopy, wherein a fluorescent guest is 
studied both before and after inclusion. In this instance, the BODIPY dyes used are not 
soluble in water hence it was not possible to assess their fluorescence in water prior to 
inclusion; instead the fluorescence properties of the dyes were studied in organic media 
before inclusion and in water subsequent to inclusion into cyclodextrins. Representative 
emission spectra are shown (Figure 69) and these belong to BODIPY 2b in ethanol and the 
BODIPY 2b-(α-cyclodextrin) inclusion complex in water. 
 
Figure 69. Emission spectra of BODIPY 2b in ethanol (green) and the BODIPY 2b-(α-
cyclodextrin) inclusion complex in water (red). 
From the spectrum, it is evident that the dye possesses the typical BODIPY emission 
spectrum as shown by the sharp emission maximum; but this is not the case for the 
inclusion complex in water as can be seen from the significantly broadened and flat 
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emission spectrum. This broadening is thought to be due to both aggregation in the water 
solution and the quenching effects of water. For all the other inclusion complexes in both α- 
and β-cyclodextrin, the observations were generally similar. 
Concluding remarks and future outlook 
A short series of BODIPY-cyclodextrin inclusion complexes have been successfully formed 
and characterised in solution using UV-visible absorption, fluorescence and circular 
dichroism spectroscopies and in the solid state using FT-IR, XRD and SEM; challenges were 
encountered in solution, however. Attempts to quantify the singlet oxygen generation of 
the inclusion complexes in water using both an Ekspla NT342B-20-AW laser and a Thorlabs 
mounted M530L3 LED as light sources. It was expected that the singlet oxygen generated 
from the brominated BODIPY dyes within the complexes should breakdown ADMA. 
However, no decrease in the concentration of the ADMA solution was observed and this 
implies either one of the following: that the BODIPY dyes included in the cyclodextrins 
were either unable to generate singlet oxygen; or that the molecular oxygen in the 
solution was not close enough to the BODIPY dyes to allow energy transfer to take place; 
or that the experimental setups used were not suitable in some regard. 
Having successfully included heavy atom containing BODIPY dyes into α- and β-
cyclodextrins and achieved water solubility, the next step to carry forward this research is 
to optimise the necessary conditions and experimental setup to be able to quantify any 
singlet oxygen that is generated under aqueous conditions. Additionally, assessing the 
toxicity of the inclusion complexes to bacterial cultures and in biological media would be 
another possible avenue of research if further progress is made. 
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Chapter 6:  
Spectroscopic assessment of 
pH-sensitivity of a distyryl 
BODIPY in organic media 
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As described in Chapter 1, BODIPY dyes have been extensively studied for their potential in 
sensing cations and anions, metal ions, enzymes and reactive oxygen species.114,131,133,135 
Additionally, pH-sensitive fluorescent probes are also worth researching since pH is an 
indicator in many cellular events e.g. abnormal cell growth, inflammation and cancer are 
all characterised by pH values lower than those of normal cells.136 
The focus of this chapter is an analysis of the suitability of BODIPY 8 in sensing pH changes 
(in organic media for the purposes of this study). The mechanism of interest here is ICT 
using a BODIPY dye, the design of which will allow turn-on fluorescence in the presence of 
an acid (Figure 70). During the ICT process, electronic interactions between electron 
donating and electron accepting groups occur. For the purposes of this study, the (N(CH3)2) 
group acts as an electron donor. The addition of an acid is expected to eliminate this ICT 
process, thereby enhancing the fluorescence intensity of the dye and also result in spectral 
changes. The BODIPY dye of interest contains two dimethyl-aminophenyl groups (N(CH3)2) 
at the 3,5-positions and these act as a receptors; (N(CH3)2) containing BODIPY dyes have 
their fluorescence quenched in polar solvents but upon protonation the fluorescence 
process is activated due to the inhibition of charge transfer processes.112,132,133,135,137  
 
Figure 70. Structure of BODIPY 8, the dye that was used for pH sensing.  
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Figure 71. Absorption spectra of BODIPY 8 in the presence of increasing amounts of TFA. A: 
Benzene, B: acetonitrile and C: DMSO. 
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During this study, three different solvents with increasing polarities were used, and 
absorption spectra (Figure 71A–Figure 71C) were measured in the presence of increasing 
amounts of TFA. The solvents are benzene (polarity index 2.7), acetonitrile (polarity index 
5.8) and DMSO (polarity index 7.2). Absorption spectra were measured from initial 
concentrations of 2.8 × 10-5 M for benzene and acetonitrile and at a concentration of 1.4 × 
10-4 M for DMSO because 2.8 × 10-5 M for DMSO gave a significantly lower absorbance 
reading.  
In benzene, the absorption spectrum is significantly red-shifted in the absence of an acid 
and possesses more pronounced charge transfer (CT) bands between 400 and 550 nm. Upon 
addition of minimal TFA (25 µL), the main absorption band blue-shifts and the CT bands 
disappear; this is an indication that charge transfer has been eliminated (Figure 71A). Upon 
increasing the polarity of the solvent, more acid was required to eliminate ICT. This is 
evident in the spectra recorded in acetonitrile and DMSO, wherein the dye does not 
instantaneously change from the unprotonated to the protonated form. Instead, as the 
amount of TFA increases the absorption maximum (associated with the main transition) for 
the unprotonated dye gradually decreases while the absorption maximum for the 
protonated form of the dye appears immediately. In addition, as the intensity of the 
absorption band associated with the unprotonated dye gradually decreases, the wavelength 
decreases to an intermediate value between that of the protonated and unprotonated 
form; this may signal the existence of a mixture of unprotonated, mono-protonated and di-
protonated species. According to the absorption spectra, in acetonitrile, the di-protonated 
or fully protonated dye is completely formed after the addition of 200 µL of TFA whereas in 
DMSO it is observed after addition of 3200 µL (Figure 71B and Figure 71C). A final point 
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worth noting in relation to solvent polarity is that the absorption maximum seems to be 
highly dependent on solvent polarity because there is significant red-shifting in the most 
polar solvent, as can be seen from the absorption maxima at 714 nm for benzene and 730 
nm for DMSO when unprotonated (Figure 71A and Figure 71C). 
In each of the solvents, the fluorescence spectra (Figure 72–Figure74), quantum yields and 
lifetimes were obtained (Table 35). In benzene, in the absence of an acid, there are two 
emission maxima at 680 and 754 nm while the maxima are not significantly different in the 
more polar acetonitrile and DMSO in the presence of 25 and 100 µL TFA, occurring at 657 
and 658 nm, respectively. The emission intensity drops by 12% on increasing the amount of 
TFA from 25 to 100 µL in benzene.  
 
Figure 72. Emission spectra of BODIPY 8 in benzene, in the presence of increasing amounts 
of TFA. A: no acid, B: 25 µL TFA present and C: 100 µL TFA present. 
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The starting amounts of TFA for acetonitrile and DMSO are much higher, but, as can be 
observed in Figure 73 and Figure 74, the emission spectra are weak despite the higher 
amounts of TFA added to eliminate ICT; this is has been previously observed to be the case 
for more polar solvents.132,137  
 
Figure 73. Emission spectra of BODIPY 8 in acetonitrile, in the presence of increasing 
amounts of TFA. A: no acid, B: 100 µL TFA present, C: 200 µL TFA present, D: 800 µL TFA 
present, E: 1600 µL TFA present and F: 3200 µL TFA present. 
In acetonitrile, the emission intensity decreases gradually as the amount of acid is increased 
and finally drops by 65% on increasing the amount of TFA from 100 to 3200 µL; this huge 
decrease can be attributed to a dilution effect of the acid on the BODIPY-containing organic 
solution as large amounts of acid were used in the last three samples, as is evident from 
their weak emission spectra relative to the first three (Figure 73).  
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Figure 74. Emission spectra of BODIPY 8 in DMSO, in the presence of increasing amounts of 
TFA. A: no acid, B: 200 µL TFA present, C: 800 µL TFA present, D: 1600 µL TFA present, E: 
3200 µL TFA present and F: 6400 µL TFA present.  
In DMSO, there is no distinct fluorescence as the emission spectra are not similar to the 
typical BODIPY spectrum for all samples except the ones containing 3200 µL TFA and 6400 
µL TFA. On increasing the amount of TFA from 100 µL to 3200 µL, the intensity increases and 
reaches a maximum at 3200 µL before dropping by 31% on increasing TFA volume to 6400 
µL, further showing the dilution effects of the large amount of acid used (Figure 74). 
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Table 36. Photophysical data for BODIPY 8 in different organic solvents in the 
presence and absence of increasing volumes of TFA. 
Solvent λAbs 
(nm) 
λExc 
(nm)* 
λEm 
(nm)* 
Stokes shift 
(nm) 
ФF ꚍF  
(ns)* 
Benzene 
714 660 680; 
754 
40 0.09 2.63 
Benzene + 25 µL 
TFA 
638 640 657 19 0.31 NS 
Benzene + 100 
µL TFA 
638 639 658 20 0.27 4.60 
Acetonitrile 711 717 794 83 0.02 NS 
Acetonitrile + 
100 µL TFA 
632 632 654 22 0.08 NS 
Acetonitrile + 
3200 µL TFA 
622 633 655 33 0.02 NS 
DMSO 
730 n.d n.d - 0.02 0.75 (97%) 
3.301 (3%) 
DMSO + 100 µL 
TFA 
708 n.d n.d - 0.02  
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DMSO + 3200 µL 
TFA 
633 633 662 29 0.03 0.26 (73%) 
1.99 (27%) 
*fluorescence lifetimes were only determined in the absence of TFA and in the presence 
of excess TFA 
*NS = not studied; *n.d = not detected 
 
Figure 75. Changes in fluorescence emission intensity in DMSO, in the presence of 
increasing amounts of TFA. 
As expected, the amount of acid required to eliminate ICT in the less polar benzene is not as 
large as in more polar solvents, and the fluorescence intensity significantly decreases in the 
more polar acetonitrile and DMSO relative to the measurements in benzene.132,137  This is 
evident in the fluorescence lifetimes and quantum yields which are very low for acetonitrile 
and DMSO relative to benzene (Table 35). 
To assess the reversibility of protonation of the dimethylamino moieties of the dye, TEA was 
added in aliquots to a solution of BODIPY 8 in DMSO, at a concentration of 1.4 × 10-4 M in 
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the presence of 3200 µL TFA and the absorption spectra recorded (Figure 76).  From the 
recorded spectra, it is evident that the protonation process is easily reversible. Furthermore, 
when small amounts of TFA were added, there was no shift in the wavelength of the 
maximum absorption band; a shift was only visible when 3200 µL of TEA was added, shifting 
the absorption band from 633 nm to 725 nm. The spectrum observed displayed a weak 
signal as can be seen but this changed when the amount of TEA was gradually increased, 
wherein the wavelength continued shifting so that the band maximum lies at 768 nm in the 
presence of 8000 µL TEA, which represents a red shift of ca. 38 nm relative to the spectrum 
in DMSO with no acid or base added. The reversibility of the spectral changes further 
demonstrates the potential utility of BODIPY 8 as an “off-on” fluorescence switch. 
 
Figure 76. Normalised absorption spectra of BODIPY 8 in the presence of increasing 
amounts of TEA. Spectra measured in DMSO. 
The reversibility which is observed spectroscopically (Figure 76) is also visible to the naked 
eye. The colour of the solution gradually changes from brown to green as TFA is added to a 
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solution of BODIPY 8, following the red-shift occurring in the absorption spectrum. When 
TEA is added in excess to reverse the process, the original brown colour returns (Figure 77). 
 
Figure 77. Colourimetric changes visualised upon addition of increasing amounts of TFA and 
TEA to a solution of BODIPY 8 in DMSO. 
Concluding remarks 
It has been successfully demonstrated using BODIPY 8 can be used as pH-sensitive 
fluorescent probe in three different solvents of differing polarity. The sensor process 
involves BODIPY dyes which have their fluorescence quenched in polar solvents due to ICT 
but upon protonation, the fluorescence process is activated due to its 
inhibition.112,132,133,135,137 This is what was observed in this study, wherein the amount of acid 
required to eliminate ICT was higher in the most polar solvent. The elimination of ICT and 
the “turn on” effect on the fluorescence properties was reversible through the addition of a 
base, further demonstrating that BODIPY 8 is able to behave as an “off-on” fluorescence 
switch in the presence and absence of species which can interact with the styryl 
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dimethylamino moieties. The most interesting aspect of this study is the potential suitability 
of BODIPY 8 as a sensor for pH in biological studies, since pH is a useful indicator of many 
cellular events. Abnormal cell growth, inflammation and cancer are all characterised by pH 
values lower than those of normal cells.136 More research still needs to be carried out in this 
regard, however, since non-toxicity and water solubility or the ability to include the 
molecule in a water-soluble carrier which can be easily excreted of metabolised if and when 
in a biological system, are key requirements for the biological application of any molecular 
dye. The main limitation in this regard is that the study was carried out in organic media. 
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Chapter 7:  
Molecular modelling 
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7.1. Geometry Optimisation and TD-DFT calculations 
Molecular modelling calculations have been used to elucidate trends in the predicted 
spectra and the electronic structures of a set of synthesised compounds, BODIPYs 1e, 2e, 5 
and 6. To perform the calculations, density functional theory (DFT) was used to carry out 
geometry optimisations using the Beck, three-Parameter, Lee-Yang-Parr (B3LYP) functional 
with 6-31G(d) basis sets using the Gaussian09 software package.139 Because the B3LYP 
functional typically underestimates long-range charge transfer excitation, which is 
frequently found in BODIPY dyes, the Coulomb-attenuated B3LYP (CAM-B3LYP) functional 
was used to perform TD-DFT calculations so as to predict the electronic absorption 
properties.193,194 This is particularly important because the CAM-B3LYP functional, unlike 
B3LYP combines elements of the hybrid B3LYP functional with increasing fractions of 
Hartree-Fock (HF) exchange parameters, resulting in a functional with improved long-range 
capabilities.194 
7.2. Molecular modelling for BODIPYs 1e, 2e, 5 and 6 
According to the TD-DFT calculations, the lowest lying S0 → S1 transition is almost entirely 
associated with the HOMO → LUMO one-electron transition (Table 36). The C2V symmetry 
adopted by BODIPY dyes upon complexation with a boron difluoride ligand makes the 
HOMO and LUMO energetically well-separated from other MOs (Figure 78) and this is 
significant because when the effect of structural changes on the optical properties are 
considered, it is primarily the HOMO and LUMO which should be considered, i.e. the other 
MOs are largely uninvolved in the observed changes. Hence, a red-shift of the BODIPY main 
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spectral band is observed because of structural changes which affect the energies of the 
HOMO and LUMO, resulting in a narrowing of the HOMO–LUMO band gap. 
 
Figure 78. MO energies of BODIPYs 1e, 2e, 5 and 6 at the CAM-B3LYP/6-31 G(d) level of 
theory. Blue and green lines are used to denote the primary localisation of MOs on the 
styryl and phenyl moieties, respectively. The HOMO and LUMO gaps are plotted against a 
secondary axis and are denoted by large red diamonds. The occupied MOs are highlighted 
with small black squares. 
Upon the addition of bromine atoms on going from BODIPY 1e to BODIPY 2e there is a 
destabilisation of both the HOMO and LUMO (Figure 78) but because the HOMO has 
significant MO coefficients at the 2,6-positions, while the LUMO only possesses small MO 
coefficients (Figure 79), the net effect of the addition of these bromine atoms is the 
destabilisation of the HOMO relative to the LUMO thereby narrowing the HOMO–LUMO gap 
and this results in the ca. 18 nm red-shift that is observed in the calculated TD-DFT spectrum 
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for BODIPY 2e (Figure 80). This is usually observed for other 2,6-dibrominated dyes, hence 
this is expected to be the case with the other BODIPY dyes synthesised in this work. 
 
Figure 79. Angular nodal patterns and MO energies of BODIPYs 1e, 2e, 5 and 6 for the 
HOMO and LUMO (at an isosurface value of 0.02 a.u). 
The MO coefficients at the 3,5-positions are unevenly distributed on the HOMO and LUMO 
of BODIPY 2e as is evident from the larger MO coefficient that is observed in the HOMO 
(Figure 79) and as such any structural modifications at these positions are expected to result 
in a change in the size of the HOM–LUMO band gap because the HOMO is more significantly 
affected. As can be seen, the introduction of the styryl groups at the 3,5-positions results in 
a further red-shift of ca. 110 nm for BODIPY 5 and ca. 127 nm for BODIPY 6 (Figure 80 and 
Table 36). Although the main absorption band is still due to the HOMO-LUMO one-electron 
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transitions for both dyes, other transitions are predicted to result in intense bands in the 
visible region, since large oscillator strengths are predicted both for the main absorption 
band (Table 36) and the absorption bands observed in the 300–450 nm region (Figure 80). 
These observations are typical of those made with other distyryl dyes, hence this is 
expected to also be the case with the other BODIPY dyes synthesised in this work, 
notwithstanding the fact that the substituents present on the styryl groups will also have an 
effect on the extent of red-shift of the main spectral band, since differing electron 
withdrawing and donating effects will change the degree of destabilization of the HOMO 
relative to the LUMO. 
 
Figure 80. Calculated TD-DFT spectra of BODIPYs 1e, 2e, 5 and 6 at the CAM-B3LYP/6-31 
G(d) level of theory. The main spectral bands associated with the HOMO → LUMO transition 
are found between 400 and 500 nm for BODIPYs 1e and 2e, and between 500 and 670 nm 
for BODIPYs 5 and 6. Simulated spectra were calculated using the Chemcraft program195 by 
using bandwidths of 30 nm. 
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Table 36. TD-DFT calculations at the CAM-B3LYP/6-31 G(d) level for B3LYP 
optimised BODIPY 1e, 2e, 5 and 6 structures 
BODIPY #a E 
(eV)b 
λcalc 
(nm)c 
fd Wavefunctione 
1e 
1 3.01 411 0.53 97% (H → L); … 
2 3.86 321 0.05 96% (H-2 → L); … 
3 4.06 305 0.00 94% (H-1 → L); … 
4 4.13 300 0.04 99% (H-3 → L); … 
2e 
1 2.89 429 0.60 97% (H → L); … 
2 3.72 334 0.11 96% (H-2 → L); … 
3 3.82 324 0.00 94% (H-1 → L); … 
4 3.9 318 0.06 93% (H-3 → L); … 
5 
1 2.30 539 1.11 96% (H → L); … 
2 3.6 344 0.98 93% (H-1 → L); … 
3 3.76 330 0.04 89% (H-4 → L); 6% (H-2 → L); 
… 
4 3.99 311 0.00 92% (H-3 → L); 3% (H-3 → 
L+2); … 
5 4.05 306 1.48 89% (H → L+2); 5% (H-1 → 
L+2); 3% (H-6 → L); … 
6 4.09 303 0.03 77% (H-6 → L); 15% (H-5 → L); 
4% (H → L+1); … 
6 
1 2.23 556 1.00 96% (H → L); … 
2 3.40 365 0.99 93% (H-1 → L); … 
3 3.51 353 0.02 58% (H-4 → L); 38% (H-2 → L); 
… 
4 3.78 328 0.00 93% (H-3 → L); 2% (H-3 → 
L+2); … 
5 3.82 325 0.17 93% (H-5 → L); … 
7 4.11 302 1.36 91% (H → L+1); 6% (H-1 → 
L+2); … 
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a- Excited state number assigned in increasing energy in the TD-DFT 
calculations. b- Calculated band energies in eV. c- Calculated wavelengths in 
nm. d- Calculated oscillator strengths. e- Wavefunctions of MOs involved in 
the transition, and their respective contributions, based on eigenvectors 
predicted by TD-DFT. H and L refer to the HOMO and LUMO, respectively. 
Concluding remarks 
The TD-DFT calculations performed have proven to be a useful tool for establishing trends in 
the energy of BODIPY molecular orbitals, which when studied they provide insight into the 
spectroscopic properties of BODIPY dyes in relation to structural modifications. This is useful 
in the design of specific BODIPY dyes for various applications such as optical limiting and 
fluorescence sensing, wherein the dyes must be significantly red-shifted and the 
intermolecular electron transfers taking place understood, respectively. The trends in the 
calculations match the experimental electronic absorption spectra, as observed not only in 
the series of BODIPY dyes modelled but also those of other dyes that have been 
synthesised, particularly the brominated BODIPYs 2a, 2b, 2c and 2d and the other distyryl 
dyes. 
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Chapter 8:  
Conclusions, limitations and 
future prospects 
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8.1. Conclusions 
The main aim of this work was to synthesise and study a series of structurally diverse 
BODIPY dyes that have properties that make them suitable for use as photosensitizers, in 
NLO and in fluorescence sensing. The applications envisaged included the use of BODIPY 
dye-cyclodextrin inclusion complexes in biomedical studies, optical limiting in the context of 
aviation and the development of a pH-sensitive colourimetric and fluorescence sensor 
suitable for use in the NIR region.  
To understand the properties of these dyes, it was also necessary to assess their 
photophysical properties.The starting point in achieving the aims listed above was to 
synthesise five BODIPY dyes, 1a–1e using the classic “one-pot three-step” acid-catalysed 
condensation reaction. These dyes have different functional groups at the para position of 
the meso-phenyl ring. BODIPYs 1a–d have many favourable photophysical properties and 
they all have similar absorption properties, typical of BODIPY dyes derived from 2,4-
dimethylpyrrole, since the meso-aryl ring lies orthogonal to the BODIPY core. The dyes did, 
however, exhibit significant differences when it comes to their fluorescence properties, with 
BODIPY 1a only highly fluorescent in the presence of an acid to eliminate ICT between the 
dimethylamino moiety and the BODIPY core; BODIPY 1c also possessed weak fluorescence 
due to the quenching effect of the nitro group which is known to strongly quench 
fluorescent dyes through what is suggested to be an electron-withdrawing effect.161 
BODIPYs 1b and 1d were significantly fluorescent and independent of solvent polarity. The 
absorption maxima were not significantly altered by changing the solvent.  
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To further red-shift the spectra and to make the dyes capable of generating singlet oxygen, 
BODIPYs 1a–1e were brominated at the 2,6-positions (and BODIPY 1a on the meso-phenyl 
ring), yielding BODIPYs 2a–2e whose absorption spectra are red shifted by ca. 30 nm relative 
to their parent dyes. BODIPYs 2a–2d possessed fair singlet oxygen quantum yields in the 
range of solvents studied. This creates an avenue for use in singlet oxygen applications, such 
as photodynamic antimicrobial chemotherapy,195 which do not require a red-shifted 
photosensitizer and to couple this singlet oxygen generating ability with the typical 
requirement for water-soluble photosensitizers, a short series of BODIPY-cyclodextrin 
inclusion complexes was formed using BODIPYs 2a–2c and α- and β- cyclodextrins. These 
complexes were characterised in solution and in the solid state, and the singlet oxygen 
generating ability assessed in water using ADMA as a singlet oxygen scavenger. There was 
no decrease in the concentration of the ADMA solution, however, and this may imply that 
the complexes were unable to generate singlet oxygen, due to rapid non-emissive 
deactivation of the S1 state, or that the molecular oxygen in the solution was not close 
enough to the BODIPY dyes to allow energy transfer to take place; or that the light sources 
used were not suitable for this particular application. Further work is needed in this area. 
BODIPY 2d was used to synthesise BODIPY 3, a new mono-styryl BODIPY dye whose 
structural characterisation was also successful. In addition, five novel di-styryl BODIPYs, 
BODIPYs 5, 6, 8, 9 and 10 were synthesised from BODIPYs 1e and 2e for BODIPYs 5 and 6, 
respectively and from 4,4’-difluoro-8-(4-carbomethoxyphenyl)-2,6-diethyl-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene for BODIPYs 8, 9 and 10. These were synthesised 
using a modified version of the Knoevenagel condensation reaction.1,3 Their main 
absorption band maxima are significantly red-shifted far above 532 nm, the second 
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harmonic of the Nd:YAG laser which is used to study the nonlinear optical limiting 
properties of these dyes. BODIPY 6 was red-shifted into the therapeutic window, with 
absorption maxima at 663 and 667 nm in DCM and DMSO, respectively; this red-shift 
coupled with the ability of the dye to generate singlet oxygen species with moderate 
quantum yield values makes 6 potentially suitable for use as a photosensitizer for singlet 
oxygen applications such as PDT. The nonlinear optical properties of BODIPYs 5, 6, 8, 9 and 
10 were investigated together with two other previously reported BODIPYs, 4 and 7.95,150,151 
All of these BODIPY dyes showed very promising optical limiting responses on the 
nanosecond at 532 nm in solution, in the range of solvents used, and this provided further 
evidence that π-expanded BODIPY dyes have considerable potential in this context. 
The potential application of BODIPY 8 as a pH-sensitive fluorescent probe was assessed in 
three different solvents of increasing polarity. It was successfully demonstrated that the 
addition of an acid to an organic solution of BODIPY 8 leads to the elimination of ICT, turning 
on the fluorescence of the dye. This was reversible upon the addition of a base, further 
demonstrating that BODIPY 8 is able to behave as an “off-on” fluorescence switch in the 
presence and absence of species which can interact with the dimethylamino moieties at the 
para-positions of the styryl groups.  
8.2. Limitations and future prospects 
 With respect to optical limiting, it will be essential to fabricate thin films to demonstrate 
the potential practical application of any molecules as optical limiters, for use in aviation 
safety or to protect sensitive optical equipment. This is one possible future avenue 
worth pursuing in relation to the structures studied here. In addition, the remarkable OL 
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response from BODIPY 4 with its unusually large permanent dipole moment provides the 
basis for the rational design of more novel BODIPY dyes with donor-π-acceptor type 
structures to be investigated for use as optical limiters on the nanosecond timescale, at 
532 nm.  
 On the BODIPY-cyclodextrin inclusion complexes, the next possible step to ensure 
successful singlet oxygen generation in aqueous media is to optimise both the 
experimental conditions and setup so that there is significant generation of singlet 
oxygen. Additionally, assessing the phototoxicity of the inclusion complexes to bacterial 
cultures and in biological media is another possible avenue of future research should 
progress be made in this regard. 
 The ability of BODIPY 8 to act as a pH-sensitive fluorescent probe was assessed in 
organic media, but the limitation in this regard is that the biological application of any 
molecule typically requires non-toxicity and water solubility or the ability to include the 
molecule in a water-soluble carrier. This creates a possible future research avenue for 
the application of BODIPY dyes as pH indicators for cellular events and as fluorescence 
probes to detect abnormal cells, particularly when included in any suitable water-soluble 
carrier such as cyclodextrins or micelles. 
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